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Summary 
In the thymus a specific subset of thymic stromal cells - medullary thymic epithelial cells 
(mTECs) - express a highly diverse set of tissue-restricted antigens (TRAs) representing 
essentially all tissues of the body, which is known as promiscuous gene expression (pGE). This 
allows self-antigens, which otherwise are expressed in a spatially or temporally restricted manner 
to become continuously accessible to developing T-cells thus, rendering them tolerant to most 
self-antigens. The scope of central tolerance is to a large extent dictated by this pool of 
promiscuously expressed genes. Lack of a single TRA can result in spontaneous organ-specific 
autoimmunity. Therefore, it is important to define the scope of pGE and 
parameters/mechanisms that regulate this gene pool.  
Promiscuously expressed genes display two prominent features: they are highly clustered in the 
genome and show a preference for TRAs. To link these features we focused on studying genes 
which are up-regulated in mature mTECs. The analysis was performed in mouse, rat and human 
in order to assess evolutionary conservation of pGE. Our analysis proceeded from the 
bioinformatic definition of TRA clusters, gene clustering and homology mapping via gene 
expression analysis using whole genome arrays to the in depth analysis of selected TRA clusters 
by RT-PCR at the population level. The mTEC compartment represents  a mosaic of clonally 
derived mTEC clusters undergoing continuous renewal, whereby the sets of genes expressed in 
single mTECs ultimately add up to a complete representation of the promiscuous gene pool at 
the population level. Hence, we wanted to elucidate what dictates pGE at the single cell level, i.e. 
whether it was random or subject to rules of co-expression.  
We observed that TRAs per se are clustered in the genome in all three species irrespective of 
structural relatedness or antigenic properties. Most of the clusters are localized in syntenic 
regions. In the thymus, the promiscuously expressed genes are enriched in TRAs that are 
partitioned into clusters, again conserved between species. These clusters harbor both TRAs and 
non-TRAs that are interspersed among each other. TRAs are preferentially regulated over non-
TRAs during mTEC differentiation. Moreover, genes within a particular gene cluster are subject 
to partial co-regulation. Based on these data, we propose these clusters to be the “operational 
genomic unit” of pGE in the thymus.  
Single cell studies of a mTEC subpopulation expressing a particular antigen revealed a 
deterministic component in the regulation of pGE. Co-expression groups in single cells not only 
defined intra-chromosomal but also inter-chromosomal (e.g. chromosome 1 and 19) gene co-
regulation. Strikingly, these co-expression patterns correlated with in situ co-localization of the 
respective chromosomal domains upon mTEC maturation as analyzed by fluorescence in situ 
hybridization. Taken together, our data show that pGE is highly conserved between species, 
maps to gene clusters and is governed by certain co-expression rules at the single cell level.  
  Zusammenfassung 
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Zusammenfassung 
Medulläre Thymusepithelzellen (mTEZ), ein spezieller Zelltyp des Thymus, exprimieren ein 
höchst diverses Repertoire an gewebespezifischen Antigenen (tissue restricted antigens, TRAs), 
welche (vermutlich) jedes Gewebe des Körpers repräsentieren. Dieses Phänomen ist als promiske 
Genexpression (pGE) bekannt. PGE ermöglicht es, Selbst-Antigene, welche sonst nur in 
peripheren Geweben örtlich und zeitlich begrenzt exprimiert werden, den T-Zellen während ihrer 
Entwicklung im Thymus permanent zugänglich zu machen und dadurch Toleranzinduktion 
gegenüber diesen TRAs zu gewährleisten. Selbst das Fehlen eines einzigen Selbstantigens im 
Thymus kann zu einer spontanen organspezifischen Auto-immunantwort führen. Daher ist es 
wichtig, den Umfang des im Thymus exprimierten Genpools im Detail zu bestimmen und die 
Regulation  dieser Genexpression  zu verstehen. 
Promisk exprimierte Gene zeigen zwei Charakteristika: Zum einen liegen sie im Genom 
größtenteils in Clustern vor, zum anderen sind die meisten von ihnen TRAs. Um eine mögliche 
Verbindung zwischen diesen Eigenschaften herzustellen, wurden Gene untersucht, deren 
Expression in reifen mTEZ im Vergleich zu unreifen mTEZ hochreguliert ist. Die Expression 
dieser Gene wurde in Maus, Ratte und Mensch vergleichend analysiert, um das Ausmaß der 
evolutionären Konservierung von pGE zu bestimmen. Die Analyse umfasste die 
bioinformatische Definition von TRA- und Gen-Clustern, das Erfassen von Homologien mittels 
genomweiter Genexpressionsanalysen und die detaillierte Untersuchung ausgewählter TRA-
Cluster mittels  RT-PCR auf der Ebene von Zellpopulationen. Diese Analysen ergaben, dass 
TRAs in allen untersuchten Spezies im Genom als Cluster organisiert sind unabhängig von ihren 
Funktionen und Struktur. Die meisten Cluster, die sowohl TRAs als auch Nicht-TRA beinhalten, 
liegen in syntenischen Regionen. Gene eines einzelnen Clusters war teilweise co-reguliert. TRAs 
in Clustern waren im Thymus häufiger exprimiert als Nicht-TRAs. Wir postulieren daher, dass 
diese Cluster die operationelle genomische Einheit darstellen, die der pGE im Thymus zugrunde 
liegt.  
Das mTEZ-Kompartiment setzt sich aus einem Mosaik von mTEZ-Klonen zusammen, die sich 
ständig erneuern. Da die Gesamtheit promisk exprimierter Gene in der mTEZ-Population sich 
aus der Summe der pGE der einzelnen mTEZ-Klone zusammensetzt, ist es notwendig, die 
Regulation von  pGE auf Einzelzellebene zu verstehen: Ist pGE auf Einzelzellebene ein völlig 
zufälliger Prozess oder werden Gene co-reguliert? Dazu wurden zusätzlich Analysen in 
Einzelzellen durchgeführt. Diese zeigten, dass Gengruppen in einzelnen Zellen entweder auf 
demselben oder auch auf unterschiedlichen Chromosomen co-reguliert werden. Dabei co-
lokalisierten die Genloci von gemeinsam regulierten Gene in situ, wie mittels FISH Analyse 
gezeigt werden konnte. Wir schließen aus diesen Ergebnissen, dass pGE neben einer 
stochastischen auch eine deterministische Komponente beinhaltet.  
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APS-1 autoimmune polyglandular 
syndrome type 1 
LPA linear polyacrylamide 
APC antigen presenting cell Lti lymphoid tissue inducer cell 
aRNA antisense RNA MACS magnetic cell separation 
ATP adenosine tri-phosphate MHC major histocompatibility complex 
BAC bacterial artificial chromosome mTEC medullary thymic epithelial cell 
BSA bovine serum albumin mTEChi mTEC expressing high levels of  
co-stimulatory molecules 
CD cluster of differentiation mTEClo mTEC expressing low levels of co-
stimulatory molecules 
cDNA complementary DNA PBS phosphate buffered saline 
CLSM confocal laser scanning 
microscopy 
PCR polymerase chain reaction 
cRNA complementary RNA PE phycoerythrin 
cTEC cortical thymic epithelial cell PerCP peridinin chlorophyll protein 
Cy  cyanine PFA paraformaldehyde 
DC dendritic cell pGE promiscuous gene expression 
DEPC diethylpyrocarbonate PI propidium iodide 
DN double negative psi pound per square inch 
DNA deoxyribonucleic acid qPCR quantitative PCR 
DNase deoxyribonuclease rpm revolutions per minute 
DNMT DNA-methyltransferase RAG recombinase activating genes 
dNTP deoxyribonucleoside triphosphate RANKL receptor activator for nuclear factor 
κ B ligand 
DP double positive RNA ribonucleic acid 
DTT dithiothreitol RPMI-
1640 
medium developed at Roswell Park 
Memorial institute 
dTTP deoxythymidine-triphosphate RT reverse transcription 
dUTP deoxyuridine-triphosphate Sav streptavidin 
EDTA ethylene diamine tetra acetic acid SC single cell 
eGE ectopic gene expression SD rats Sprague Dawley rats 
FACS fluorescence activated cell sorting SP single positive 
FISH fluorescence in situ hybridization SSC sodium saline citrate 
FITC fluorescein isothiocyanate TAE tris-acetate EDTA 
FCS fetal calf serum TCR T-cell receptor 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
TRA tissue-restricted antigen 
HPSF high pure salt free Treg regulatory T-cell 
KO knock-out WT wild type 
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1. Introduction 
The immune system is a remarkably versatile defense system that has evolved to protect multi-
cellular organisms from invading pathogens. The hallmark of all metazoan species is innate 
immunity, which primarily depends on the recognition of highly conserved pathogen associated 
molecular patterns (PAMPs) by germ line-encoded pattern recognition receptors. However, 
microorganisms continually develop new ways to evade host defense tactics that have been 
termed the “host-versus-pathogen arms race’’. This selective pressure presumably led to the 
evolution of a new, more sophisticated defense mechanism, called adaptive immune system 
(Cannon et al., 2004; Flajnik and Du Pasquier, 2004). The adaptive immune system is capable of 
specifically recognizing an apparently limitless variety of foreign invaders owing to its ability to 
generate an enormous variety of cells and molecules that act together in a dynamic network 
whose complexity rivals that of the nervous system.  
It was approximately 500 million years ago in jawed vertebrates that the adaptive immune system 
evolved the remarkable ability to mount specific immune responses to a virtually unlimited 
variety of antigens. The two arms of recombinatorial adaptive effector system are 
developmentally separated, but functionally intertwined lineages of clonally diverse lymphocytes. 
These are named T- and B-cells because they are generated in the thymus or in the avian bursa of 
Fabricius respectively (Cooper et al., 1965; Cooper and Alder, 2006). For antigen recognition, 
both T- and B-cells use the same type of immunoglobulin domain (Ig)-based receptors. The T-
cell receptors (TCR) and B cell receptors (BCR) are assembled during lymphocyte differentiation 
by somatic recombination of different variable (V), diversity (D) and joining (J) immunoglobulin 
(Ig) gene segments, imprecise V(D)J splicing, and insertion of non-template nucleotides at the 
junctions (Tonegawa, 1983; Yanagi et al., 1984). As a consequence of this random rearrangement 
process potentially harmful receptors that recognize self constituents are also generated. Thus, to 
eliminate these auto-reactive lymphocytes, self-tolerance mechanisms are invoked to distinguish 
foreign from self, which is a fundamental feature of the adaptive immune system.  
The T-cells which are one of the main players in adaptive immunity carry a highly diverse 
repertoire of TCRs which they use to recognize foreign- or self-antigens in combination with self 
major histocompatibility complex (MHC) (self-restriction of the T-cell repertoire). The 
generation, maturation and selection of this highly diverse T-cell repertoire occur in the thymus. 
In the thymus immature T-cells (designated thymocytes) undergo a strict quality control ensuring 
a repertoire of T-cells that under normal, i.e. healthy conditions does not attack and destroy host 
tissue (i.e. self-tolerant), but holds the competence to react to a vast range of foreign antigens. 
Thus, the function of the thymus which was only discovered in the early 1960s by Jacques Miller 
confers this fundamental self-tolerance (Miller, 1961). 
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1.1. The thymus 
1.1.1. Evolution of the thymus 
The appearance of the thymus in evolution is linked to the appearance of lymphocytes expressing 
highly diverse antigen-recognition receptors. T-cell development is strictly restricted to well-
organized three-dimensional microenvironments of a specialized organ-the thymus, while B-cell 
development proved rather flexible with regards to its site, occurring in the bursa of Fabricius in 
birds, Ileal Peyer’s patches in sheep, appendix in rabbits and bone marrow in mammals (Alitheen 
et al., 2010). The thymus evolved as the primary lymphoid organ to allow the generation of a large 
MHC-restricted T-cell repertoire. Only T-cells required an autonomous, physically separated 
organ, and not merely a niche to develop and confine the destructive potential of T-cells 
(Rodewald, 2008).  
Invertebrates and the most primitive vertebrates are not known to posses a thymus. Among 
vertebrates, the lowest showing key features of an adaptive immune system, such as re-arranging 
T- and B-cell receptor, RAG genes, MHC genes and a thymus, are the cartilaginous fish (jawed 
vertebrates, gnathostomes) like rays and sharks. The jawless (agnatha such as lamprey and 
hagfish), vertebrates have no thymus. They have been found to assemble diverse lymphocyte 
antigen receptor (VLRs) through gene conversion of leucine-rich repeat (LRR)-encoding modular 
units that are expressed on the surface of two distinct lymphocyte lineages (Cooper and Alder, 
2006; Guo et al., 2009). Thus, recombinatorial mechanisms for the generation of anticipatory 
receptors have evolved independently in both jawless and jawed vertebrates (Cooper and Alder, 
2006).  
The origin of the thymus in the inner layer of an embryonic gut ancestor is reminiscent of GALT 
(gut-associated lymphoid tissue), which is a key lymphoid structure in species prior to the 
appearance of a thymus. Thus, the thymus may have evolved as a GALT derivative (Du Pasquier, 
1993). In the most primitive thymus-bearing species i.e. cartilaginous fish (rays and sharks), the 
thymus anlagen are located in the second to sixth pouch, whereas they are found in the second 
pouch in frogs, in the second and third in reptiles, and in the third and/or fourth in bony fish, 
birds and mammals. Thus, species are flexible in positioning of the thymus anlage somewhere 
along the pharyngeal foregut endoderm. Numbers and positions of the final thymus or thymi 
may also vary. Chickens have seven, sharks five, and urodele amphibians (e.g. salamander) three 
thymus pairs, while many teleost fish species, anuran amphibians (e.g. frogs), and many mammals 
have only one thymus composed of two bilateral lobes (Rodewald, 2008). In the end, irrespective 
of the number and positioning, the function of the thymus is T-cell development and the 
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selective elimination of potentially auto-reactive T-cells that is likely to be universal throughout all 
jawed vertebrates (Hansen and Zapata, 1998).  
1.1.2. Cellular composition of the thymus  
The thymus is the primary site for T lymphopoiesis, providing the essential niches and signals for 
maturing T-cells not only during the fetal stages of development but throughout postnatal life. 
The thymic structure and cellular composition is conserved throughout evolution (Anderson and 
Jenkinson, 2001) into anatomical separate compartments which include the sub-capsular area, the 
cortex, the cortical-medullary junction and the medulla (Figure 1). Thymic epithelial cells (TECs) 
constitute the major component of the stromal compartment and can be subdivided according to 
their function, morphology and specific antigen profile into different subpopulations- the cortical 
(c) and medullary (m) TECs. The different TECs together with other stromal cells of 
hematopoietic (dendritic cells, macrophages) and non-hematopoietic origin (fibroblasts and 
endothelial cells) form a three dimensional meshwork (Boyd et al., 1993). The thymic stroma 
plays a key role at multiple stages of thymocyte development: on the one hand it ensures T-cell 
lineage specification of common lymphoid precursors and on the other hand it is essential for 
self-MHC restriction via positive selection and the elimination of auto-reactive T-cells via 
negative selection (Petrie, 2003; Starr et al., 2003). “Thymic-cross-talk” between the thymic 
stromal cells and developing thymocytes is essential to provide appropriate signals for promoting 
and regulating thymocyte development and in turn thymocyte-derived signals are essential for the 
development of the stromal cell compartment (van Ewijk et al., 1995; van Ewijk et al., 2000). 
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Figure 1 
Cellular composition of and traffic of thymocytes within the thymus 
In the post-natal thymus, a) circulating multi-potent lymphoid progenitors enter the thymus through the vasculature 
that is enriched around the cortico-medullary junction. This entry is regulated by (P)-selectin glycoprotein ligand 1 
(PSGL1). b) They migrate towards the capsule as CD4- CD8- double-negative (DN) thymocytes, which is regulated 
by chemokine signals through CXC-chemokine receptor 4 (CXCR4) and CC-chemokine receptor 7 (CCR7).  
c) Further migration to the subcapsular region is mediated by CCR9 signals. d) These DN thymocytes go through a 
transition from DN to DP which is marked by the up-regulation of the CD4 and CD8 co-receptors. The double 
positive (DP) CD4+ CD8+ thymocytes expressing appropriate TCRαβs, undergo positive selection. High-affinity 
interactions or lack of interactions result in deletion of thymocytes via apoptosis. e) Those that survive this selection 
differentiate into either CD4 or CD8 single-positive (SP) thymocytes. They show an increase in surface expression of 
CCR7, are attracted to the medulla by a gradient, where mTECs express CCR7 ligands. f) In the medulla, further 
selection (negative) of SP thymocytes includes the deletion of tissue-specific-antigen-reactive T-cells, survival of non-
self reactive T-cells and the generation of regulatory T-cells. g) Mature SP T-cells express sphingosine-1-phosphate 
receptor 1 (S1P1) through which the cells are attracted back to the circulation that contains a high concentration of 
sphingosine-1-phosphate. cTEC, cortical thymic epithelial cell; DC, dendritic cell; mTEC, medullary thymic epithelial 
cell. (Adapted from Takahama, 2006) 
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1.2. Thymocyte differentiation and selection 
Most of the hematopoietic cell lineages undergo differentiation in the bone marrow, whereas T- 
cells develop within the thymus. This process consists of multiple steps that require a relocation 
of developing lymphocytes into the thymus (Figure 1). During their journey through the thymus, 
developing thymocytes pass several checkpoints at which they either die or survive until they are 
released to join the peripheral T-cell pool as mature T-cells.  
1.2.1. Early T-cell development within the thymic cortex 
The seeding of the thymus with lymphoid progenitor cells occurs in the area close to the cortico-
medullary junction, where the vasculature is well developed (Lind et al., 2001). This mechanism is 
not completely understood, however it has been reported that the seeding into the adult thymus 
is regulated by the adhesive interaction between platelet (P)-selectin glycoprotein ligand 1 
(PSGL1), which is expressed by circulating lymphoid progenitor cells, and P-selectin, which is 
expressed by the thymic endothelium (Rossi et al., 2005). Interestingly, the entry of lymphoid 
progenitor cells into the thymus is not a continuous event but an intermittent and gated event 
that occurs in waves during embryogenesis and in adulthood (Le Douarin and Jotereau, 1975; 
Havran and Allison, 1988; Fossa et al., 2001).  
Upon entry into the thymus, T-lymphoid progenitor cells begin to differentiate, proceeding 
through the double-negative (DN) stages of T-cell development (Benz et al., 2008).  These cells 
lack the expression of CD4 and CD8 and are named CD4/CD8 double-negative thymocytes 
(Scollay et al., 1988). The DN T-lymphoid progenitor cells are commonly identified by the 
expression profiles of CD25 and CD44 (Pearse et al., 1989; Shinkai et al., 1992) and sequentially 
go through the DN1 (CD44+CD25-), DN2 (CD44+CD25+), DN3 (CD44-CD25+) and DN4/pre-
DP (CD44-CD25-) stages. The survival and development of DN thymocytes are supported by 
Notch ligands (delta-like 4) and cytokines such as interleukin-7, both of which are produced by 
cTECs (Zuniga-Pflucker, 2004). 
Along this developmental process, DN thymocytes migrate outward from the cortico-medullary 
junction to the sub-capsular region of the cortex (Lind et al., 2001; Petrie, 2003). Chemokine 
receptors, especially CXCR4, CCR9 and CCR7, are important in this outward migration of DN 
thymocytes (Plotkin et al., 2003; Benz et al., 2004; Misslitz et al., 2004). A prerequisite for 
directional cell migration is not only a gradient of an attractant, but also a substrate for cell 
adhesion. Adhesion molecules, such as integrins a4b1 and a4b7 expressed by DN thymocytes and 
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vascular cell adhesion molecule-1 (VCAM-1) expressed by cTECs mediate this adhesion. In 
addition, chemokines are critical for the “crawl” and are involved in the movement of DN 
thymocytes to the sub-capsular region (Prockop et al., 2002).  
DN1 cells have by far the longest single period of intra-thymic residence lasting for up to two 
weeks until they progress to the DN2 stage, during which they expand by about 1000-fold 
(Egerton et al., 1990; Porritt et al., 2003). In the thymic cortex, on their way to the sub-capsular 
region, DN thymocytes begin to rearrange their Tcrβ locus. The cells that succeed in generating 
an in-frame Tcrβ rearrangement begin assembling TCRβ  and along with the invariant pre-TCRα 
chain form the cell-surface pre-TCR complex (von Boehmer and Fehling, 1997). This first 
checkpoint of thymocyte development known as β-selection allows cells to progress beyond the 
DN3 stage. This is marked by an up-regulation of the CD4 and CD8 co-receptors (Petrie and 
Zuniga-Pflucker, 2007). The transition from CD4/CD8 double negative to double positive 
immature T-cells is referred to as DN4 or pre-DP stage. They show a low expression of CD25 
and CD44 and are immediate precursors to CD4/CD8 double-positive (DP) thymocytes (Petrie 
and Zuniga-Pflucker, 2007). The rearrangement of the TCRα gene locus is initiated only after a 
massive expansion of cells carrying a functional pre-TCR. During this expansion phase, the Rag 
genes are turned off to prevent any premature rearrangements of the TCRα locus. The 
expression of the pre-TCR complex on the cell surface along with Delta-Notch interactions, 
initiate the signals for further development to DP thymocytes that express αβTCR antigen 
receptors (Zuniga-Pflucker, 2004). The DP thymocytes expressing a αβTCR in the cortex 
constitute the unselected repertoire of T-cells (Jameson et al., 1995).  
1.2.2. Positive selection 
Highly motile DP thymocytes pause to interact through their TCR with peptide-MHC complexes 
that are expressed on cTECs (Bousso et al., 2002; Ehrlich et al., 2009). Following TCR recognition 
of peptide-MHC ligands with low-affinity, DP thymocytes receive signals for survival and further 
differentiation into single-positive (SP) thymocytes. This second checkpoint, referred to as 
positive selection, enriches for ‘useful’ T-cells that recognize self-MHC molecules. High-affinity 
interactions result in deletion of thymocytes via apoptosis, this process contributes to the deletion 
of self-reactive T-cells. DP thymocytes which fail to receive TCR signals are also destined to die 
at this stage. Only 3-5 % of developing thymocytes survive this checkpoint of T-cell development 
at the cortical DP-thymocyte stage (Egerton et al., 1990; Goldrath and Bevan, 1999).  
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1.2.3. CD4/CD8 lineage commitment 
Concomitantly with positive selection occurs the so-called CD4/CD8 lineage choice in which 
thymocytes either differentiate into MHCII-restricted CD4 or MHCI-restricted CD8 single 
positive (SP) T-cells. This decision-making process is not yet fully understood. Two models have 
been proposed based on a stochastic or instructive mechanism of lineage choice. 
Both models are based on the assumption that the selective termination of one or the other co-
receptor irreversibly defines the lineage fate. The stochastic selection model suggests that the 
termination of CD4 or CD8 co-receptor gene expression during positive selection of DP 
thymocytes occurs randomly and thymocytes receive a second TCR rescue signal in case the 
expression of the right co-receptor was maintained, otherwise they die. The instructional model 
suggested that MHCI- and MHCII-restricted TCR signals are distinct from one another with 
respect to signal strength. A modification of the instructive model is the kinetic model which 
poses that the duration of the TCR signal and not the signal strength determines the lineage 
choice. TCR signals of long duration result in CD4 expression, short TCR signals result in CD8 
expression. The kinetic model is the most compatible with experimental data (Singer et al., 2008).  
The positively selected thymocytes then begin relocating from the cortex to the medulla 
(Witt et al., 2005). The CCR7 ligands (CCL19 and CCL21), predominantly produced by mTECs, 
were shown to be involved in the chemotactic attraction of these cells into the medulla  
(Ueno et al., 2004). It was recently shown that CCR7-mediates chemotaxis of CD4 SP cells 
towards the medulla can be separated from migration into the medulla which is under the control 
of distinct G protein-coupled receptors (GPCR). Both CCR7 and GPCR act in concert to 
properly target CD4 SP cells to the medulla (Ehrlich et al., 2009). 
1.3. Central tolerance 
It was more than 100 years ago that the clonal selection theory by Paul Ehrlich first 
conceptualized the problem of self-reactivity (‘horror autotoxicus’) as inherent to the adaptive 
immune system and postulated the existence of mechanisms (contrivances) that could prevent 
deleterious self-reactivity. It took eighty years of work and great advance in immunology until the 
paradigm of “developmental tolerance” was demonstrated in the chicken/quail model by  
Le Douarin and associates. They found that embryonic tissues from quail engrafted into age-
matched chickens were rejected soon after birth and more importantly, this graft rejection could 
be prevented by solely transplanting thymic rudiments from the graft donor (Ohki et al., 1987). 
Subsequent studies in mice demonstrated that transplantation of the thymus anlage, i.e., pure 
thymic epithelium, confers tolerance to transplanted tissues such as limb buds or skin  
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(Salaun et al., 1990; Le Douarin et al., 1996; Salaun et al., 2005). In addition, neonatal thymectomy 
up to day 3 was shown to lead to a multiorgan autoimmune syndrome including gastritis, 
sialadenitis, hepatitis, and diabetes (Asano et al., 1996). At that time, the mechanism how thymic 
epithelium can induce tolerance to a wide spectrum of peripheral antigens was not understood. In 
1989 Linsk et al. proposed on pure theoretical grounds that the thymus represents a patch quilt of 
ectopically expressed genes (Linsk et al., 1989).  
It was long believed that the pool of self-epitopes available for T-repertoire selection comprises 
ubiquitous antigens and antigens specific to the various types of thymic antigen-presenting cells 
(APCs). Moreover, self-antigens were known to gain access to the thymus either via the 
circulation or by association with immigrating cells (Kyewski et al., 1984; Klein and Kyewski, 
2000b; Klein et al., 2009). The first impactful evidence for ectopic expression of insulin in wild 
type mice was reported by Hanahan and colleagues (Jolicoeur et al., 1994) in a study of tolerance 
toward antigens implicated in diabetes. This seminal study was supported over the years by 
several reports showing the existence of specialized peripheral antigen expressing cells in the 
thymus (Pribyl et al., 1996; Wakkach et al., 1996; Egwuagu et al., 1997; Kojima et al., 1997; Pugliese 
et al., 1997; Hanahan, 1998; Heath et al., 1998; Klein et al., 1998; Sospedra et al., 1998; Mallet et al., 
1999; Klein et al., 2000; Diez et al., 2001; Bruno et al., 2002). Direct proof of the expression of a 
highly diverse set of TRA (tissue-restricted antigens) representing essentially all tissues of the 
body by medullary thymic epithelial cells (mTECs) within the thymus was shown by two groups 
(Derbinski et al., 2001; Anderson et al., 2002). This phenomenon of “promiscuous gene 
expression” (pGE) allows self-antigens, which are expressed in a spatially or temporally restricted 
manner (such as pregnancy- or puberty-associated self-antigens) to become continuously 
accessible to developing T-cells (Derbinski et al., 2005), thus rendering the T-cell repertoire self-
tolerant (pGE, is described in more detail in later chapters).  
Two modes of how auto-reactive T-cells are directly rendered harmless were shown; first T-cells 
are clonally deleted from the repertoire, a hallmark of T-cells central tolerance (negative selection) 
and second potentially harmful T-cells are silenced by undergoing anergy. “Clonal anergy” 
involves the functional inactivation of self-reactive T-cells. There are several mouse models 
supporting this model (Ramsdell et al., 1989). It should be added that the molecular definition of 
anergy lags behind its functional characterization (Mueller, 2010). 
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1.3.1. Negative selection 
Negative selection is the third and last checkpoint, which is crucial for the induction of tolerance 
to self-antigens (central T-cell tolerance). In this process, autoreactive SP thymocytes are 
removed from the repertoire. In 1987, Marrack et al. showed that T-cells carrying the Vβ17a TCR 
chain were deleted in animals expressing super-antigens derived from the mouse mammary 
tumor virus and presented in the context of I-E MHC molecules, while the same T-cells normally 
matured and migrated to the periphery in the absence of super-antigens. Thus, for the first time 
clonal deletion of T-cells that recognized antigen in the thymus was reported  
(Kappler et al., 1987). The clonal deletion model was further validated in various TCR transgenic 
mouse models expressing a receptor for a self-antigen along with the corresponding self-antigen 
(e.g. Hemagglutinin, HA) or a naturally expressed antigen (e.g. H-Y) (Starr et al., 2003).   
SP thymocytes migrating from the cortex to the medulla are negatively selected through high-
affinity interactions with peptide-MHC presenting APCs, which lead to apoptosis. This clonal 
deletion of self-reactive thymocyte occurring mainly in the medulla is induced by mTECs and 
DCs. MTECs do so by promiscuous gene expression while DCs can cross-present mTEC 
derived self-peptides (Lo and Sprent, 1986; Marrack et al., 1988; Matzinger and Guerder, 1989; 
Gallegos and Bevan, 2004; Kyewski and Derbinski, 2004; Koble and Kyewski, 2009). Gallegos  
et al. showed that presentation of Ova peptide exclusively by mTECs allowed deletion of cognate 
CD8+ T-cells. It was only for the deletion of Ova specific CD4+ T-cells, that cross-presentation 
of Ova on DCs was indispensable (Gallegos and Bevan, 2004). Thus, clonal deletion can be 
induced autonomously by mTECs and DCs, but different thresholds for deletion may exist.   
Several co-stimulatory cell surface molecules like CD28, CD5, CD43, CD40 and Fas have been 
described to play a role in the induction of negative selection (Punt et al., 1994; Kishimoto and 
Sprent, 1999; Williams et al., 2002). It has also been reported that CCR4 ligands, TSLP, CCL17 
and CCL22 expressed in the medulla by Hassall’s corpuscles, DCs and mTECs play a role in 
establishing central tolerance, though the precise function still remains obscure (Takahama, 
2006). 
The SP thymocytes spend approximately 4 days in the medulla where they presumably scan a 
sufficient number of APCs to cover the entire self-antigen repertoire presented by these APCs 
before being exported from the thymus (McCaughtry et al., 2007). Negative selection is believed 
to occur mainly in the medulla or at the cortical-medullary junction (Sprent, 2005). This process 
involves several synergistic events including the activation of the JNK/p38 pathways which leads 
to the induction of the pro-apoptotic factors- BIM, Bax and Bak, ultimately resulting in induced 
cell death which is the basis of negative selection (Bouillet et al., 2002; Rathmell et al., 2002).  
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1.3.2. Dominant tolerance - regulatory T-cells 
The mechanisms of T-cell tolerance described above act by elimination or inactivation of a given 
T-cell specificity and thus can be defined as “recessive” (cell-intrinsic) mechanisms. Yet self-
reactive T-cells exist in the normal periphery despite the existence of deletion operative in the 
thymus (Sakaguchi et al., 2007). Obviously, central tolerance mechanisms do not cripple all self-
reactive T-cells, thus raising the question of the existence of additional mechanisms of tolerance 
to keep these cells in check. Efforts in the 1980s propounded another mechanism of self- 
tolerance, namely “dominant tolerance” (trans-acting), in which regulatory T-cells actively and 
dominantly suppress lymphocytes, in particular the self-reactive T-cells that exist in the normal 
periphery. Three main cell types have been considered as potential regulatory T-cell subsets: 
CD4+CD25+ regulatory T-cells (Treg), CD8αα+ intestinal epithelial lymphocytes and natural killer 
T (NKT) cells. All are thought to be induced by cognate recognition of self-peptide-MHC in the 
thymus (Baldwin et al., 2004; Hogquist et al., 2005).   
It was in the early 1970s that Gershon demonstrated that T-cells not only enhance but also 
suppress immune responses to exogenous antigens (Gershon and Kondo, 1970). Treg cells were 
first recognized as natural controllers of self-reactive T-cells and characterized by CD25+CD4+ 
and were later shown to specifically express the transcription factor FoxP3. The deficiency of 
Tregs produces autoimmune disease and also other aberrant or excessive immune responses to 
non-self antigens (Sakaguchi, 2005).  
Foxp3+ Treg cells make up 5-10 % of the peripheral CD4+ T-cell repertoire and are generated in 
the thymus (natural Tregs) but also in the periphery from naive T-cells (induced Tregs). In the 
thymus, Foxp3+ cells are detected as early as late CD4+CD8+ double-positive to CD4+CD8-
single-positive stages (Fontenot et al., 2005). The interaction of developing thymocytes with 
thymic stromal cells activates a transcriptional program in parallel with or upstream of Foxp3. 
Once the Foxp3 gene is switched on, Foxp3 may stabilize and sustain the Treg cell phenotype 
and confer suppressive activity (Gavin et al., 2007). It has been suggested that Treg fate is 
instructed by high-affinity/avidity self-reactive TCRs for self-antigens, which is just below the 
threshold for negative selection (Maloy and Powrie, 2001; Hogquist and Moran, 2009), as 
discussed in the next chapter (Figure 2). Recent studies show that TCR repertoires of Treg cell 
and conventional T-cell overlap, although according to different studies the extent of overlap 
varies (Pacholczyk et al., 2006; Pacholczyk et al., 2007). Thus, it appears that additional signals and 
molecules seem to play a role in the branching of Treg lineage from the conventional developing 
thymocyte.  
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MTECs were hypothesized to be the major Treg-inducing cells but other APCs such as cTECs or 
DCs were also considered (Bensinger et al., 2001; Watanabe et al., 2005). The absence of mature 
mTECs due to deficiency of NF-κB kinase or TRAF6, which transduce CD40 signals from the 
TNF receptor family, hampers Treg cell development (Kajiura et al., 2004; Akiyama et al., 2005). 
Aschenbrenner et al. directly showed mTECs to be able to generate Tregs (Aschenbrenner et al., 
2007). Presently it is known that thymic epithelial cells as well as different thymic DC-subtypes 
can efficiently induce Treg development of immature thymocytes, albeit strikingly different 
optimal doses of cognate antigen were needed in in vitro studies (Wirnsberger et al., 2009). A 
combination of factors, TCR affinity/avidity and the time point of Treg induction by different 
APCs seem to matter. 
Notably, Treg cell deficiency and Aire deficiency produce a similar spectrum of autoimmune 
diseases (Anderson et al., 2002; Kuroda et al., 2005). It is supposed, however not formally shown, 
whether Aire deficiency affects the generation of tissue-restricted antigen-specific Foxp3+ Treg 
cells in addition to its established effect on negative selection of tissue-restricted antigen-specific 
self-reactive T-cells. The significance of central tolerance processes has been highlighted in two 
inherited autoimmune syndromes. In both cases, the affected molecules are transcriptional 
regulators that are crucial for these two distinct central-tolerance mechanisms (recessive and 
dominant): mutations in the autoimmune regulator-AIRE gene lead to defective pGE and as a 
result a defective clonal deletion of auto-reactive T-cells resulting in a multi-organ syndrome 
known as autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) 
(Villasenor et al., 2005), whereas mutations in the forkhead box P3 (FOXP3) gene impairs the 
development of Treg cells causing immune deficiency-polyendocrinopathy-X-linked syndrome 
(IPEX) (Sakaguchi, 2005). Although, there are various peripheral mechanisms (not described in 
this thesis) that control self-reactive lymphocyte, central-tolerance mechanisms, are essential for 
the maintenance of self-tolerance. Foxp3+ Treg cells bridge central and peripheral tolerance. The 
two tolerance mechanisms are complementary as  Aire-/-Foxp3-/- mice show a faster and more 
extensive disease than either Aire-/-Foxp3+/+ or Aire+/+Foxp3-/- mice (Chen et al., 2005; Mathis 
and Benoist, 2010).  
1.4. Models of selection of the T-cell repertoire which is self-MHC 
restricted and self-tolerant 
At present there are two hypotheses based on the avidity or the affinity of the TCR-peptide-
MHC interaction. The avidity model predicts that the quantity of peptide-MHC complexes 
expressed by cTECs dictates whether a thymocyte expressing an interacting TCR will be 
positively selected or deleted, whereas the affinity model instead postulates a crucial role of the 
quality of the individual TCR-peptide-MHC interaction. Fetal thymic organ culture (FTOC) with 
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very low concentrations of antigenic peptide could mediate positive selection, while high avidity 
interactions promoted cell death, thus, supporting the avidity model (Sebzda et al., 1994). Other 
studies clearly speak in favor of the affinity hypothesis. Irrespective of whether the selecting 
peptide was related or not, in vitro studies supported the idea that the TCR affinity for ligands 
mediating positive selection was much lower than for negative selection (Hogquist et al., 1994). 
More recent refinements of the affinity model suggest a very small window of affinity defining 
whether a thymocyte is positively or negatively selected (Daniels et al., 2006). Additionally, 
thymocytes having a TCR with an affinity too low to interact sufficiently with any self-
protein/MHC complex undergo apoptosis, an event also termed as ‘death by neglect’. 
Thymocytes having a high affinity (higher than those positively selected but lower than those 
negatively selected) may become natural Tregs (Figure 2). Nevertheless, Tregs require additional 
signals to commit to the Treg lineage.  
A recent study by Hinterberger, M. provided evidence for the avidity model of Treg induction. 
She showed that high antigen dose presented by mTECs lead to deletion of specific T-cells, 
whereas lower antigen doses on mTECs favored Treg development at the expense of negative 
selection. The optimal antigen dose might vary between different TCR affinities as well as 
between different APC, i.e. DC and mTECs. Thus, there is a window of avidity for the 
development of Tregs that might partially overlap with positive selection or negative selection. 
This could explain why negative selection and Treg induction of T-cells with the very same TCR 
occurs in parallel in vivo (Hinterberger, 2009). There appears to be a balance between Treg 
induction and negative selection, which is shifted to the one or the other direction depending on 
the availability of the given antigen and the overall avidity.  
  Introduction 
13 
 
Positive
Selection
Negative
Selection
Treg
Death by
Neglect
Affinity/Avidity
setyco
myhTforeb
mu
N
 
Figure 2 
The affinity/avidity model of thymocyte selection  
The affinity/avidity of the T-cell receptor for self-peptide-MHC ligands is a crucial parameter that drives the 
developmental outcome of T-cell selection. Progenitors having no affinity or very low affinity will die by neglect. 
This is the fate of most thymocytes. If the TCR has a low affinity/avidity for self-peptide-MHC, the progenitor 
survives and is positively selected. If the progenitor has a higher affinity/avidity for self-peptide-MHC, it may lead to 
clonal deletion or differentiate into a ‘regulatory’-cell phenotype-Treg. It is not exactly known what determines 
whether an individual T-cell is tolerized by negative selection or is selected to become a regulatory T-cell. (Adapted 
from Hogquist et al., 2005) 
 
Another controversial issue of T-cell selection is the nature of the peptides presented in the 
cortex that are required for positive selection. The so-called “altered peptide hypothesis” 
suggested that the ligands presented by cTECs differ from those presented in the medulla and in 
the periphery. Previous findings did not support an altered peptide hypothesis, though several 
recent studies changed this view. They indicate that cTECs generate MHC-bound peptides 
through pathways distinct from other APCs (i.e. peripheral and thymic medullary, also mTECs) 
(Klein et al., 2009). First evidence for a distinct proteolytic pathway was the detection of a cTEC-
specific endoprotease, Cathepsin L that was critical for CD4+ T-cell development, presumably 
generating peptides for MHCII suitable for positive selection (Nakagawa et al., 1998). Similarly, a 
cTEC-specific serine protease TSSP was identified, whose inactivation lead to the decreased 
positive selection of some transgenic TCRs (Gommeaux et al., 2009). Recently, a cTEC-specific 
thymoproteosome was identified which is essential for normal CD8 T-cell development (Murata 
et al., 2007; Nitta et al., 2010). Furthermore, another study by the Klein group showed the 
  Introduction 
14 
importance of macroautophagy in the generation of certain but not all peptide-MHCII 
complexes for positive selection (Nedjic et al., 2008). It is argued that the generation of a unique 
set of self-peptides for positive selection would prevent a disproportionately large fraction of SP 
cells to be subject to clonal deletion due to the re-encounter of the same/shared peptides on 
mTECs or DCs that promoted their positive selection. Such an “excessive” loss of T-cells could 
have resulted in an evolutionary pressure on cTECs to evolve mechanisms for an altered peptide 
generation (Klein et al., 2009).  
1.5. MTEC differentiation and promiscuous gene expression (pGE) 
In order to render T-cells tolerant to most self-antigens, developing T-cells are presented with a 
comprehensive repertoire of antigens by thymic APCs including spatially and temporally 
restricted antigens. It was in 1989 that Linsk et al. proposed that the thymus represents a patch 
quilt of ectopically expressed genes (Linsk et al., 1989). Efforts since then put forth the present 
scenario in which a specific subset of thymic stromal cells - mTECs - express a highly diverse set 
of tissue-restricted antigens (TRAs) representing essentially all tissues of the body, a phenomenon 
which is known as “promiscuous gene expression” (pGE) (Derbinski et al., 2001; Anderson et al., 
2002). This allows self-antigens to become continuously accessible to developing T-cells.  
PGE is a characteristic feature of mTECs, though a less pronounced expression of tissues 
specific transcripts could be detected in other thymic APCs; mTECs show the highest expression 
of promiscuous genes, followed by cTECs, thymic DCs and macrophages (Gotter et al., 2004; 
Derbinski et al., 2005). MTECs are highly heterogeneous with regard to ectopic gene expression 
as only 1-3 % of all mTECs express a given antigen at the protein or mRNA level (Smith et al., 
1997; Hanahan, 1998; Derbinski et al., 2001; Klein et al., 2001; Avichezer et al., 2003; Chentoufi et 
al., 2004; Cloosen et al., 2007; Taubert et al., 2007; Derbinski et al., 2008).  
1.5.1. MTEC development  
During mouse development, the thymic anlage arises from the third pharyngeal pouch around 
E10, with the potential to generate both cortical and medullary structures (Bennett et al., 2002). 
Recent studies indicate that a common TEC progenitor can give rise to both lineages during 
embryonic thymogenesis and during adulthood (Bleul et al., 2006; Rossi et al., 2006). The early 
thymus development occurs independently of thymocytes, showing that TEC differentiation is 
either cell autonomous or involves input from additional non-hematopoietic and/or non-T- 
lineage hematopoietic cells (Klug et al., 2002; Jenkinson et al., 2005). In addition, it was found that 
the neural crest-derived mesenchyme and its product, fibroblast growth factor (FGF) is crucial 
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for early thymus organogenesis and thymus function (Jenkinson et al., 2003). A member of the 
forkhead family of transcription factors, Foxn1 is necessary to direct differentiation of bipotential 
progenitor cells into fully functional TECs and to date is the only marker that identifies early 
thymic epithelial cell commitment (Nehls et al., 1996; Bleul et al., 2006). Reversion of a 
conditional allele of Foxn1 to wild-type function in single cells in vivo leads to the formation of 
either delineated mTEC clusters (“clones”), cTEC clusters or both suggesting the existence of bi- 
and uni-potent precursors in the postnatal thymus. Hence, from these data one can envisage two 
scenarios, the first being a self-renewing bipotent precursor that gives rise to two lineage-
committed and transient precursors without self-renewing capacity (Figure 3). Alternatively, a 
committed precursor may have limited self-renewing capacity thus replenishing a finite precursor 
pool throughout adult-hood without resorting to bipotent TEC stem cells (Anderson et al., 2007).  
MTECs can be subdivided into three populations based on their expression of the co-stimulatory 
molecules CD80, MHCII and the transcriptional regulator Aire with the sequential order of 
differentiation: CD80loMHCIIloAire- mTECs, CD80hiMHCIIhiAire- mTECs and 
CD80hiMHCIIhiAire+ mTECs. PGE increases in this order (i.e. the ability to express a larger and 
more diverse array of TRAs), being highest in Aire+ mTECs (Figure 3). PGE is largely governed 
by the transcriptional regulator Aire and is crucial for central tolerance (Anderson et al., 2002; 
Derbinski et al., 2005; Johnnidis et al., 2005; Gray et al., 2007).  
There have been debates as to whether MHCIIhi expressing mTECs represent the most mature 
terminally differentiated cell or immature cell subset. Two models have been proposed: the 
‘‘developmental or progressive restriction model’’ contends that immature mTECs transcribe the 
greatest number and diversity of promiscuous genes, and can be thought of as ‘‘multi-potential.’’ 
As a consequence of Aire expression, the cells would be provoked to differentiate according to 
peripheral epithelial cell type specific programs, during which each mTEC would follow one 
particular pathway and pGE would be progressively restricted to adhere to that program (Gillard 
and Farr, 2005). An alternative explanation, the ‘‘terminal differentiation model’’, proposes a 
hierarchy in pGE based on the mTEC differentiation stage: as these cells mature from an  
Aire-CD80loMHCIIlo (immature) stage to the end-stage Aire+CD80hiMHCIIhi (mature), they 
would transcribe and display the highest degree and diversity of pGE. According to this model, 
single mTECs would express TRAs of mixed tissue origin rather than emulating cell lineage-
affiliated patterns (Derbinski et al., 2005). In recent years there has been accumulating evidence 
that strongly supports the ‘‘terminal differentiation model’’. For example Gray and colleagues 
showed that MHCIIlo mTECs contain actively dividing cells while Aire+ MHCIIhi mTEC cells are 
post-mitotic and undergo apoptosis within a few days (Gray et al., 2007). The turnover of 
MHCIIhi mTECs was recently shown to be around 3 weeks (Gabler et al., 2007). This post-
mitotic cell population had a longer half-life in the absence of Aire (in Aire-/- mice). Thus, Aire 
has been implicated in mediating apoptosis in post-mitotic mTECs (Gray et al., 2007; Dooley et 
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al., 2008). It remains an unresolved issue why Aire+ mTECs are driven into apoptosis. One 
possible explanation would be that the overload of the transcription and translation machinery 
(due to pGE) may lead to apoptosis of Aire+ mTECs and the other would be that Aire promotes 
DNA double-stranded breaks, that would incite the DNA-damage response, thus providing an 
explanation for induction of mTEC death (Kyewski and Derbinski, 2004; Ferguson et al., 2008; 
Abramson et al., 2010).  
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Figure 3 
Development and differentiation of TEC subpopulations   
CTECs and mTECs are derived from a common self-renewing bipotent progenitor that gives rise to two lineage-
committed, transient precursors with/without self-renewing capacity. Further, the progenitor differentiates from 
immature MHCIIlo mTECs to Aire- MHCIIhi mTECs to finally form the mature Aire+ MHCIIhi mTECs. During 
embryogenesis mTECs receive critical RANKL signals from lymphoid tissue inducer cells. Postnatally the CD4 SP 
thymocytes provide RANKL, CD40 and lymphotoxin signals. As the mTECs mature, the level of pGE increases and 
finally terminally differentiated Aire+ MHCIIhi mTECs are driven into apoptosis (Adapted from Tykocinski et al., 
2008). 
The identification of precursor-progeny relationships and different stages of mTECs that are 
developmentally connected is important in elucidating the checkpoints that regulate formation of 
thymic microenvironments and provides an opportunity to identify the molecular mediators. 
Early TEC development is independent of thymocytes, proper cTEC and mTEC development 
however requires “cross-talk” with T-cells. Several molecules and pathways have been implicated 
in mTEC development. The NF-κB pathway plays an important role in mTEC development. 
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Inactivation of the TNF receptor-associated factor TRAF6 or the NF-κB complex component 
RelB and NF-κB inducing kinase (NIK) severely disrupted mTEC development and medulla 
formation (Burkly et al., 1995; Boehm et al., 2003; Kajiura et al., 2004; Akiyama et al., 2005; 
Tykocinski et al., 2008).  Also, the receptor activator of NF-κB (RANK) expression by mTECs, is 
directly responsible for differentiation of Aire+ mTECs (Rossi et al., 2007). During fetal thymus 
development, lymphoid tissue inducer cells were identified as a key population of RANK ligand 
(RANKL)-expressing cells. Subsequent studies have shown a role for RANK and CD40 in 
postnatal thymic maintenance and development of adult mTECs (Akiyama et al., 2008; Hikosaka 
et al., 2008; Irla et al., 2008). Interestingly in the adult thymus both RANKL and CD40L are 
provided by CD4+CD8- thymocytes (Hikosaka et al., 2008; White et al., 2008). The lymphotoxin-β 
receptor (LTβ-R) was also initially thought to induce development of Aire+ mTECs (Chin et al., 
2003), though others showed that this was not the case although LTβ-R signalling clearly 
influences some aspects of mTEC development (Boehm et al., 2003; Martins et al., 2008; Seach et 
al., 2008). Collectively these data imply the persistence of a common TEC progenitor throughout 
life that can finally differentiate into mature cTEC and mTEC lineages through signalling 
pathways that are non-redundant but complementary and share common second messengers.  
1.5.2. The role of Aire in pGE 
The importance of the transcriptional regulator Aire in tolerance was revealed in the genetic 
analysis of a rare autosomal recessive disorder, autoimmune polyendocrinopathy-candidiasis 
ectodermal dystrophy (APECED). Over 60 mutations have by now been localized in the AIRE 
gene of different APECED patients (Mathis and Benoist, 2009). Affected patients develop a 
spontaneous autoimmune disease targeted primarily at endocrine organs including the 
parathyroids, adrenals, thyroid, ovaries and pancreatic islets (Vogel et al., 2002). After the 
generation of Aire-deficient mice, it became clear that Aire is directly linked to central tolerance 
and loss of Aire resulted in the development of multi-organ immune infiltrates and 
autoantibodies (Anderson et al., 2002; Ramsey et al., 2002; Kuroda et al., 2005). Within the 
thymus, several studies have consistently demonstrated that Aire is restricted to mTECs and DCs 
(Derbinski et al., 2001; Anderson et al., 2002). It was these initial observation that lead to the 
speculation that Aire might control TRA expression in the thymus (Klein and Kyewski, 2000a). 
This was confirmed by detailed analysis using microarrays. Aire controls the expression of a large 
set (hundreds or thousand) of TRAs in mTECs (Anderson et al., 2002; Derbinski et al., 2005; 
Johnnidis et al., 2005). It was however observed that even lack of a single TRA can result in 
organ-specific autoimmunity as shown in the case of an eye-specific antigen (IRBP), stomach-
specific antigen (Mucin 6) and insulin (DeVoss et al., 2006; Gavanescu et al., 2007; Fan et al., 
2009). 
  Introduction 
18 
Aire targets an unusually diverse set of genes that are highly enriched in tissue-specific genes and 
preferentially clustered in the genome. The precise molecular mechanism of Aire’s action is still 
unclear. It was observed that Aire is necessary but not sufficient for transcription of its target 
genes in single-mTECs and their expression appears to be stochastic (Derbinski et al., 2008). 
Moreover, a number of Aire-dependent genes have been identified which are expressed 
independently of their tissue-specific transcription factors in mTECs. Regulation of these genes 
thus differs between the peripheral tissue and their ectopic expression in mTECs. It is therefore 
perhaps not surprising that different transcriptional start sites are used in the thymus and 
periphery (Villasenor et al., 2008).  
Previous studies from several groups show Aire to have multiple potentials (Peterson et al., 2008; 
Tykocinski et al., 2008; Kyewski and Peterson, 2010). Recently, the Mathis group screened for 
Aire interaction partners and identified a large set of proteins that associate with Aire. They fell 
into four major functional classes involving nuclear transport, chromatin binding/structure, 
transcription and pre-mRNA processing. They speculate that after translocation in the nucleus 
through the nucleopore complex, Aire preferentially localizes to transcriptionally inert chromatin 
regions via binding to unmethylated H3/4 tails, thus conferring targeting of specific genes. 
Within these regions, it interacts with TOP2a to promote DNA double-stranded breaks, activates 
DNA-PK and other partners and in turn attracts chromatin remodeling complexes. Several of 
these Aire-interactors might also participate in the so-called ‘‘eviction complex’’ that removes 
H2A-H2B dimer in front of RNAPII as it proceeds along nucleosome-packaged DNA, and 
reassembles the octamer behind, thereby enhancing elongation efficiency. Additionally, Aire-
containing complex would promote the accumulation of fully mature mRNA by re-activating 
RNAPII stalled at the 5’ end, by suppressing improperly initiated transcripts, and/or by 
stabilizing short-lived pre-mRNAs through proper splicing (Abramson et al., 2010). 
Two recent papers showed the expression of Aire in peripheral lymphoid stromal cells. Lee et al.  
described a population of lymph node stromal cells expressing a repertoire of TRA transcripts 
that overlaps quite a bit, with that of thymic mTECs (Lee et al., 2007). Gardner et al. also found 
TRA transcripts in stromal cells residing in both the lymph nodes and spleen (Gardner et al., 
2008). The repertoire of TRA transcripts in these stromal cells appeared to be of limited diversity 
and seemed rather distinct from that of thymic mTECs. Till date the physiological relevance of 
this phenomenon is unknown, though there are speculations that Aire participates in peripheral 
tolerance. 
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1.6. Objective of this study 
In view of the essential role of pGE by mTECs in negatively selecting T-cells, this project aimed 
at studying certain aspects of the regulation of pGE. The scope of central tolerance is to a large 
extent dictated by the pool of promiscuously expressed genes. Promiscuous genes expressed at 
sufficient levels will induce self-tolerance. More so, lack of a single TRA can result in 
spontaneous organ-specific autoimmunity. Therefore, it is important to precisely define the scope 
of pGE and parameters/mechanisms that regulate this gene pool. Promiscuously expressed genes 
display two prominent features: they are highly clustered in the genome and show a preference 
for TRAs. To link these features it was set out to precisely define the genomic organization of 
this gene pool in mouse, rat and human. In particular, we probed to what extent and according to 
which rules predefined genomic clusters of TRAs are transcribed in mTEC subsets (immature 
and mature mTECs). Our analysis proceeded from the bioinformatic definition of TRA clusters, 
gene clustering and homology mapping via gene expression analysis using whole genome arrays 
to the in depth analysis of selected TRA clusters by RT-PCR at the population level.  
Promiscuous genes expressed in single mTECs is to some degree stochastic with a heterogeneous 
pattern, that in sum all patterns add up resulting in a constant, complete representation at the 
population level. Hence, to elucidate: what dictates the pool of pGE at the single cell level, 
whether it was constraint or random, studies were performed on single mTECs. Gene expression 
and chromosomal co-localization studies of single mTECs expressing a particular antigen (like 
Mucin1, MUC1) were carried out. Patterns emerging from these combined studies could yield 
insights into the evolutionary mechanisms responsible for selecting this gene pool. Conceivably, 
positional clues in the genome and/or particular properties of self-antigens (e.g. immunogenicity) 
could have been driving forces during the co-evolution of pGE and adaptive immunity. 
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2. Materials and Methods 
2.1.  Materials 
2.1.1. Chemicals 
Table 2.1: Overview of chemicals 
Product Supplier 
Acetone Riedel-de Haën  
Agarose  Invitrogen  
Citrate, sodium salt Merck 
Diethylpyrocarbonate (DEPC) Sigma 
Ethylenediaminetetraacetic acid (EDTA)  Sigma 
Ethanol (absolute)  Riedel-de Haën  
Ethidium Bromide (10 g/l)  Roth  
Fetal calf serum (FCS) Biochrom 
Fixogum Marabu 
Formaldehyde Merck 
Formamide Merck 
Glycerol Merck 
HCl (1 M)  J.T. Baker  
HEPES  Invitrogen/Gibco 
Hoechst 33342  Sigma 
Isopropanol  Riedel-de Haën  
Kaisers Glycerin gelatine Merck 
LPA  Ambion 
β-Mercaptoethanol  Invitrogen/Gibco 
Methanol Merck 
Sodium Azide (NaN3) Merck 
Sodium Chloride (NaCl) Fluka 
Sodium hypochlorite (bleach) Roth 
10x Phosphate Buffered Saline (PBS) Biochrom 
PFA (Paraformaldehyde) Merck 
Percoll™  Amersham 
Penicillin/Streptomycin PAA 
Poly-L-Lysine, 0.01 % Sigma 
ProLong® Gold Invitrogen 
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Product Supplier 
Propidium Iodide  Sigma  
RPMI 1640  Invitrogen/Gibco 
TetraSpeck™ beads, 0.2 µm Invitrogen 
Tissue-Tek® Sakura 
Triton-X-100 Merck 
Trizol®  Invitrogen  
Trypan Blue Merck  
Tween 20  Gerbu 
2.1.2. Buffers, solutions and media 
All solutions were prepared with double distilled water purified by Millipore Milli-Q Plus 
(Millipore, Billerica, USA). Reagents were sterilized by autoclaving. 
2.1.2.1. General buffers and stock solutions 
DEPC Water (RNase free) 0.1 % (v/v) DEPC in water. Dissolved over-night 
under the hood and then autoclaved.  
 
1x TE Buffer Invitrogen 
 
PBS 136 mM NaCl  
2.56 mM KCl  
10 mM Na2HPO4 
1.76 mM KH2PO4 
pH 7.2-7.4  
 
2.1.2.2. Immunohistology 
PBS/Tween 20 0.1 % (v/v) Tween 20 in 1x PBS, pH 7.2-7.4 
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2.1.2.3. Agarose gel electrophoresis 
Agarose 1.5 % (w/v) Agarose in 100 ml 1x TAE 
5 μl Ethidium Bromide (10 mg/ml) 
 
TAE Buffer 40 mM Tris/Acetate 
1 mM EDTA 
pH 7.5-8.0 
 
2.1.2.4. Isolation of TECs 
RPMI 1640 Medium  5 % Fetal Calf Serum (FCS)  
10 mM HEPES  
2 mM Glutamine  
50 μM β-Mercaptoethanol  
50 μg/ml Streptomycin  
50 U/ml Penicillin  
 
Serum-free RPMI Medium Same supplements as above only without FCS 
 
Collagenase Solution 0.2 mg/ml Collagenase IV  
10 mM HEPES  
2 % FCS (v/v)  
in RPMI 1640 medium  
pH 7.3 (Stored at -20 °C; thawed for the experiment 
and warmed)  
 
Collagenase/Dispase Solution 0.2 mg/ml Collagenase IV  
0.2 mg/ml Dispase Grade I  
25 μg/ml DNase  
10 mM HEPES  
2 % FCS (v/v)  
in RPMI 1640 medium  
pH 7.3 (Stored at -20 °C; thawed for the experiment 
and warmed)  
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Trypsin Solution 0.05 % Trypsin  
0.5 mM EDTA  
0.3 % BSA  
50 μg/ml DNase  
in PBS, pH 7.3  
(Stored at -20 °C; thawed for the experiment and 
warmed)  
 
Percoll Stock 9 parts Percoll (ρ 1.13 g/cm3)  
1 part 10x RPMI/HEPES (ρ 1.00 g/cm3)  
gives ρ 1.117 g/cm3 
 
FACS Buffer 3-5 % FCS (v/v)  
0.1 % NaN3 
in PBS, pH 7.2-7.4 
 
Trypan Blue 0.2 % Trypan Blue  
150 mM NaCl  
pH 7.0  
 
MACS Buffer 0.5 % BSA (v/v) 
5 mM EDTA 
in PBS, pH 7.2-7.4 
 
 
2.1.2.5. Illumina expression profiling whole genome BeadArrays 
Reagents as described in company protocol (performed by Genomics and Proteomics Core 
Facility - Dr. B. Korn). 
2.1.2.6.  µMACS™ SuperAmp™ Technology for Illumina BeadArrays 
Reagents as described in TechNote (Pinto et al., 2009). 
 
  Materials and Methods 
24 
2.1.2.7. Fluorescence in situ hybridization 
20x SSC 3 M sodium chloride 
300 mM trisodium citrate 
pH 7.0 
 
0.3x PBS 150 ml 1x PBS 
500 ml autoclaved Millipore water 
pH 7.0 
 
4 % Paraformaldehyde/0.3x PBS 4 g PFA 
0.3x PBS 
pH 7.0 
 
0.5 % Triton-X-100/PBS 1 ml Triton-X-100 
500 ml 1x PBS 
 
20 % Glycerol/PBS 25 ml Glycerol 
500 ml 1x PBS (Store at 4 °C) 
 
0.1 N HCl/H2O 50 ml 1 N HCl 
500 ml 1x PBS 
 
50 % Formamide/2x SSC 100 ml Formamide (v/v)  
200 ml 2x SSC 
pH 7.4 (Store at 4 °C) 
 
70 % Formamide/2x SSC 140 ml Formamide (v/v) 
200 ml 2x SSC 
pH 7.0 (Store at 4 °C) 
 
0.2 % Tween 20/4x SSC 1 ml Tween 20  
500 ml 4x SSC 
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2.1.3. Enzymes and proteins 
Table 2.2: Overview of enzymes and proteins 
Product Supplier 
AmpliTaq Gold Applied Biosystems 
BSA  Sigma 
Collagenase Type IV  Worthington 
Dispase Grade I (neutral Protease) Worthington 
DNase (for collagenase/dispase and 
trypsin Mix)  
ICN 
DNase I (1U/μl) with 10x buffer and  
25 mM EDTA  
Invitrogen  
 
DNAaway MβP 
Electro Zap Ambion 
FCS  Biochrom  
MuLV Reverse Transcriptase Applied Biosystems 
Mouse Serum Dianova 
Power SYBR Green Master Mix Applied Biosystems 
Proteinase K  Merck  
RedTaqTM
 
DNA Polymerase (1 U/μl) with 
10x buffer  
Sigma 
RNase Block Ribonuclease Inhibitor Stratagene 
RNase H (2 U/μl)  Fermentas 
RNA Zap Ambion 
Superase•In (20 U/μl)  Ambion  
SuperScript IITM
 
Reverse Transcription  
(200 U/μl) with 5x buffer and 100 mM 
DTT  
Invitrogen  
T4gp32  USB  
Trypsin (2.5 %)  ICN  
Uracil-DNA Glycosylase (1 U/μl)  Eurogentec  
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2.1.4. Antibodies, secondary reagents   
Table 2.3: Overview of primary and secondary antibodies used for FACS  
Antigen Clone 
Species/ 
Isotype 
Conjugate 
Reference/ 
Supplier 
CD45  30-F11  Rat IgG2b, κ  PerCP  Pharmingen  
CD45 2D1 Mouse IgG1, κ PerCP Pharmingen 
CD45 OX-1 Mouse IgG1, κ PE-Cy5 Pharmingen 
CD80  16-10A1  Hamster 
IgG2, κ 
PE  Pharmingen  
EpCAM GZ1 Mouse IgG1 Alexa 488 BioVendor Laboratory 
Medicine Inc. 
EpCAM HEA125 Mouse IgG1 Biotin G. Moldenhauer, DKFZ 
Heidelberg 
FcR (FcγIII/IIR)  2.4G2  Rat IgG2b, κ  Supernatant AG Altevogt, DKFZ 
Heidelberg  
F(ab’)2 anti-
Mouse 
- Goat IgM (μ 
chain specific) 
RPE SouthernBiotech 
gp40 (EpCAM/ 
Tacstd1)  
G8.8  Rat IgG  Cy5  (Farr et al., 1991) 
His38 - Mouse IgM Ascites Jan Rozing, 
University of Groningen
HLA-DR L243 Mouse Alexa 647 
Alexa 680 
G. Moldenhauer, DKFZ 
Heidelberg 
Ly51 (6C3/BP-1 
Antigen/Enpep)  
6C3  Rat IgG2a, κ  FITC  Pharmingen  
MHC Class II  
(I-A/I-E)  
2G9  Rat IgG2a, κ  PE  Pharmingen  
MUC1 214D4 Mouse IgG1 Alexa 647 Upstate 
MUC1 214D4 Mouse IgG1 Alexa 647 University of Maastricht 
RT1B OX-6 Mouse IgG1, κ Purified Pharmingen 
Streptavidin - - PE Pharmingen 
TEZ CDR2 Mouse IgG2b Alexa 488 AG Kyewski, DKFZ 
Heidelberg 
 
  Materials and Methods 
27 
Table 2.4: Overview of primary and secondary antibodies used for immunohistology 
Antigen Clone 
Species/ 
Isotype 
Conjugate 
Reference/ 
Supplier 
Keratin 14  AF64 Rabbit Purified Covalence 
Goat IgG  - Rabbit Cy3 Jackson Research 
 
2.1.5. MicroBeads used for MACS purification 
Table 2.5: Overview of MACS beads used for cell separation 
Name Company 
Anti-CD45-Microbeads 
(Human) 
Miltenyi Biotech 
Anti-CD45-Dynal Beads 
(Human) Invitrogen 
 
2.1.6. Conventional PCR 
All primers were HPSF-purified and obtained from MWG-Biotech. Almost all primers were 
designed to cross intron-exon boundaries. 
2.1.6.1. Primers for conventional PCR 
Table 2.6: Overview of primers for conventional PCR 
Primer Name Primer Sequence 
Mouse/Rat ß-Actin Primer (348 bp)  
Forward 5’- TGG AAT CCT GTG GCA TCC ATG AAA C -3’ 
Reverse 5’- TAA AAC GCA GCT CAG TAA CAG TCC G -3’ 
Annealing-Temperature 55 °C  
Human ß-Actin Primer (208 bp)   
Forward 5’- CGT GGA CAT CCG TAA AGA CC -3’ 
Reverse 5’- ACA TCT GCT GGA AGG TGG AC -3’  
Annealing-Temperature 58 °C  
  Materials and Methods 
28 
2.1.6.2. Real-time PCR primers  
Mouse gene expression analysis: 
Table 2.7: Overview of primers for mouse gene expression analysis with real-time PCR  
Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
5430425J12Rik (300/300)  
Forward 5’- CAC CCT TGA GAA CCA ACT TTC C -3’ 
Reverse 5’- TGC CCT AGG CCC ACT TTG -3’ 
Aire (300/900)  
Forward 5’- GTA CAG CCG CCT GCA TAG C -3’ 
Reverse 5’- CCC TTT CCG GGA CTG GTT TA -3’ 
Brd9 (900/300)  
Forward 5’- AGT GAG AGC CTG CCG AAC AC -3’ 
Reverse 5’- CTC TGT AGC TGG CGG AGG AA -3’ 
Cep72 (900/900)  
Forward 5’- GAG TCT GACT ACC GCC TGT TTG T -3’ 
Reverse 5’- TTC TCT CAC AGG ACG GTC ATC TAG -3’ 
Clptm1l (900/900)  
Forward 5’- CCA ACT GCA TCC AGC CCT AT -3’ 
Reverse 5’- GAC CGT GTG GTG GTG TAA ACA C -3’ 
Csnb (300/900)  
Forward 5’- TGT GCT CCA GGC TAA AGT TCA CT -3’ 
Reverse 5’- GGT TTG AGC CTG AGC ATA TGG -3’ 
Ins2 (300/300)  
Forward 5’- CAC CAG CCC TAA GTG ACT CG -3’ 
Reverse 5’- ATC CAC AGG GCC ATG TTG AA -3’ 
Irx1 (300/50)  
Forward 5’- ACC CTC ACA CAG GTC TCC AC -3’ 
Reverse 5’- TCG ATG TCA ATG CTC TCC AG -3’ 
Irx2 (50/300)  
Forward 5’- GAA CAC CGA AAG AAC CCG TA -3’ 
Reverse 5’- CAT CCT GTG CCT TGT CTG AA -3’ 
Irx4 (900/900)  
Forward 5’- CCC GTC TAC TGC CCT GTC TA -3’ 
Reverse 5’- TCC TTG GAC TCG AAG CTG TT -3’ 
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Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
Lpcat1 (300/300)  
Forward 5’- TGG AGG AAG GTC GTG GAC TT -3’ 
Reverse 5’- GAA GCC GCC AGC AAA CC -3’ 
Mrpl36 (900/900)  
Forward 5’- GAG GTG CGC TCA GTT CTC TGT -3’ 
Reverse 5’- TTG ATG ACA CCT TTG GTT TTG AA -3’ 
Ndufs6 (900/900)  
Forward 5’- TTG TAG ATC GTC AGA AAG AGG TGA A -3’
Reverse 5’- GCG GTG CTC CAC CTC ATT -3’ 
Nkd2 (900/300)  
Forward 5’- CCT GAT GCA CAC CAT CTA CG -3’ 
Reverse 5’- CAA TCT CTG TTC TGC CAC GA -3’ 
Slc12a7 (900/900)  
Forward 5’- GCG TCC ACG CTT CAA GTT C -3’ 
Reverse 5’- CAG CGC GAG GCA GAG ACT -3’ 
Slc6a18 (900/900)  
Forward 5’- TTT GAG GGT ATC CCG CTT TTC -3’ 
Reverse 5’- GCC TAC GCC ACC GAG GTA -3’ 
Slc6a19 (900/900)  
Forward 5’- CAT CAG TGA CTC AGG CTC CA -3’ 
Reverse 5’- CCA CGG ATG AGA AAG ATG GT -3’ 
Slc6a3 (900/900)  
Forward 5’- TGG CTT CGT TGT CTT CTC CT -3’ 
Reverse 5’- CAG CTG GAA CTC ATC GAC AA -3’ 
Tert (900/900)  
Forward 5’- TGT TGG TGA CGC CTC ACT TG -3’ 
Reverse 5’- CAT ACT CAG GAA CGC CAT GGA -3’ 
Tppp (900/300)  
Forward 5’- TCT CTG GCG TCA CGA AAG CT -3’ 
Reverse 5’- TTG GTC GAA ACG CTC CTT GT -3’ 
Trip13 (900/900)  
Forward 5’- TTC CTG GCT CAT GCT CTC TAC A -3’ 
Reverse 5’- TGT TTG TCC ACT GCC AGA GAT AG -3’ 
Ubc (300/900)  
Forward 5’- CAC CAG CCC TAA GTG ACT CG -3’ 
Reverse 5’- ATC CAC AGG GCC ATG TTG AA -3’ 
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Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
Zdhhc11 (50/50)  
Forward 5’- CGA CAG GTC CAA ACA CAC AC -3’ 
Reverse 5’- ACA CCA AGA ATC CCA ACT GC -3’ 
 
Rat gene expression analysis: 
Table 2.8: Overview of primers for rat gene expression analysis with real-time PCR  
Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
Aire (900/300)  
Forward 5’- TCT GGC CTC AAA GAG CAT CTC T -3’ 
Reverse 5’- TTG CCC TCT GGC TTC TTA GG -3’ 
Hprt (900/900)  
Forward 5’- GCC CTT GAC TAT AAT GAG CAC TTC A -3’ 
Reverse 5’- TCT TTT AGG CTT TGT ACT TGG CTT TT -3’ 
Ins2 (900/900)  
Forward 5’- GCC CAG GCT TTT GTC AAA CA -3’ 
Reverse 5’- TCC CCA CAC ACC AGG TAG AGA -3’ 
 
Human gene expression analysis: 
Table 2.9: Overview of primers for human gene expression analysis with real-time PCR 
Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
AC007405.6-202 (50/900)  
Forward 5’- AAG AAT ACT CAG GCC CCA CTA GAG -3’ 
Reverse 5’- CCT TGG CCT CAG GAT TTT CTG -3’ 
ACBD5 (900/300)  
Forward 5’- TGA AGT CAA GCA TGG AGG AGA A -3’ 
Reverse 5’- CAA GTG TTG CAT CCT ATG TCC TCT T -3’ 
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Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
AIRE (900/900)  
Forward 5’- CTG ATG AGA GAG TGC TGA GAA GGA -3’  
Reverse 5’- GTT TAC AGC CGA GCA CTG ACA A -3’  
APBB1IP (300/900)  
Forward 5’- CTG GGA GAG ATG GAT CTT CTG ACT -3’ 
Reverse 5’- TTC CAG TGC ATT TAA GGA CTC ATT T -3’ 
ANKRD26 (900/900)  
Forward 5’- GAG AGG CTA GCA GAG GTC AAC AC -3’ 
Reverse 5’- CAC ACA AGG TGG CTC CAT GA -3’ 
CEACAM3 (900/900)  
Forward 5’- CAG CCT CAC TTC TAA ACT TCT GGA A -3’  
Reverse 5’- TGA GCG GCA TGG ATT CAA TA -3’  
CEACAM4 (900/900)  
Forward 5’- ACT GCC AGA TCG ACC ACA AAG -3’  
Reverse 5’- ACG CTC CAT CAA CCC ACA A -3’  
CEACAM5 (300/300)  
Forward 5’- TCC AGA ACT CAG TGA GTG CAA AC -3’  
Reverse 5’- CTC CCG AAA GGT AAG ACG AGT C -3’  
CEACAM6 (300/900)  
Forward 5’- ATA TGT GCC AAG CCC ATA ACT C -3’  
Reverse 5’- AGC TGA GAG GAC AGG AGC ACT T -3’  
CEACAM7 (900/900)  
Forward 5’- CTG CTC ACA GCC TCG CTT TTA A -3’  
Reverse 5’- GAA CGG CAC GAC ATC AAT ATT G -3’  
GAD65 (300/300)  
Forward 5’- GCA ATT AAA ACA GGG CAT CCT AGA -3 
Reverse 5’- ATG TTA GTA TTT GCT GTT GAT GTC A -3’ 
GAD67 (300/50)  
Forward 5’- TTT GAT CGC TCC ACC AAG GT -3’  
Reverse 5’- TCC AAG TTG AAG CCC TCC AT -3’  
GAPDH (900/900)  
Forward 5’- TCG ACA GTC AGC CGC ATC T -3’  
Reverse 5’- CCG TTG ACT CCG ACC TTC A -3’  
Probe 5’- CGT CGC CAG CCG AGC CAC AT -3’ 
GORASP2 (300/900)  
Forward 5’- CGC CCA TTT GAG GAA GGA A -3’ 
Reverse 5’- TGG ACC TCT GTA AAC CCA TCT TTA A -3’ 
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Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
GPR158 (900/900)  
Forward 5’- CCG ATC TGG ATC CTA CCT GA -3’ 
Reverse 5’- CGT AAT GCG TCT CAT GAT GG -3’ 
HMG1L4P (900/900)  
Forward 5’- AAC TTG TCG GGA GGA GTG TAA GAA -3’ 
Reverse 5’- ATG GCC TTC CAC CTC TCT GA -3’ 
INS (900/300)  
Forward 5’- GCA GCC TTT GTG AAC CAA CA -3’  
Reverse 5’- GTG TGT AGA AGA AGC CTC GTT CC -3’ 
PDSS1 (300/900)  
Forward 5’- GCA CAC TAC CTT GAG AAG ACA TTC A -3’ 
Reverse 5’- ACA TCC TAG AAC AGA GAC ATA CTG CTT 
T -3’ 
MASTL (900/300)  
Forward 5’- CGT TGA TGA TGG GCG AAT TC -3’ 
Reverse 5’- TTC TGG CCA AGG GAT ATC ATG -3’ 
METTL8 (50/300)  
Forward 5’- TGA TGT ATG TGA TGA TGG CTT ACC T -3’ 
Reverse 5’- TTA CAA CAC CTT GCA TCC TGT CA -3’ 
MUC1 (300/300)  
Forward 5’- CTT TCT TCC TGC TGC TGC TCC T -3’ 
Reverse 5’- AGC CGA AGT CTC CTT TTC TCC A -3’  
Probe 5’- AGC TTG CAT GAC CAG AAC CTG TAA CAA 
CTG T -3’ 
MUC4 (900/300)  
Forward 5’- AGA GGT ATC GCC CTG ATA GAT TCC -3’ 
Reverse 5’- ACG GTA GTT GGG CCT TTC TTC -3’ 
MYH6 (900/300)  
Forward 5’- TTC TCC GTG AAG GGA TAA CC -3’ 
Reverse 5’- CGT CTT CCC ATT CTC GGT TTC AGC -3’ 
MYH7 (900/900)  
Forward 5’- GGC CCC TTT CCT CAT CTG TAG -3’ 
Reverse 5’- CGG TCA CTG TCT TGC CAT ACT CAG -3’ 
MYO3A (300/50)  
Forward 5’- CTA GCT GAC CTT CAT CCC ATG AG -3’ 
Reverse 5’- GAA GTC ATT GAA TTC TGC TGA CCA T -3’ 
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Primer Name and Conc. 
(µM/µM) 
Primer Sequence 
MYO3B (900/50)  
Forward 5’- CTG ATA AAA GTG AGG TGC CCA AT -3’ 
Reverse 5’- CCC GGG TGA CCA CAC AGT -3’ 
SP5 (900/50)  
Forward 5’- TCT TCT GCG GGA AGA GCT T -3’ 
Reverse 5’- TGG TGA GTC TTG ACG TGC TT -3’ 
SSH3BP (900/900)  
Forward 5’- GAT GTG GGC CAT GGT GTC A -3’ 
Reverse 5’- TGT TCT CGA CAG TGT GCC AGT T -3’ 
TLK1 (900/300)  
Forward 5’- TGT ATG GTC GGT TGG AGT CA -3’ 
Reverse 5’- GCC TTG GCT TCA CTG CTT AC -3’ 
YME1L1 (900/900)  
Forward 5’- CTG AAA GCT CAA GCA CTC ACA CA -3’ 
Reverse 5’- GCA GCA GAA CGA AGA GAA TCA GA -3’ 
 
SC-PCR 
Table 2.10: Overview of primers for human SC-PCR 
Primer Name Primer Sequence 
MUC1 A2 5’- GGT ACC ATC AAT GTC CAC GA -3’ 
MUC1 B2 5’- ACG GAA GCA GCC TCT CGA TA -3’ 
MUC1 C2 5’- GAC AGC CAA GGC AAT GAG AT -3’ 
CEA A2 5’- TGG CTA CTG GCC GCA ATA AT -3’ 
CEA B2 5’- CAT GAT TGG AGT GCT GGT TG -3’ 
CEA C2 5’- CCA AGC CCA GCT CAT TTT TG -3’ 
CEACAM6 A 5’- TTC CAT GTA TAC CCG GAG CT -3’ 
CEACAM6 B 5’- CCT GTG GTG GGT AAA TGG TC -3’ 
CEACAM6 C2 5’- GGT AAT TGG CCT TTG AGG GG -3’ 
CEACAM3 A 5’- AAG AAC CAG CAT CCA GCG TG -3’ 
CEACAM3 B 5’- AGC TCT GCC TTC TCG ATG TC -3’ 
CEACAM3 C 5’- GCG GAA GCT AAG AAG CCA CT -3’ 
MUC4 A 5’- GGA GTT TCC CTC TTC CCC TA -3’ 
MUC4 B 5’- TTC ACC TCC CCA CTC TTC AA -3’ 
MUC4 C 5’- AAG TCA GCA TCG TCC CAG AA -3’ 
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Primer Name Primer Sequence 
EpCAM A2 5’- TGA GCG AGT GAG AAC CTA CTG -3’ 
EpCAM B 5’- CGG ACT GCA CTT CAG AAG GA -3’ 
EpCAM C 5’- CCC CAT TTA CTG TCA GGT CC -3’ 
 
2.1.7. Nucleotide and nucleic acids  
Table 2.11: Overview of DNA, nucleotides and oligonucleotides 
Product Supplier 
BAC clone- RP11-263K19-Gold Cyanine-3 
UTP 
Empire Genomics 
BAC clone- RP11-343B1 Green 5(6)-
Rhodamine Green dUTP 
Empire Genomics 
dNTP Set (100 mM) GE Healthcare 
dNTP-Mix (10 mM) MBI Fermentas  
dNTP-Mix (2 mM) MBI Fermentas  
GeneAmp 10mM dNTP Mix with dTTP Applied Biosystems 
Human COT-1 DNA Invitrogen 
Oligo (dT)7 Primer DKFZ Heidelberg 
Oligo (dT)20  (500 μg/ml) DKFZ Heidelberg 
Salmon Sperm DNA Invitrogen 
Total Organ RNA from different mouse 
and human organs 
Stratagene 
 
2.1.8. Microarrays, kits and standards 
Table 2.12: Overview commercial kits 
Product Supplier 
Alexa Fluor® 488 Protein Labeling Kit  Molecular Probes  
Alexa Fluor® 647 Monoclonal/Protein 
Labeling Kit 
Molecular Probes 
Alexa Fluor® 680 Protein Labeling Kit Molecular Probes 
Expression BeadChip, Whole Genome 
Gene Expression Analysis 
Illumina 
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Product Supplier 
GeneRulerTM 100 bp DNA Ladder plus 
(0.5 µg/µl)  
MBI Fermentas  
High Pure RNA Isolation Kit  Roche  
Illumina® TotalPrep RNA Amplification 
Kit 
Ambion 
Power SYBR Green  Applied Biosystems 
qPCRTM Core Kit for SYBR™ Green I  Eurogentec  
qPCRTM Core Kit Eurogentec  
RNeasy® Mini Kit  Qiagen  
 
2.1.9. Instruments 
Table 2.13: Overview of equipment 
Product Supplier 
Agilent 2100 Bioanalyzer  Agilent Technologies  
AutoMACSTM Pro Separator Miltenyi Biotech  
BD FACSAriaTM (SOP) Cell Sorter Becton Dickinson 
BD FACSCantoTM Flow Cytometer Becton Dickinson 
BD FACSVantageTM SE Cell Sorter  Becton Dickinson 
CCD Camera (Cosmicar)  Pentax  
Centrifuge Rotatanta 460 R Hettich 
Cryostat (CM 3050 S) Leica 
Gel electrophoresis Camera AGS 
GeneAmp® 7300 Sequence Detector ABI 
GeneArray Scanner Hewlett-Packard 
Heating Block Grant/Eppendorf 
Homogenisator (Ultra-Turrax® T25) IKA 
Incubator HeraCell 240 Heraeus 
Leica CM 1900 Cryostat Leica 
Leica TCS SP5 Leica 
Magnetic bar (MR 2000) Heidolph 
Microscope Axio Imager.Z1 Zeiss 
Nano Drop® 1000 photometer Thermo Scientific 
PCR-Machine (PTC-100™) MJ Research 
Power Supply (EPS 500/ 400) Pharmacia 
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Product Supplier 
Quadro MACS® separator Miltenyi Biotech 
Sterile Hood HeraSafe Typ KS12 Kendro 
Table Centrifuge (Biofuge fresco)  Heraeus 
UV Table Konrad Benda 
Water Bath (Thermomix® M)  Braun 
Zeiss Axio Imager.Z1 fluorescence 
microscope 
Zeiss 
 
2.1.10. Consumables 
Table 2.14: Overview of consumables 
Product Supplier 
ABI PRISM 96-well Optical Reaction Plate 
and Optical Caps 
Applied Biosystems 
AutoMACS columns Miltenyi Biotech 
Cell-Strainer-Cap-Tubes (5 ml) Becton Dickinson 
Centrifuge tubes (15 ml and 50 ml) TPP 
Coverslips, all sizes Lankenbrinck 
Filter tipps (10 μl,  20 μl,  200 μl and 1000 
μl) 
Starlabs 
Gauze  (PA-60 Nybolt) Eckert 
Glass slides (Histobond) Marienfeld Laborglas 
MicroAmp Optical Adhesive Film Applied Biosystems 
MicroSpinTM G-50 columns Amersham 
Multi-pipets (0.1 ml, 0.2 ml, 0.5 ml, 2.5 ml 
and 5 ml) 
Eppendorf 
Neubauer chamber Blau Brand 
Pasteur pipets  WU-Mainz 
PCR reaction tubes (200 μl)  Biozym 
Petri dishes (all sizes) TPP 
Round-bottom screw-cap tube (sterile) Nunc 
Round bottom tubes (13 ml) Becton Dickinson 
Safe-Lock reaction tubes (0.5-2 ml) Eppendorf 
Sterile filters  (0.2 μm and 0.45 μm) Millipore 
Strips of 8 thermo tubes-Ultra Clear Cap 
Strips  
Abgene 
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Product Supplier 
Strips of 8 tubes, thin wall micro test tubes,  
0.2 ml and Domed cap for thin wall micro 
test tubes 0.2 ml, stripes of 8 caps 
Nerbe 
Syringes (10 ml and 50 ml) Terumo 
Thermo-Fast® 96 Detection Plate Abgene 
2.1.11. Software  
Table 2.15: Overview of software used 
Software Company 
AxioVision 4.5 Zeiss 
Amplify 3.1.4 Freeware 
BD FACSDiva Becton Dickinson  
BeadStudio 3.1 Illumina 
Bioconductor Freeware 
ChromasLite Freeware 
ClustalW Freeware 
EditSeq 5.06 DNAStar 
FlowJo 8.6 Tree Star 
GeneAmp 7300 SDS Software Applied Biosystems 
Image J National Institutes of Health, USA 
LAS AF Lite Leica 
LinRegPCR LinRegPCR 
MatLab The MathWorks Inc. 
Microsoft Office Microsoft 
Primer ExpressTM 1.0 Applied Biosystems Applied Biosystems 
Primer ExpressTM 2.0 Applied Biosystems Applied Biosystems 
R Project Freeware 
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2.1.12. Mouse, rat and human material 
C57BL/6 mice and SD rats were bought from Charles River Wiga (females, 3-4 weeks old) and 
were used for organ preparations at the age of 5-6 weeks.  
The Aire knock-out (KO) mice were bred in the barrier of the central animal facility at the 
DKFZ. The mice were originally from Peltonen’s lab. All mice were kept under specific 
pathogen-free conditions at the animal facility of the German Cancer Research Center. 
Human thymus samples for this study were obtained in the course of corrective cardiac surgery at 
the Department of Cardiac Surgery, Medical School, University of Heidelberg headed by Prof. 
Dr. med. Matthias Karck. This study has been approved by the Ethics Committee of the 
University of Heidelberg. 
Table 2.16: List of individuals from which thymic samples were studied 
Human Sample Number Gender Age 
14 male 4 months 
24 female 2 months 
32 male 2 months 
53 male 2 months 
55 male 7 days 
59 male 7 days 
72 male 5 days 
74 female 3 years 
76 male 6 months 
77 male 4 months 
83 male 7 months 
87 female 4 months 
88 female 3 months 
89 male 7 days 
92 male 5 months 
93 female 8 months 
94 male 2 months 
96 female 3.5 months 
97 female 4 months 
101 female 5 months 
102 female 10 months 
103 female 3 months 
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Human Sample Number Gender Age 
104 male 3 days 
105 female 7 days 
106 male 9 months 
108 male 7 days 
109 male 14 days 
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2.2. Methods 
2.2.1. Antibody labeling 
Table 2.17: List of antibodies conjugated using labeling kits 
Antibodies Conjugate Kits 
anti-mouse EpCAM Alexa 647 Alexa Fluor® 647 Protein Labeling Kit 
anti-rat EpCAM Alexa 488 Alexa Fluor® 488 Protein Labeling Kit 
anti-rat MHCII Alexa 647 Alexa Fluor® 647 Protein Labeling Kit 
anti-human CDR2 Alexa 488 Alexa Fluor® 488 Protein Labeling Kit 
anti-human HLA-DR Alexa 647 
Alexa 680 
Alexa Fluor® 647 Protein Labeling Kit  
Alexa Fluor® 680 Protein Labeling Kit  
anti-human MUC1 Alexa 647 Alexa Fluor® 647 Monoclonal Labeling Kit
All conjugations were performed using labeling kits from Invitrogen and according to the 
manufacturer’s instructions, in which 1 mg/ml antibody was used for the protein labeling kit, 
while 100 µg/100 µl antibody was labeled using the monoclonal antibody kit. 
2.2.2. Immunohistochemistry 
2.2.2.1. Organ preparation for cryosections 
After the removal of the thymus from the thorax of the mouse or rat, the organ was embedded in 
a plastic mold with Tissue-Tek® and gradually frozen on dry ice. The organ was then preserved at 
-80 °C until further use.  
5 µm cryosections were cut at -22 °C to -24 °C using the Leica CM 1900 Cryostat. The sections 
were then dried over-night on Histobond® slides. 
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2.2.2.2. Immunohistochemical staining 
The tissue sections were fixed with Acetone (-20 °C) for 10 min at room temperature. 
Subsequently they were air dried and encircled using a Pap pen. The slides were then washed for 
5 min in 1x PBS pH 7.4 at room temperature and blocked with 3 % BSA/1x PBS for 20 min at 
room temperature in a humidity chamber. After washing the slides with 1x PBS/0.1 % Tween for 
10 min at room temperature, the primary antibody (diluted with PBS and centrifuged) was added 
and incubated for 30 min at 37 °C and then 30 min at room temperature in a humidity chamber. 
The slides were then washed once in 1x PBS/0.1 % Tween for 5 min and twice in 1x PBS pH 7.4 
for 5 min each and then briefly rinsed in distilled water. The secondary antibody was treated in 
the same way as the primary antibody. After incubation for 30 min at 37 °C and 30 min at room 
temperature in a dark humidity chamber, the slides were washed as prior. In some cases, the 
sections were counter stained with Hoechst 33342 for 2 min and washed as mentioned above. All 
samples were embedded with warm Kaiser’s Glycerol Gelatine and covered with coverslips. 
Images were taken with a Zeiss Axio Imager Z.1 fluorescence microscope. Immunohistochemical 
staining was performed to establish the staining of the anti-His38 ascites and anti-MHCII on rat 
thymus (Figure 4). 
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Figure 4 
Immunohistochemical staining with the anti-His38 ascites and anti-MHCII mAb on rat thymus 
(A) MHCII antibody labeled with Alexa 647 stained the rat medulla more intensely than the cortex (40x).   
(B)  His38 ascites-Cy3 stained the rat thymic cortex and the outer cortex (C) just below the thymic capsule (20x). 
Marking: M = medulla; C = cortex. 
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2.2.3. Isolation of thymic epithelial cells 
2.2.3.1.  Isolation of mouse thymic epithelial cells 
2.2.3.1.1.  Enzymatic digestion of mouse thymic tissue 
Mice were killed with CO2 and the thymi were removed from the thorax into a petri plate filled 
with RPMI 1640 medium (containing 5 % FCS) on ice. Residual fat and connective tissue if any 
were removed from the thymi. The thymi were then cut into small pieces and stirred in a round-
bottom tube containing ~20-25 ml medium at low speed on a magnetic stirrer for 10-15 min at 
room temperature. The supernatant containing thymocytes was decanted and the remaining 
tissue was further digested until complete dissociation into a single cell suspension. The tissue 
was digested thrice with 10 ml collagenase for 15 min each at 37 °C, thrice with 
collagenase/dispase for 25 min each at 37 °C and two-three rounds of trypsin for 20 min each at 
37 °C in a water bath with magnetic stirring. During the digestion steps, the tissue was agitated 
regularly with a pasteur pipet. After each digestion step, the supernatant was collected separately 
on ice and washed in RPMI 1640 medium containing 5 % FCS (1400 rpm for 5 min at 4 °C). The 
cell pellet was then resuspended in 10 ml RPMI 1640 medium containing 5 % FCS and kept on 
ice. The cells from each fraction were then counted and depending on the cell count, usually 
from the 2nd collagenase/dispase fraction till the last trypsin fraction, were pooled and filtered 
through 60 µm gauze.  
2.2.3.1.2. Enrichment of mouse TECs using density gradients 
In order to enrich for TECs, density gradients were used, as described below.  
After pooling the digestion fractions the cells were washed twice (1400 rpm for 5 min at 4 °C) in 
RPMI 1640 medium without FCS. In the meanwhile, the various density solutions were prepared 
as described in Table 2.18. The cell pellet was then suspended in Percoll stock/RPMI,  
ρ = 1.07 g/cm3, over which, the other two gradient layers (6 ml of Percoll stock/RPMI,  
ρ = 1.045 g/cm3 and 6 ml of medium (-FCS), ρ = 1.00 g/cm3) were carefully added using a glass 
pasteur pipet. Not more that 5 x 108 cells were used for one gradient. The gradients were then 
centrifuged at 4000 rpm (3500 g, Hettich Rotanta 460R; without breaks) at 4 °C for 30 min. 
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Table 2.18: Different density gradient solutions for the isolation of mouse and rat thymic epithelial cells 
Density (g/cm3) 
RPMI Medium without FCS  
(ml) 
Percoll Stock (ml) 
1.0 6           (normal pH) 0 
1.045 3.69 2.31 
1.07 2.41 3.59 
 
Percoll stock: 9 parts Percoll (Amersham Biosciences, ρ = 1.13 g/cm3) + 1 part RPMI/HEPES (10x)  
(ρ = 1.00 g/cm3). This gives a density of ρ = 1.117 g/cm3. 
RPMI medium (-FCS) with normal pH 6.5 was prepared by adjusting the pH with 1 M HCl (until it turns yellow). 
 
After centrifugation, the cells were collected in a 50 ml Falcon containing RPMI 1640 medium 
(with FCS) from both interphases using a pasteur pipet. The cells were then washed twice  
(1600 rpm for 8 min at 4 °C) in medium. At the end, the cell pellet was resuspended in RPMI 
1640 medium or FACS buffer (5 % FCS) and counted. Following which, they were stained for 
FACS (Section 2.2.3.1.3). 
2.2.3.1.3. Staining of mouse TECs  
For cell staining, firstly the cells were blocked with 1 ml (for every 1 x 108 cells) of anti-Fc-
receptor supernatant (2.4G2) for 15 min on ice. The cells were then washed (1400 rpm for 5 min 
at 4 °C) and stained with an antibody cocktail (Table 2.19) for 15 min on ice in FACS buffer. 
After staining, the cells were washed, filtered through 35 µm filters and stained with PI directly 
prior to sorting. Cell populations were sorted on a BD FACSDiVa (Becton Dickinson) on purity 
mode under medium pressure (Figure 5). 
Table 2.19: Overview of different antibody combinations used for mouse TEC cell sorting 
TEC Populations Sorted Antibodies used Dilution 
MHCIIhi/MHCIIlo mTEC and cTEC 
anti-Ly51-FITC 
anti-CD45-PerCP 
anti-EpCAM-Alexa 647 
anti-MHCII-PE 
PI (1 mg/ml) 
1:100 
1:100 
1:100 
1:2000 
1:1000 
 
 
 
 
(pH 6.5)
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Figure 5 
Sort gates for the isolation of mouse MHCIIhi and MHCIIlo mTECs 
The mouse mTEC and cTEC cell populations were separated using anti-Ly51 and anti-EpCAM mAbs. The mTECs 
were further differentiated into mature and immature subsets using anti-MHCII mAbs.  
2.2.3.2. Isolation of rat thymic epithelial cells 
2.2.3.2.1. Enzymatic digestion of rat thymic tissue 
Rats were killed with CO2 and the thymi were removed from the thorax into a Petri plate filled 
with RPMI 1640 medium (containing 5 % FCS) on ice. The digestion steps for the isolation of 
thymic epithelial cells from rat were the same as performed in mice (Section 2.2.3.1.1).  
2.2.3.2.2. Enrichment of rat TECs using density gradients 
For the enrichment of rat TECs, density gradients were used as those in mice (Section 2.2.3.1.2), 
only that separate gradients were performed for the collagenase/dispase and trypsin fractions. 
Depending on the cell number, either both or the upper interphase of the collagenase/dispase 
gradients were added to both interphases of the trypsin gradients. 
2.2.3.2.3. Staining of rat TECs 
The cell staining was performed as described in Table 2.20. Cells were washed, filtered through 
35 µm filters and stained with PI directly prior to sorting. Cell populations were sorted on a  
BD FACSDiVa (Becton Dickinson) on purity mode under medium pressure (Figure 6). 
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Table 2.20: Overview of blocking/staining scheme and different antibody combinations used for rat 
thymus cell sorting 
Steps 
1 2  3  
Block 
Goat 
Serum 
His38 Ascites 
1:500 for 30 min 
Goat anti-mouse 
IgM-PE (1:200) Block 
Mouse 
Serum 
anti-EpCAM-Alexa 488 (1:100) 
anti-CD45-CyChrome (1:100) 
anti-MHCII-Alexa 647 (1:1500) 
PI (1 mg/ml, 1:1000) 
 
 
 
 
Figure 6 
Sort gates for the isolation of  rat MHCIIhi and MHCIIlo mTECs  
The rat mTEC and cTEC cell populations were separated using anti-His38 ascites and anti-EpCAM mAbs. The 
mTECs were further differentiated into mature and immature subsets using anti-MHCII mAbs.  
2.2.3.3. Isolation of human thymic epithelial cells 
2.2.3.3.1. Enzymatic digestion of human thymic tissue 
Human thymus samples for this study were obtained in the course of corrective cardiac surgery at 
the Department of Cardiac Surgery, Medical School, University of Heidelberg headed by  
Prof. Dr. med. Matthias Karck. This study has been approved by the Ethics Committee of the 
University of Heidelberg. The age of the children for this study ranges from 3 days to 3 year.  
The thymus samples directly after removal were slit (to facilitate oxygenation) and transported in 
RPMI 1640 medium (containing 5 % FCS) on ice. The tissue was then cut into small pieces and 
stirred in a 250 ml conical flask containing ~50-60 ml RPMI 1640 medium at low speed on a 
magnetic stirrer for 10 min at 4 °C. This step was repeated twice, after each step the supernatant 
containing thymocytes was decanted. The remaining tissue was divided into two 100 ml conical 
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flasks and digested until complete dissociation into a single cell suspension. To do so, the tissue 
was digested thrice with 10 ml collagenase/dispase for 20 min each at 37 °C and three-four 
rounds of trypsin for 10 min each at 37 °C in a water bath with magnetic stirring. During the 
digestion times, the tissue was agitated regularly with a broken glass pasteur pipet. After each 
digestion step, the supernatant was collected separately on ice and washed in RPMI 1640 medium 
containing 5 % FCS (1400 rpm for 5 min at 4 °C). The cell pellet was then resuspended in 10 ml 
RPMI 1640 medium containing 5 % FCS and kept on ice. The cells from each fraction were then 
counted and depending on the cell count, usually from the last collagenase/dispase and all trypsin 
fractions were pooled and filtered through 60 µm gauze.  
In order to enrich for TECs, either density gradients (Section 2.2.3.3.2) or Anti-CD45-Dynal beads 
(Invitrogen; Section 2.2.3.3.3) or Anti-CD45-Microbeads (Miltenyi Biotech; Section 2.2.3.3.4) were 
used.  
2.2.3.3.2. Enrichment of human TECs using density gradients 
For density gradients, after pooling the digestion fractions, the cells were washed (1400 rpm for  
5 min at 4 °C) in RPMI 1640 medium without FCS. In the meanwhile, the various density 
solutions were prepared as described in Table 2.21. The cell pellet was then taken up in Percoll 
stock/RPMI, ρ = 1.07 g/cm3, over which, the other three gradient layers (6 ml of Percoll 
stock/RPMI, ρ = 1.045 g/cm3; 6 ml of Percoll stock/RPMI, ρ = 1.03 g/cm3 and 6 ml of medium 
(-FCS), ρ = 1.00 g/cm3) were carefully added using a glass pasteur pipet. Not more that 5 x 108 
cells were used for one gradient. The gradients were then centrifuged at 4000 rpm (3500 g, Hettich 
Rotanta 460R; without breaks) at 4 °C for 30 min. 
Table 2.21: Different density gradient solutions for the isolation of human thymic epithelial cells 
Density 
(g/cm3) 
RPMI Medium without 
FCS  (ml) 
Percoll Stock (ml) 
1.0 6         (normal pH) 0 
1.03 4.46 1.54 
1.045 3.69         pH 6.5 2.31 
1.07 2.41 3.59 
 
Percoll stock: 9 parts Percoll (Amersham Biosciences, ρ = 1.13 g/cm3) + 1 part RPMI/HEPES (10x)  
(ρ = 1.00 g/cm3). This gives a density of ρ = 1.117 g/cm3.  
RPMI medium (-FCS) with normal pH 6.5 is prepared by adjusting the pH with 1 M HCl, until it turns yellow. 
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After centrifugation, the cells were collected in a 50 ml Falcon containing RPMI 1640 medium 
(with FCS) from the upper two interphases using a pasteur pipet. The cells were then washed 
twice (1600 rpm for 8 min at 4 °C) in medium. At the end, the cell pellet was resuspended in 
RPMI 1640 medium or FACS buffer (5 % FCS) and counted. Following which, the cells were 
stained for FACS (Section 2.2.3.3.5). 
2.2.3.3.3. Enrichment of human TECs using Anti-CD45-Dynal beads 
For TEC enrichment using Anti-CD45-Dynal beads (Invitrogen), the cells corresponding to  
~ 2 x 109 cells (from the pooled trypsin factions) were washed (1400 rpm for 5 min at 4 °C) in 
FACS buffer. The cell pellet was taken up in 10 ml FACS buffer and incubated with Anti-CD45-
Dynal beads (4 x 108 beads/ml) in a 1:1 ratio for 20 min at 4 °C. Prior to incubation, the beads  
(~ 3 ml) were washed thrice in 20 ml FACS buffer and incubated for 5-10 min on the magnet till 
the solution was clear. The solution was decanted.  
After incubation, the cell-bead mix was placed on the magnet and the clear solution containing 
the CD45- cells was collected. The beads were washed (1400 rpm for 5 min at 4 °C) twice in  
15 ml FACS buffer and placed on the magnet. After each wash, the clear solution containing the 
CD45- cells was collected and washed with FACS buffer (1400 rpm for 5 min at 4 °C). The cell 
pellet was resuspended in RPMI 1640 medium or FACS buffer (5 % FCS) and counted, 
following which, the cells were stained for FACS. 
2.2.3.3.4. Enrichment of human TECs using Anti-CD45-Microbeads 
For the use of Anti-CD45-Microbeads (Miltenyi Biotech) to enrich for TECs, the cells 
corresponding to ~ 2-3 x 109 cells (from the pooled trypsin factions) were washed (1400 rpm for 
5 min at 4 °C) in GM buffer and taken up in 20 ml FACS buffer. The cells were then incubated 
with a 1:35 dilution of Anti-CD45-Microbead for 20-30 min at 4 °C. After incubation, the cell-bead 
mix was washed with GM buffer (1400 rpm for 5 min at 4 °C). The cell pellet was resuspended in 
10 ml GM buffer and filtered through 70 µm gauze. After which, they were aliquoted in ten  
15 ml tubes each having ~2 x 108 cells/ml. The CD45+ cells were then depleted using the 
autoMACSTM Pro Separator (Miltenyi Biotech), “Depletion program” as per the manufacturer’s 
recommendations. The collected CD45- cell fractions were pooled, washed, resuspended in 
FACS buffer (5 % FCS) and counted, following which, the cells were stained for FACS. 
2.2.3.3.5. Staining of human TECs 
For cell staining, firstly the cells were blocked with 5 % mouse serum in FACS buffer (1 ml for 
every 1 x 108 cells) for 15 min on ice. For MUC1 antigen sorts, 5 % BSA solution was used for 
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blocking. The cells were then washed (1400 rpm for 5 min at 4 °C) and stained with an antibody 
cocktail (Table 2.22) for 15 min on ice in FACS buffer. After staining, the cells were washed 
(1400 rpm for 5 min at 4 °C), filtered through 35 µm filters and stained with PI directly prior to 
sorting. Cell populations were sorted on a BD FACSDiVa or BD FACSAriaTM (SOP) Cell Sorter 
(Becton Dickinson) on purity mode under medium pressure (Figures 7 and 8). 
Table 2.22: Overview of different antibody combinations used for human TEC cell sorting 
TEC Populations Sorted Antibodies used Dilution
MHCIIhi/MHCIIlo mTEC and cTEC 
anti-CDR2-Alexa 488 
anti-CD45-PerCP 
anti-EpCAM-Biotin 
Sav-PE 
anti-HLA-DR-Alexa 647 
PI (1 mg/ml) 
1:100 
1:5 
1:100 
1:100 
1:500 
1:1000 
MUC1+ and MUC1- mTEC 
anti-CDR2-Alexa 488 
anti-CD45-PerCP 
anti-EpCAM-Biotin 
Sav-PE 
anti-HLA-DR-Alexa 680 
anti-MUC1-Alexa 647 
PI (1 mg/ml) 
1:100 
1:5 
1:100 
1:100 
1:100 
1:100 
1:5000 
 
Figure 7 
Sort gates for the isolation of  human mTECs using Anti-CD45-Microbeads  
The human mTEC and cTEC cell populations were separated using anti-CDR2 and anti-EpCAM mAbs. The 
mTECs were further differentiated into mature and immature subsets using anti-MHCII mAbs. The MHCII profile 
varied between the different human thymus samples.  
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Figure 8 
Sort gates for the isolation of MUC1 antigen specific mTECs using Anti-CD45-Microbeads  
The human MUC1 expressing mTECs were stained and sorted for their MUC1 expression versus that of the 
negative control, without MUC1 antibody. 
2.2.4. Counting of live cells 
Cells were mixed in various dilutions with trypan blue and counted in a Neubauer counting 
chamber using a tabletop light microscope. The dead cells take up the trypan blue dye due to 
their disrupted cell membrane and appear blue, thus being able to be distinguished from their 
translucent live counterparts.  
2.2.5. RNA isolation 
Total cellular RNA was isolated using the High Pure RNA Isolation Kit (Roche) according to the 
manufacturer’s instructions, from 2 x 104-106 cells. 
Negative Control 
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2.2.6. RNA precipitation and RT-PCR 
2.2.6.1. RNA precipitation 
Total RNA eluted in 50 µl Elution buffer was precipitated if need be, depending on the 
concentration as measured using the Nano Drop® 1000 photometer. The precipitation was 
performed over-night at -20 °C using 5 µg LPA and 2.5x sample volume of absolute ethanol  
(-20 °C), after which, the samples were centrifuged at 13,000 rpm for 30 min at 4 °C, then 
washed with 70 % ethanol (-20 °C) and re-centrifuged for 13 min. The pellet was then air-dried 
and re-suspended in 8-16 µl of RNase free water and either stored at -80 °C or directly used for 
RT-PCR. 
2.2.6.2. RT-PCR 
Genomic DNA was digested using 1 µl DNAse I (1 U/µl) for 30 min at 37 °C, followed by heat 
inactivation of the enzyme at 65 °C for 10 min. Subsequently, the RT-PCR was performed using 
the SuperScript II ™ RT (Invitrogen) as described in the manual.  
For lower RNA amounts an alternative protocol was used, which is as follows: 
To 4.5 µl RNA add 100 ng (200 ng/µl) (dT) - T7 primer, incubate at 70 °C for 10 min in a PCR 
block. To this add 4.5 µl ice-cold RT mix (2 µl 5x First Strand Buffer, 0.5 µl dNTP (10 mM),  
0.5 µl T4gp32 (8 mg/ml, USB), 0.5 µl SuperaseIN, 1 µl H2O). Incubate the mixture at 50 °C for 
2 min. After which, 0.5 µl SuperScript II ™ RT enzyme (Invitrogen) was added. The reaction was 
incubated for 60 min at 50 °C.  
The resulting cDNA from either protocol was purified on gel chromatography columns 
(MicroSpin™ G50 columns) according to manufacturer’s specifications, in order to remove excess 
nucleotides and oligonucleotides.  
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2.2.7. Conventional PCR 
For 25 µl reaction of a conventional PCR:  
Reagents End Concentration Volume 
Forward Primer 250 nM 2.5 µl 
Reverse Primer 250 nM 2.5 µl 
dNTPs 200 µM 2.5 µl 
10x Reaction Buffer 1x 2.5 µl 
RedTaq® DNA-Polymerase 0.125 U 1 µl 
cDNA - 2 µl 
H2O - 12 µl 
Total Volume - 25 µl 
 
The following PCR cycle parameters were used for the thermocycler: 
Steps Time Temperature 
Denaturation 3 min 94  °C 
Denaturation 1 min 94  °C 
Annealing 1 min 55 or 58  °C        40 cycles 
Elongation 2 min 72  °C 
Elongation 3 min 72  °C 
 ∞ 4 °C 
 
The conventional PCR was used to control the success of the cDNA synthesis using β-Actin as a 
house-keeping gene. Since the β-Actin primers were intron spanning, the cDNA template gave a 
shorter product of 348 bp for mouse and rat cDNA using agarose gel electrophoresis. For 
human cDNA, the primers gave a product of 208 bp and had an annealing temperature of 55 °C.  
2.2.8. Quantitative PCR (qPCR) 
For quantitative gene expression analysis, real-time PCR was performed using the GeneAmp® 
7300 Sequence Detector. Each primer pair was titrated for the optimum concentration, as mentioned 
in Tables 2.7-2.9.  
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Each reaction volume of 25 µl contained:  
? Optimum primer concentration 
? Power SYBR® Green PCR Master Mix (Applied Biosystems)/ qPCR™ 
Core Kit for SYBR™ Green I (Eurogentec) 
? Template cDNA 
The reaction mix was either pipetted as triplicates or duplicates in a Thermo-Fast® 96 Detection 
Plate (Abgene). 
The following reaction parameters were used: 
Steps Time Temperature 
Activation* 2 min 50 °C 
Activation of Hot GoldStar Polymerase 10 min 95 °C 
Denaturation 
 
15 s 95  °C  
                  40 or 45 cycles 
Annealing and Elongation 1 min 60 °C        
* Activation step was always performed, but was usually for the activation of UNG for qPCR™ 
Core Kit for SYBR™ Green I. 
The melting curves were compared to positive controls to ensure specificity of the PCR 
amplification. In some case, probes were used (with qPCRTM Core Kit) to increase the specificity of 
the PCR reaction. Relative quantification of gene expression was performed using the ΔΔCt 
(threshold value), with Ubc (for mouse), Hprt (for rat) and GAPDH (for human) as a house-
keeping gene for normalization. ΔΔCt-method according to ABI User Bulletin #2; can be 
obtained under www.appliedbiosystems.com. Real-time PCR was performed to validate the 
sorted samples from all species (mouse, rat and human) for a set of known differentially 
expressed genes (Figure 9). 
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Figure 9 
qPCR analysis of sorted samples from mouse, rat and human 
Real-time PCR was performed to validate the sorted samples of all species (mouse, rat and human), prior to 
microarray hybridization for a set of known differentially expressed genes. One example from each sort for each of 
the species studies is shown. The MHCIIhi mTECs in all sepcies are enriched for pGE. The genes were normalized 
using a house-keeping gene (Ubc for mouse, Hprt for rat and GAPDH for human) and the expression was 
calculated using the ΔΔCt-method relative to the MHCIIhi mTECs. Genes tested: Aire-Autoimmune regulator; Ins-
Insulin; Csnb-Casein beta; GAD67-glutamic acid decarboxylase 67. 
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2.2.9. Microarrays 
Illumina expression profiling whole genome BeadArrays was used and the protocol followed was 
as described in the company manual (performed by the Genomics and Proteomics Core Facility 
of the DKFZ- Dr. B. Korn). For analysis of the array results, BeadStudio 3.1 (Illumina Inc.) was 
used to obtain the raw data which were further analyzed using R project and Perl software. 
2.2.10.  µMACS™ SuperAmp™ Technology for Illumina BeadArrays 
The µMACS™ SuperAmp™ protocol (Miltenyi Biotec) is a recently established method for RNA 
amplification of small/rare cell populations. The amplified cDNA can be labelled and hybridized 
to microarrays for gene expression profiling. This technology was used and the samples were 
hybridized on Illumina’s expression profiling whole genome BeadArrays. Technical details were 
established and performed as described in a TechNote (Pinto et al., 2009). 
2.2.11. Single-cell PCR (SC-PCR) 
SC-PCR is a technique used to analyse the transcriptome of a single cell for up to 20 genes of 
interest and was essentially performed as described by Peixoto et al. (Peixoto et al., 2004). 
The different steps of the SC-PCR were performed on separate benches with dedicated pipets, 
ice-boxes, etc. The benches and ice-boxes were cleaned with sodium hypochlorite and DNAaway 
prior to starting the experiment to prevent cross-contamination. All reactions were performed on 
ice. Throughout the experiment, the same machines (the same order of heating blocks) were 
used.  
2.2.11.1. Primer design, dilution and storage 
Primers for SC-PCR were designed with the Amplify 3 program to be 20mers with a preferable 
GC content of 50 %. All primers were spanning exon-intron boundaries. Generation of primer 
dimers and potential cross priming was tested in silico. The primers were routinely tested by 
BLAST search for specificity. Lyophilized primers were resuspended in 1x TE buffer at 1 mM 
final concentration. From these stock solutions 100 µM aliquots were prepared (in water) and 
both solutions were stored at -80 °C. Working solutions of 25 µM or 12.2 µM were prepared 
from the 100 µM solutions with water. The working solutions were stored at -20 °C. No solution 
used in SC-PCR had gone through more than three freeze/thaw cycles. 
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2.2.11.2. Efficiency and competition primer tests 
Each primer pair (primer pairs A-C and B-C from all genes of interest) was tested with the same 
template and the qPCR efficiency was assessed using the LinRegPCR program (“Efficiency test”) 
(Figure 10A). In order to test the primer competition in the multiplex PCR, the first PCR was 
performed on the same template using: 1) a mix of all the A-C primer pairs (all genes); 2) an 
individual A-C primer pair (for each gene). The second PCR was a qPCR, using the first PCR as a 
template for each B-C primer pair (for each gene). Ct values and PCR efficiencies were compared 
between individual and multiplex PCRs to assess the degree of primer competition 
(“Competition test”) (Figure 10B). 
2.2.11.3. Cell sorting and storage 
Cell sorting was performed with a BD FACSDiVa (Becton Dickinson) at 16 psi in single cell 
mode using the automatic cell deposition unit. Cells were collected in 5 µl PBS-DEPC (0.1 %) in 
0.2 ml PCR 8-well stripes arranged in 96 well format, frozen in liquid nitrogen and stored at  
-80 °C. Routinely, positive and empty wells were included in the plates to check the specificity of 
the reaction. Each experiment was independently tested for instrument precision by sorting 
fluorescent beads and visually inspecting their deposition in a target area corresponding to the 
surface area of the 5 µl cell collecting volume.  
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Figure 10 
Efficiency and competition test of SC-PCR primers  
(A)  Efficiencies between the individual primer pairs tested did not vary significantly, primer pairs A-C and B-C 
were tested in sequential PCR reactions.  
(B) Primer competition in the multiplex PCR, the first PCR was performed on the same template using: 1) a  mix 
of all the A-C primer pairs (all genes); 2) an individual A-C primer pair (for each gene). The second PCR was a 
qPCR, using the first PCR as a template for each B-C primer pair (for each gene). There was no significant 
competition between the primer pairs as both “alone” and “multiplex” reactions achieved the same Ct values in 
the second amplification round. 
B 
A 
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2.2.11.4. Lysis of cells, reverse transcription and PCRs 
Cell Lysis, reverse transcription, first PCR amplification and real-time quantitative PCR were 
performed using DNA Engine Dyad (MJ Research) and 7300 Real Time PCR System (Applied 
Biosystems) instruments. The cycle number for the first PCR reaction was lowered from 15 to 14 
and 50 cycles for the second round real-time quantitative PCR, since we observed an improved 
correlation between input cDNA and resulting threshold cycle (Ct) values. 
The RT-PCR and the following gene expression studies of each sorted single cell were performed 
in the same tube. SC-PCR was highly sensitive and specific, as first a multiplex PCR was 
performed with outer primer pairs of all genes of interest (primers A and C) for 14 cycles and 
then a 50 cycle second round amplification-nested real-time PCRs were performed with the inner 
primer pairs (primers B and C) for each gene individually, using the first PCR as a template 
(Figure 11).  
 
Figure 11 
Schematic representation of the two amplification rounds performed in SC-PCR  
14 cycles pre-amplification was performed in multiplex PCR with an outer primer pair, the second step amplification 
was performed as real-time PCR with a single inner primer pair. 
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Cells were lysed in the plate for 2 min at 65 °C in the PCR machine. 10 µl RT-Mix was added and 
reverse transcription performed in the PCR machine as below: 
1x RT-Mix  PCR program for RT  
H2O 2.34 µl  37 °C 60 min  
PCR buffer II (10x) 1.5 µl  95 °C 10 min  
MgCl2 2 µl  4 °C ∞  
dNTPs  
(10mM each) 
1.5 µl     
Oligos “C” 
(12.2 µM each) 
0.16 µl x 6  
(no. of oligos) 
    
RNase Block 1 µl     
MuLV 0.7 µl     
Total 10 µl     
70 µl first PCR Master Mix was then added and the PCR was carried out in the PCR machine.  
1x Master Mix 1st PCR  PCR program for 1st PCR 
H2O 46.3 µl  95 °C 10 min  
PCR buffer II (10x) 8.5 µl  94 °C 45 sec 
MgCl2 7 µl  60 °C 1 min 
dNTPs  
(2.5 mM each) 
7 µl  72 °C 1 min 30 sec 
10 cycles 
Oligos (25 µM each of 
“A” and “C”) 
0.05 µl x 2 x 6  
(2 x no. of genes) 
 72 °C 10 min  
AmpliTaq Gold 0.6 µl     
Total 70 µl     
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From the resulting 85 µl template, 4 µl/well were transferred to an ABI PRISM 96-well Optical 
Reaction Plate (Applied Biosystems) for individual gene qPCR with specific inner primers (primer 
pair B-C).  
1x Master mix for 2nd PCR (qPCR)  PCR program for 2nd PCR (qPCR) 
H2O 7.52 µl  95 °C 10 min  
Primer “B” (25 µM) 0.24 µl  95 °C 30 sec 
Primer “C” (25 µM) 0.24 µl  60 °C 30 sec 
Power SYBR Green Mix 12 µl  72 °C 45 sec 
50 cycles 
Total 20 µl  Melting curve analysis 
Our data were analyzed in a qualitative fashion, since the PCR efficiency varied among cells for 
the same and different genes. In case of an atypical melting curve, the product from the 
respective well was re-amplified by the appropriate primer combination for 15 cycles with 
“conventional” PCR, analyzed on an agarose gel, purified with QIAquick PCR Purification Kit 
and sequenced in house.  
Expression frequencies and co-expression patterns were tested for significance with the Chi-
Square Test. Co-expression studies were tested for significance with the Jonckheere-Terpstra 
Test.  
2.2.12. Fluorescence in situ hybridization (FISH) 
2.2.12.1.  FISH probes 
Labelled FISH probes BAC clone- RP11-263K19-Gold Cyanine-3 UTP and RP11-343B1 Green 
5(6)-Rhodamine Green dUTP were ordered from Empire Genomics. 
2.2.12.2.  Cell fixation 
Slides were coated with 0.1 mg/ml Poly-L-Lysine for 1 hour at room temperature and then 
washed twice in water and air-dried. The FACS cells (in 50 µl 50 % RPMI/ 50 % FCS) were then 
dropped onto the coated slides and allowed to settle for 1 hour at 37 °C. The slides were washed 
for 1 min in 0.3x PBS and fixed for 10 min in 4 % PFA/0.3x PBS. Thereafter, the slides were 
washed thrice for 5 min each in 1x PBS. The nuclear membrane was permeabilised for 20 min in 
0.5 % Triton-X-100/PBS, following which, they were washed thrice for 3 min each in 1x PBS. 
The samples were immersed in 20 % Glycerol/PBS as a cryo-preservative and left to equilibrate 
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for 1.5 h at room temperature or over-night at 4 °C. The samples were then subjected to  
4 freeze/thaw cycles in liquid nitrogen, then washed thrice for 5 min each in 1x PBS and 
incubated for 7.5 min in 0.1 N HCl/H2O. After which the slides were washed three times for  
5 min each in 2x SSC. They were then equilibrated in 50 % formamide/2x SSC over-night at 4 °C 
and stored in this solution at 4 °C for up to three months.  
2.2.12.3. In situ hybridization (ISH) 
For ISH, both the cellular DNA as well as the probe DNA were denatured, combined together 
and renatured allowing the single stranded probe DNA to bind to single strands of the genomic 
DNA. The probes (2 µl of each probe, 1 µl human COT-1, 1 µl Salmon Sperm, 6 µl probe 
buffer) were denatured at 78 °C for 7 min and partially renatured for 20 min at 37 °C. In the 
meanwhile, the PFA-fixed cells (cellular DNA) were denatured at 72 °C for 3 min, immediately 
thereafter the probes were dropped onto 18 x 18 mm cover slips and combined with the 
denatured cell nuclei on the slides. The coverslips-slides were then sealed with rubber cement 
(Fixogum) and left to renature over 2 nights in a moist chamber at 37 °C in the dark.  During the 
entire preparation of PFA-fixed nuclei it was crucial to keep samples wet at all times as drying 
would lead to a collapse of the 3D architecture of the nucleus. 
After renaturation, the cover slips were removed and excess probe was washed off thrice for  
5 min each in 0.5 % Tween 20/4x SSC at 42 °C followed by three washes of 5 min each with  
1x SSC at 60 °C. Then the slides were dipped in 0.5 % Tween 20/4x SSC, equilibrated in PBS for 
5 min and stained with HOECHST 33342 (1:1000 of 1 mg/ml stock) for 3-4 min. Slides were 
washed twice for 3 min each in 1x PBS and embedded on to 22 x 22 mm coverslips in 15 µl 
ProLong Gold (Invitrogen). The ProLong Gold was left to harden over 1-2 nights before images 
were taken. 
2.2.12.4. Image acquisition and analysis 
Z-stack images were acquired at the Microscopy Core Facility, DKFZ, Heidelberg, with a Leica 
TCS SP5 Confocal Microscope using the 63x oil objective. 
Image analysis was performed using a custom-made ImageJ plugin. In order to exclude false-
positive spots, the position and the slices of appearance of the FISH probes were manually 
selected in the ImageJ software. FISH probes were confirmed to be sphere-shaped in 3D by 
determining the area of the (2D) spots of a FISH probe across confocal slices (Figure 12). In the 
ImageJ plugin the distance between FISH probes was then calculated as the 3D Euclidean 
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distance between the spot centres of the confocal slices with the largest area for each FISH 
probe, which was considered as the probe (sphere) centre (Figure 13). An output file consisting 
of the x, y and z co-ordinates of sphere centres of each FISH probe and distance measurements 
(four distances per cell) were generated for each image and the co-localization of the two 
chromosomes was studied.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 
Intensity measurements for the FISH probes  
(A)  Example of green FISH probe and a plot of it’s intensity. The arrow indicates the point of maximum intensity.   
(B)   A plot of the confocal slices versus intensity of a FISH probe. Each FISH probe appears and disappears over 
certain slices and there is always a slice where the probes intensity is maximum. This slice was considered as its 
z-position of the FISH probe. A sketch of a FISH probe was drawn, with the cross in the centre representing 
the slice of maximum intensity. 
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In order to set a threshold for the minimum distance between the FISH probes, which we would 
consider to be co-localized, we estimated the radius of the sphere described by a FISH probe in 
two different ways, which both yielded the same result. First, we determined the typical diameter 
of the (2D) spot with maximum area of a FISH probe (Figure 14A). This was found to be  
1.3 µm, yielding a radius R of 0.65µm. In a second estimate of the sphere radius, we measured the 
average number of slices in which the probes appear as 6. With a distance of 0.21 µm between 
consecutive confocal slices, this yields a diameter of 6 x 0.21 = 1.26 µm and a radius of 0.63 µm 
(Figure 14B), which is similar to the first estimate. 
If two FISH probes are adjacent or over-lapping then the 3D distance between probe centres 
should be less than or equal to the sum of the radii of both probes (Figure 14A). Taken together, 
we considered 1.2 µm to be the maximum distance for co-localization between any two FISH 
probes. Using the Matlab software the plots of distance measurements between the FISH probes 
for each human sample were generated. 
 
 
 
 
 
 
 
 
Figure 13 
3D Euclidean distance measurements between the FISH probes 
(A) A sketch of the distance (d) between two FISH probes as calculated using the slice of maximum intensity for 
each probe in the z-plane.  
(B) The 3D Euclidean measurements used to calculate the distance between the FISH probes. 
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Figure 14 
Estimations used to set the threshold for the minimum distance between the FISH  probes  
(A)   First an estimation was used to set a threshold for the minimum distance between the FISH probes, which we 
would consider to be co-localized. The typical diameter (D) of the FISH probes was found to be 1.3 µm, 
yielding a radius (R) of 0.65µm. Hence, if two FISH probes are adjacent or over-lapping then the sum of the 
radius (R) for both probes should be less than or equal to the diameter (R1+R2 ≤ D).  
(B)   The second criterion we considered was the average number of slices in which the probes appear as 6 and  
0.21 µm as the distance between consecutive confocal slices. This yields a diameter of 6 x 0.21 = 1.26 µm and a 
radius of 0.63 µm. Together; we considered 1.2 µm to be the maximum distance for co-localization between 
any two FISH probes. 
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3. Results 
3.1. Expression patterns and evolutionary conservation of promiscuous 
gene expression (pGE) 
The scope of promiscuous gene expression (pGE) largely determines the extent of central T-cell 
self-tolerance. Global gene expression patterns among thymic stromal cells clearly singled out 
mTECs as a cell type specialized in expressing TRAs (Derbinski et al., 2001; Anderson et al., 2002; 
Gotter et al., 2004; Derbinski et al., 2005). MTECs are a heterogeneous population with regards to 
their phenotype, expressing varying levels of co-stimulatory molecules like CD80, CD86 and 
MHCII, which denotes progressive maturation. The complete representation of pGE requires 
differentiation steps as shown previously in murine and human mTECs whereby the majority of 
promiscuously expressed genes is up-regulated in a subset, characterized by high level expression 
of MHCII, CD80/86 in addition to the expression of Aire (Nelson et al., 1993; Derbinski et al., 
2005; Derbinski and Kyewski, 2005; Taubert et al., 2007). Hence, to affirm previous observations 
showing a correlation between promiscuous gene expression and induction of these 
differentiation markers we chose to separate mTECs according to their relative expression levels 
of MHCII (into immature, MHCIIlo and mature, MHCIIhi mTECs). More so, we sought to gain a 
comprehensive insight into: firstly to what extent is the genome represented in the thymus, 
secondly to decipher underlying mechanisms/parameters/rules governing pGE and thirdly to 
study the evolutionary conservation of pGE. This study focused on mTEC subsets in different 
species (i.e. mouse, rat and human) and the phenomenon of pGE at a global level. 
We could have opted for the separation of complete mTECs from cTECs in order to get an 
insight into the above queries. But since they represent two distinct lineages, it would include the 
expression of lineage-specific genes. Hence, we decided to study gene expression within the 
mTEC cell-lineage focusing on its two different subsets of immature and mature mTECs. The 
MHCII molecule is well characterized in mice, rats and humans, thus in this study mTECs were 
separated into mature and immature subsets based on MHCII expression. The lower and upper 
30 % of MHCIIlo and MHCIIhi expressing mTECs from each species were enriched by density 
gradients/magnetic beads and sorted by FACS (Section 2.2.3, Figures 5, 6 and 7). RNA was 
isolated and part of the RNA was used for cDNA synthesis to perform a control qPCR to 
validate the quality of the sorts using a set of known differentially expressed genes (Section 2.2.5 - 
2.2.8 and Figure 9).  
A RNA collection of 3 mouse sorts (20 female mice each, in the range of 6-8 weeks of age), 5 rat 
sorts (5-6 female rats each, in the range of 7-9 weeks of age) and 11 human sorts (ranging from  
3 days to 3 years of age) were in vitro transcribed into labeled cRNA (Illumina® TotalPrep RNA 
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Amplification Kit, Ambion) and hybridized onto Expression BeadChip, Whole Genome Gene 
Expression Arrays (Illumina). The data were then further processed using Bead Studio 3.1 
(Illumina), R and Bioconductor packages. 
3.1.1. Estimation of the number of differentially expressed genes between 
MHCIIlo and MHCIIhi mTECs 
The probes on the arrays were annotated based on Ensembl genes. After Quantile normalization 
of the microarray data, the differentially expressed genes between MHCIIlo and MHCIIhi mTECs 
of each species were estimated using the criteria of p ≤ 0.01 and Fc (fold-change) greater/lesser 
than or equal to 2 (Fc ≥ 2 or Fc ≤ 2). 
 Mouse Rat Human 
Differentially expressed genes 1889 700 2000-3000 (2205) 
Up-regulated genes 1263 360 ~1226 
Down-regulated genes 626 340 ~980 
 
Table 3.1 
Comparison of differentially expressed, up-regulated and down-regulated genes between MHCIIlo and 
MHCIIhi mTECs from mouse, rat and human thymus 
Data represent 3 mouse sorts, 5 rat sorts and 11 human sorts. Values for humans are an estimation owing to the 
large inter-individual differences. 
 
The number of differentially expressed, up- and down-regulated genes between the three species 
was rather similar (Table 3.1), taking into consideration that the number of probes on the rat 
microarrays were half compared to mouse and human (22,000 probes for rat vs. 45,000 probes 
for mouse and 48,000 probes for human).  
In addition, the autoimmune regulator (Aire) dependency was also studied in mouse where the 
KO strain was available. Microarrays of MHCIIlo and MHCIIhi mTECs from Aire-/- female mice 
(3 sorts, 6-7 female mice each), were performed. Aire has been shown to control pGE at least 
partially by regulating the expression of numerous genes in mTECs with a predilection for TRAs 
(Anderson et al., 2002; Derbinski et al., 2005). This issue is of particular importance in the 
pathophysiology of the human autoimmune polyglandular syndrome type 1 (APS-1). APS-1 is a 
rare recessive, autosomally inherited monogenic disease, which is caused by mutations in the 
AIRE gene (Pitkanen and Peterson, 2003). This disease is modeled in Aire-/- mice and offers 
valuable information to study tolerance mechanisms since thymi of APS-1 patients are not 
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available for study (Anderson et al., 2002; Ramsey et al., 2002). From the microarray data the Aire-
dependent genes were defined as those genes whose: 1) difference in average expression of 
MHCIIhi - MHCIIlo mTECs in WT mice was significantly different from the difference in average 
expression of MHCIIhi - MHCIIlo mTECs in KO mice; 2) fold change was greater/lesser than or 
equal to 2 between MHCIIhi and MHCIIlo mTECs in WT mice and greater than the fold change 
in KO mice.  
Criteria for defining Aire-dependent genes: 
1. [avg. exp. MHCIIhi mTECs - avg. exp. MHCIIlo mTECs] in WT mice - [avg. exp. MHCIIhi 
mTECs - avg. exp. MHCIIlo mTECs] in KO mice 
2.  [Fc ≥ 2 or Fc ≤ 2 between MHCIIhi and MHCIIlo mTECs] in WT mice > [Fc ≥ 2 or Fc ≤ 2 
between MHCIIhi and MHCIIlo mTECs] in KO mice 
Using the above criteria, global analysis in Aire-/- female mice showed that a large number of 
genes were Aire-dependent in the up-regulated gene set. Yet, a large number of genes were also 
observed to be Aire-independent, thus confirming that Aire regulates only a part (~36 %) of 
genes that are differentially expressed in MHCIIhi vs. MHCIIlo mTECs (Table 3.2). 
 Up-regulated genes Down-regulated genes 
Aire-dependent genes 455 32 
Aire-independent genes 808 594 
 
Table 3.2 
Set of Aire-dependent and -independent up-regulated and down-regulated genes 
Data is a compilation of 3 Aire-/- mouse sorts. 
 
The human data showed large inter-individual variability, to such an extent that a common set of 
differentially expressed genes cannot be deduced. Table 3.5A shows the estimated number of up- 
and down-regulated genes within and between each patient. 
Extrapolating from the gene array analysis, we estimate that ~10 % of all known genes are turned 
on in mature MHCIIhi mTECs in addition to differentiation-dependent genes. This however is an 
under-estimate due to a methodological limitation, as the currently available genome-wide 
screening microarray platform has low sensitivity. Use of most modern Deep Sequencing 
technology may ultimately precisely define the promiscuously expressed gene pool. 
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3.1.2. Linking features of promiscuous gene expression 
After having defined the pools of differentially expressed genes in the different species, further 
studies into the properties of these genes were carried out. Anderson et al. first showed that genes 
expressed in mTECs are enriched for TRAs (Anderson et al., 2002). Subsequently our working 
group (Gotter et al., 2004; Derbinski et al., 2005) as well as Johnnidis’ (Johnnidis et al., 2005) 
described the bulk of promiscuously expressed genes that are turned on in the mature mTEC 
subset to be: 1) enriched in TRAs and 2) tend to co-localize in clusters in the genome. A direct 
link between these two features i.e. enrichment for TRAs and clustering had not been formally 
shown (Figure 15). How are these two features linked? One possibility is that TRAs are clustered 
in the genome irrespective of functional or structural relatedness. PGE would project onto such 
TRA clusters to various extents in mTECs. In order to test this notion, TRAs were operationally 
defined, their genomic position deduced and genome-wide analysis of gene clusters was 
performed.  
pGE
Enriched TRAs Gene clustering
?
 
Figure 15 
Linking features of pGE 
PGE is known to enrich for TRAs and clustered genes. How do these features link? 
3.1.2.1. Defining tissue-restricted antigens (TRAs) 
Gene expression data from the public database at http://symatlas.gnf.org (Su et al., 2004) were taken 
for the identification of tissue-restricted genes. This database contains expression assignments for 
many different tissues and cell types derived by gene array analysis. A gene was defined as a TRA, 
if its expression was above 5X the median (the median expression over all tissues) in less than 
five tissues. From the database in mouse, 61 different tissues were listed. The gene expression 
data for 20,000 non-redundant annotated genes were analyzed over 61 tissues. By these criteria, 
5000 genes in the mouse genome were defined as TRAs (Figure 16).   
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Figure 16 
Defining TRAs in mouse 
The public database http://symatlas.gnf.org (Su et al., 2004) was used to identify tissue-restricted antigens (TRAs). Array 
expression data of each gene was plotted across the various tissues. The median expression was set across all tissues 
and a gene was defined as a TRA, if its expression was above 5X the median in less than five tissues.  
(A) Example of a TRA, Casein beta (Csn2) exclusively expressed in the mammary gland. Note that Csn2 is not 
detected in the thymus, though it is known to be expressed as a TRA in the thymus. This is due to 3 reasons:  
1) pGE tested by PCR is 10,000 or more fold lower in mTECs than in the respective tissue cell type  
(J. Derbinski unpublished data); 2) here the expression is tested in complete thymus and not purified mTECs;  
3) the array data is of lower sensitivity than PCR, hence making Csn2 too low to score. 
(B) Example of a non-TRA, 4632404H12Rik, which is widely expressed across all tissue. 
A 
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The same method was used to define TRAs in human over 57 tissues listed in the database. A 
total of 3294 TRAs are present in the human genome from 22,284 non-redundant annotated 
genes (Figure 17).  
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Figure 17 
Defining TRAs in human 
The public database http://symatlas.gnf.org (Su et al., 2004) was used to identify tissue-restricted antigens (TRAs) in 
human just as described above for mouse.  
(A) Example of a TRA, L-lactate dehydrogenase A chain (LDHA) primarily expressed in smooth muscle.  
(B) Example of a non-TRA, Lysophospholipase II (LYPLA2), which is widely expressed across all tissues. 
 
Owing to the lack of sufficient information in the Symatlas database as well as in the annotation 
of the rat genome, only 12 different tissues could be defined. Since this would create a bias while 
calculating the median expression over these tissues, TRAs in rat were defined using mouse 
orthologs. Next we analyzed whether these defined TRAs are randomly distributed or clustered 
in the genome.   
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3.1.2.2. Gene clustering 
In order to analyze gene clustering independent of gene density, a 10-gene sliding window 
approach was used as described by Derbinski et al. (Derbinski et al., 2005). In this method, a 
sliding 10-gene window is used to count for the number of TRAs within 10 consecutive genes on 
each chromosome (Figure 18). Firstly, the physical position of the non-redundant annotated 
genes was designated on their chromosomes using the Ensembl database. Then, the 10-gene 
sliding window clustering algorithm was run and the cluster size was recorded. As it turned out 
that in some cases, immediately neighbored clusters were < 10 genes apart, an assembly step was 
appended to the algorithm to combine such clusters. The significance of the clustering was 
determined by repeating the same procedure 1,000 times in each case with a list of random genes 
of the same size as the experimental dataset and the results were compared with the number of 
clusters found. 
Chromosome
Non-TRAs
TRAs
Genes  
Figure 18 
10-gene sliding window clustering algorithm 
To analyze gene clustering, a 10-gene sliding window was used to count for the number of TRAs within 10 
consecutive genes on each chromosome. Then the window was moved to the adjacent gene and the same procedure 
was performed over all chromosomes, to finally give a cluster plot, described in Figure 19. For immediately 
neighbored clusters which were < 10 genes apart an assembly step was appended to the algorithm to combine such 
clusters. 
Preferential chromosomal localization has been reported for genes co-expressed in certain cell 
lineages and serving a common function (Wang et al., 2001; Ramalho-Santos et al., 2002; Hurst et 
al., 2004). We analyzed, if TRAs per se are clustered in the genome. Indeed, in all three species it 
was observed that TRAs tend to co-localize in clusters, the largest comprising up to 117 genes in 
mouse (Figure 19A), 130 genes in rat (Figure 19B) and 63 genes in human (Figure 19C). This 
clustering of more than 4 TRAs was highly significant when compared with random distributions 
of genes. Taken together, TRAs are clustered in the genome in the studied species, this is highly 
significant and the degree of clustering is similar between all three species. 
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Figure 19 
Genome-wide TRA cluster maps in mouse, rat and human 
After running the 10-gene sliding window clustering algorithm, the cluster size k (number of TRAs in a cluster,  
x-axis) is plotted versus the number of clusters of a particular size (k; y-axis). The significance of clustering was 
determined by repeating the same procedure 1,000 times in each case with a list of random genes of the same size as 
the experimental dataset (violet bars).  
(A) Mouse genome-wide TRA clusters show that TRAs are significantly clustered in the genome, with the largest 
cluster comprising 117 TRAs.  
(B) Rat genome-wide TRA clusters show that TRAs are significantly clustered in the genome, with the largest 
cluster comprising 130 TRAs.  
(C) In human, the same was observed; TRAs are significantly clustered in the genome, with the largest cluster 
comprising 63 TRAs.   
In all cases clusters >4 TRAs are significantly different from the random samples. 
C 
Human 
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3.1.3. Gene clusters are present in syntenic regions across species 
Since TRAs in all three species are clustered in the genome, it was of interest to know if they are 
localized within certain conserved regions i.e. syntenic regions on the same or on different 
chromosomes of the different species. Hence, matching of orthologous gene TRA clusters in the 
mouse and human genome was performed based on HomoloGene (NCBI). 
It was observed that most of the clusters were localized in syntenic regions conserved between 
mouse and human (Figure 20). The gene order in these clusters in both species was mostly 
conserved, i.e. a co-linear relationship was observed (Figure 20A). In some cases, the gene order 
was inverted (Figure 20B). The gene density of TRAs in the clusters was generally higher in 
mouse than in human. This analysis was not performed in rat due to the poor annotation of the 
rat genome. 
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Figure 20 
TRA cluster maps of syntenic regions 
(A)  An example of a co-linear syntenic cluster on mouse chromosome 11 and human chromosome 7 shows  
8 orthologs. Clusters in both species have different gene density (30 % in human and 59 % in mouse) and 
numbers of TRAs (49 TRAs in human versus 26 TRAs in mouse). The gene order in both species was 
conserved. 
(B) An example of an inverted syntenic cluster on mouse chromosome 4 and human chromosome 1 shows an 
overlap of 18 orthologs. Clusters in both species have different gene densities (30 % in human and 40 % in 
mouse) and numbers of TRAs (62 TRAs in human versus 72 TRAs in mouse). The gene order in both species 
was inverted in this case. 
 
3.1.4. Gene homology within TRA clusters in the mouse genome 
In order to investigate, if TRA clusters in the genome arose from gene duplication or are the 
result of co-localization of structurally and functionally related genes, a homology match was 
performed on the TRAs within each cluster. To do so, the nucleotide sequence of each particular 
TRA within a cluster was compared to the sequence of every other TRA within the same cluster. 
A homology plot denoting the percent sequence identity (% Id) of each such comparison within 
every cluster was plotted (Figure 21A). The percent identity of majority of the TRAs within 
clusters is ~30 %. The threshold probability of four nucleotides (ATGC) is 25 %. A few outliers 
(circles) having a high percent identity ~60-99 % are likely to be gene families (Figure 21A). For a 
set of random genes, the percent identity was in the range of 25-30 % homology (Figure 21B). 
Thus, the bulk of the TRA clusters contain structurally unrelated genes that do not insinuate a 
common deviation by gene duplication or gene conversion, which would explain their co-
localization in the murine genome.  
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Figure 21 
Homology plot of mouse TRA clusters 
The nucleotide sequence of each particular TRA within a cluster was compared to the sequence of every other TRA 
within the same cluster. A homology plot denoting the percent sequence identity (% Id) of each such comparison 
within all clusters was plotted. 
(A) In mouse clusters, the %Id of majority of the TRAs is ~30 %, while the threshold probability of four 
nucleotides (ATGC) is 25 %. The circles represent outliers having a high percent identity, ~60-99 % which are 
likely gene families.  
(B) In comparison, a homology analysis with a set of random genes was performed. The percent identity is also in 
the range of 25-30 % and very few high %Id genes pairs were detected compared to the mouse TRA clusters. 
Thus, the bulk of the mouse TRA clusters contain non-homologous genes.  
3.1.5. Analysis of gene expression between immature and mature mTECs 
in the thymus 
We defined TRAs, their genomic distribution and demonstrated that TRAs are clustered in the 
genome irrespective of structural relatedness or apparent immunological criteria. It was 
previously published that promiscuously expressed genes are enriched in TRAs (Anderson et al., 
2002; Gotter et al., 2004; Derbinski et al., 2005; Johnnidis et al., 2005) and during progressive 
maturation, mTECs show an increased pGE, concomitant with Aire expression. Using a more 
complete second generation microarray platform, larger and better annotated genome database 
and robust computed TRA definition, we sort to reanalyze previous findings: 1) TRA enrichment 
and 2) Aire-dependency in mouse. Previous studies were performed on both (immature and 
mature) mTEC subsets in mouse and on complete mTECs in human; here our studies extend to 
these subsets in mouse, human and rat.  
3.1.5.1. Analysis of the differentially expressed gene content in murine 
mTECs: TRAs and Aire dependency  
PGE has been tightly correlated with the differentiation stage in mTECs i.e. mature mTECs 
(Derbinski et al., 2005). In this study MHCII was chosen to separate mTECs into immature and 
mature stages of differentiation. Based on genome-wide TRA definition, the thymic differentially 
expressed genes (MHCIIlo vs. MHCIIhi mTECs) were designated as TRAs or non-TRAs. Due to 
the importance of Aire in regulating the expression of numerous genes in mTECs with a 
predilection for TRAs (Anderson et al., 2002; Derbinski et al., 2005; Johnnidis et al., 2005) and the 
availability of Aire-/- mice, the Aire dependency was studied. To delineate the size and diversity of 
Aire-dependent vs. Aire-independent gene pool, genome-wide microarrays were performed using 
Aire-/- mice.  
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 Up-regulated genes Down-regulated genes 
Total gene number 1263 626 
Aire-dependent genes 455 (240 TRAs, 53 %) 32 (17 TRAs, 50 %) 
Aire-independent genes 808 (391 TRAs, 48 %) 594 (234 TRAs, 39 %) 
 
Table 3.3 
Comparing the percentage of Aire-dependent and -independent differentially expressed genes in murine 
thymus (between MHCIIlo and MHCIIhi mTECs) 
The percentage of TRAs was calculated in each gene set. 
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Figure 22 
Representation of TRAs and Aire dependency in mouse thymic differentially expressed genes 
The percentage of TRAs in up- or down-regulated Aire-dependent or -independent genes were plotted. It was 
observed that MHCIIhi mTECs have a large number of Aire-dependent and -independent genes. The down-
regulated gene pool shows a small number of Aire-dependent genes, though 50 % are TRAs. Most of the down-
regulated genes are Aire-independent. The plot corresponds to Table 3.3.  
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In mice, 1263 genes were up-regulated versus 626 genes which were down-regulated from 27,000 
well annotated mouse genes. It was observed that MHCIIhi mTECs express a large number of 
Aire-dependent and -independent genes, both of which appeared to be enriched in TRAs. The 
up-regulated Aire-dependent genes showed 5 % more TRAs as compared to the Aire-
independent gene set (Table 3.3 and Figure 22). The down-regulated gene pool showed a small 
number of Aire-dependent genes, though 50 % were TRAs (Table 3.3). Most of the down-
regulated genes were Aire-independent, consisting of 39 % TRAs (Table 3.3 and Figure 22). 
Nonetheless both up- and down-regulated genes appeared to have similar percentages of Aire-
dependent TRAs while the up-regulated gene pool had 9 % more Aire-independent TRAs. Thus, 
it appears that the maturation stage i.e. MHCIIhi mTECs and not Aire per se has an effect on 
both number and fraction of TRAs. 
3.1.5.2. How is pGE projected onto pre-existing genome-wide mouse TRA 
clusters? 
We affirmed previous observations that pGE in mTECs is enriched in TRAs and in part 
regulated by Aire while others are Aire-independent. The percentage of TRA content is far above 
the background of 10.8 % in the genome. Here we aimed at studying the projection of pGE onto 
pre-existing genome-wide TRA clusters that were defined in the previous chapter.  
In the mouse genome, 364 gene clusters ranging from 4 - 117 TRAs were identified. The set of 
thymic differentially expressed genes (Aire-dependent and -independent genes) were plotted onto 
these clusters giving rise to cluster maps for each chromosome. It was observed that, 
promiscuously expressed TRAs tend to map to these clusters; within each cluster, TRAs were 
intermingled with non-TRAs. It was rather rare that a cluster comprised purely TRAs. Moreover 
Aire-dependent and -independent genes were interspersed among each other. Part of the genes 
within clusters was regulated during mTEC differentiation (Example Figure 23A).  
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Figure 23 
Example of cluster 13 on mouse chromosome 13 
(A) 364 clusters, ranging from 4 - 117 TRAs were identified. Here, an example of one such TRA cluster onto which 
the projection of mouse mTEC differentially regulated genes is depicted. Color code legend represents each 
type of gene set, Aire-dependent (red and blue boxes, filled colored boxes-TRAs; non-filled colored boxes-non-
TRAs) and -independent (orange and green boxes; filled colored boxes-TRAs, unfilled colored boxes-non-
TRAs) differentially regulated genes between MHCIIlo and MHCIIhi mTECs as well as remaining unregulated 
genes (cyan-TRAs and white-non-TRAs boxes). TRAs were intermingled with non-TRAs. No pure TRAs 
cluster was identified. Aire-dependent and-independent genes were interspersed among each other. The gray 
box depicts TRAs and the brown box represents the non-TRAs. While the red and maroon circles within these 
boxes represent the regulated TRAs or non-TRAs respectively. The orange arrow represents the region in 
which real-time PCR analysis was performed to confirm the gene regulation within a cluster. 
(B) Real-time PCR analysis of a region (marked by orange arrow Figure 23A) of cluster 13 on chromosome 13 in 
WT MHCIIlo and MHCIIhi mTECs, normalized to Ubiquitin. It was observed that the genes detected by the 
microarray to be differentially expressed (either up- or down-regulated) between MHCIIlo and MHCIIhi 
mTECs reflect the same expression pattern using PCR. Dotted line represents the level of Aire expression in 
MHCIIlo mTECs, which was considered as a minimal expression threshold. 
 
The set of differentially expressed genes projected onto the genome-wide clusters are deduced 
from bioinformatic processing of the microarrays which is likely to be incomplete. Even though 
chips contain all known well annotated genes, array analysis is less sensitive than real-time PCR 
and promiscuously expressed genes are expressed at low levels. Therefore, the total number of 
differentially expressed promiscuous genes will be underestimated by at least a factor of two. 
Hence, to gain a more complete, true picture of gene regulation within clusters and to study if 
neighboring genes are regulated as a unit or whether individual genes are subjected to differential 
regulation as observed with the array data, we performed real-time PCR. A core region of cluster 
13 on chromosome 13 was selected and differential gene expression within this region was 
analyzed using real-time PCR in MHCIIlo/hi WT mTECs (Figure 23B; region marked orange 
arrow). It was observed that the genes depicted on the microarrays to be differentially expressed 
(either up- or down-regulated) between MHCIIlo and MHCIIhi mTECs reflect the same 
expression pattern using PCR (Figure 23B; Slc6a3, Lpcat1, Slc12a7 and Nkd2). Some, genes 
considered to be unregulated did not always follow the array expression and were differentially 
regulated (Figure 23B; e.g. Irx2, Tppp and Tert). Taking the level of Aire expression in MHCIIlo 
mTECs as a minimal expression threshold, it was observed that several genes qualified as 
expressed and their expression was higher than that in microarrays. A three-log difference in 
expression was seen for certain genes (Figure 23B e.g. Slc6a3, Slc6a18). In addition, the Aire 
dependency of the genes within this cluster region was studied using Aire KO. Most of them had 
the same pattern of expression on both platforms i.e. array and PCR (data not shown). 
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Overall, a heterogeneous contiguous expression pattern was observed in mTECs at the 
qualitative level using real-time PCR (with the exception of Slc6a19, which was detected in 
complete thymus but not purified WT mTECs). Extrapolating from the gene array analysis, we 
estimate ~10 % of all known genes are turned on in mature MHCIIhi mTECs in addition to 
differentiation-dependent genes. This however is an under-estimate due to a methodological 
limitation, as the currently available genome-wide screening microarray platform has low 
sensitivity. Use of most modern Deep Sequencing technology may eventually precisely define the 
promiscuously expressed gene pool. 
3.1.5.3. Are TRAs regulated over non-TRAs within gene clusters in murine 
mTECs? 
Within each cluster, TRAs were intermingled with non-TRAs (Figure 23A). It was of interest to 
study, if the TRAs within clusters are preferentially regulated in mTECs over the non-TRAs. 
Hence, the proportion of regulated TRAs vs. regulated non-TRAs from each of the 364 clusters 
was statistically analyzed. Combined regulation within all 364 clusters showed that there was a 
higher tendency of the TRAs being regulated within the clusters versus that of the non-TRAs. 
11.7 % TRAs versus 4.6 % non-TRAs were regulated (Figure 24). The preferential TRA 
regulation within clusters is highly significant (p ≤ 2.2 x 10-16). The percentage of regulation of 
TRAs within clusters ranged from 0 to 50 %. 
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Figure 24 
Preferential regulation of TRAs within clusters 
Over the 364 clusters, the regulation of TRAs versus non-TRAs (e.g. red and maroon circles, Figure 23A) was 
plotted. The extent of the TRAs being regulated within the clusters was higher versus that of the non-TRAs. This 
difference is highly significant having a p ≤ 2.2 x 10-16.  
 
3.1.5.4. Analysis of the differentially expressed gene content in rat mTECs 
In rat, the mTECs were separated into immature and mature cells based on MHCII as in mouse 
and human. 700 genes were found to be differentially expressed from 22,000 annotated rat genes. 
From these, 360 were up-regulated and 340 were down-regulated.  
An ortholog match between rat and mouse using HomoloGene (NCBI), showed 624 mouse 
orthologs (from 700 differentially expressed genes), 94.4 % of which were also differentially 
regulated in mouse (589 genes) (Table 3.4). 75.7 % up-regulated and 64.3 % down-regulated 
genes followed the same regulation pattern in rat and mouse. Thus, there exists a large over-lap 
of promiscuously expressed genes between these two species, further corroborating the notion of 
an evolutionary conservation of pGE. 
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Rat 
Mouse 
Orthologs 
Regulated in 
mouse 
Percentage 
overlap - 
Regulated rat 
and mouse genes
Differentially 
expressed genes 
700 624 589 94.4 % 
Up-regulated genes 360 333 252 75.7 % 
Down-regulated 
genes 
340 291 187 64.3 % 
 
Table 3.4 
Set of rat differentially-, up- and down-regulated genes between MHCIIlo and MHCIIhi mTECs and their 
corresponding mouse orthologs 
The regulation of the mouse orthologs and the percentage overlap between the two species are shown. 
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Figure 25 
Percentage of TRAs within regulated rat genes 
The percentage of genes up- or down-regulated in mature rat mTECs is shown. MHCIIhi mTECs are enriched in 
TRAs, having a higher percentage of TRAs than MHCIIlo mTECs (40 % TRAs vs. 31 % TRAs). The rat TRAs were 
defined using mouse orthologs.  
Owing to the lack of sufficient information in the Symatlas database as well as in annotation of 
the rat genome, TRAs in rat were defined using mouse orthologs. Of 360 up-regulated genes in 
rat, 141 correspond to mouse TRA orthologs (~40 %). While in the set of 340 down-regulated 
genes in rat, 104 correspond to mouse TRA orthologs, (~31 %). MHCIIhi mTECs are enriched in 
TRAs versus MHCIIlo mTECs (Figure 25). The percentage of TRAs in rat is under-estimated as a 
number of genes will be missed by way of comparing the genomes between the two species; as 
observed it is lower than in mouse (Figure 22). 
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3.1.5.5. Analysis of the differentially expressed gene content in human 
mTECs 
The immature and mature mTECs (MHCIIlo and MHCIIhi respectively) from 11 different 
individuals ranging from 3 days to 3 years of age were isolated from their thymus. The mTECs 
were enriched using three different methods (Density gradients, depletion of CD45+ cells using 
either Dynal beads or Miltenyi beads) as described earlier (Section 2.2.3.3). Gene array results 
showed substantial variations in the number of differentially expressed gene between the 
different individuals. The number of differentially expressed genes ranged from ~700 to 6000 
(Table 3.5A). Differences were observed irrespective of the different isolation methods used. 
Hence, it can be excluded that the variation arose due to the isolation methods used. 
Seeking for a common set of differentially expressed genes between individuals we found a 
negative correlation between the number of individuals and the number of common/overlapping 
genes. The intersection interval which is the extreme point in the comparison containing genes 
that are differentially expressed in all 11 individuals showed only 24 common differentially 
expressed genes, 18 genes were up-regulated and 6 genes were down-regulated (Table 3.5B). 
AIRE can be considered as a measure for the degree of enrichment of MHCIIhi mTECs of the 
individual samples. Since, AIRE is the driving force for many of the promiscuously expressed 
genes in the mature mTEC population, the correlation between the number of differentially 
expressed genes and fold change in AIRE expression was determined. There does exist a 
correlation between the fold change in AIRE expression (between MHCIIlo and MHCIIhi 
mTECs) and the number of differentially expressed genes, (correlation coefficient, r = 0.5), 
though two individual samples were outliers (Table 3.5C and Figure 26).   
This is the first time that such striking inter-individual difference in pGE is found, though 
Taubert et al.  also reported considerable variability in the expression of several target auto-
antigens in mTECs (Taubert et al., 2007). These variations could result from differences in the 
genetic background, environmental factors, disease/health condition of the individuals and pre-
medication. The observed variations in antigen expression are likely to influence T-cell repertoire 
selection and thus tolerance thresholds in human provided they reflect steady state values. 
Taken together, the results in the three species show that promiscuously expressed genes are 
enriched in TRAs that are partitioned into clusters and this phenomenon is conserved between 
species. Clusters harbor both TRAs and non-TRAs that are interspersed between each other. 
TRAs are preferentially regulated during mTEC differentiation. Moreover, genes within a 
particular gene cluster are subject to partial co-regulation. The bulk of the TRA clusters contain 
structurally unrelated genes. Based on these data, we propose these clusters to be the 
“operational genomic unit” of pGE in the thymus. 
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Table 3.5 
Representation of gene expression data from different individual thymi 
Human mTECs (MHCIIlo and MHCIIhi) were isolated from thymus samples for 11 different individuals ranging 
from 3 days to 3 years of age. The mTECs were enriched using three different methods (Density gradients, Dynal 
beads and Miltenyi beads) as described earlier (Section 2.2.3.3). 
(A) Comparison of differentially-, up- and down-regulated genes between MHCIIlo and MHCIIhi mTECs from 
each individual thymus.  
(B) Number of differentially-, up- and down-regulated genes expressed in at least “n” individuals, n = 2 to 10. 
Union and intersection intervals are the extreme points in the comparison: where union means all genes that 
are found to be differentially expressed in at least one individual; intersection contains genes that are 
differentially expressed in all 11 individuals. 
(C) Fold change of AIRE expression between MHCIIlo and MHCIIhi mTECs from individual thymi.  
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Figure 26 
Correlation between number of differentially expressed genes and fold change in AIRE expression in the 
different individual thymi 
Correlation plot of the number of differentially expressed genes and fold change in AIRE expression between 
MHCIIhi and MHCIIlo mTECs in the 11 individual samples, (correlation coefficient, r = 0.5). Two individual samples 
were outliers. 
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3.2. “Holes” in the thymic antigen repertoire: implications for central 
tolerance and autoimmunity 
Genome-wide studies of pGE in mTECs showed a respectful representation of the genome in 
the thymic antigen repertoire, but this is not a complete representation. “Holes” or absence in 
expression of certain genes in the thymus, should lead to lack of central tolerance for particular 
antigens, therefore it would be a preferential target for autoimmune disease. An important 
question in organ-specific autoimmune diseases is: why the loss of self-tolerance is so selective 
that only certain tissues and auto-antigens are targeted?  
Two prominent examples of target antigens in autoimmune diseases are: glutamic acid 
decarboxylase (GAD) involved in insulin-dependent diabetes (IDD) (Tisch, 1996; Yoon et al., 
2000; Lernmark, 2002) and cardiac myosin heavy chain (MyHC) involved in myocarditis 
(Wolfgram et al., 1985; Neu et al., 1987; Rose, 2000). Both cases involve two isoforms in which 
the expression of either one of the two is lacking in the thymus. This lack of expression may 
represent a “pitfall” of pGE. It is possible that the non-expressed isoform is embedded in a silent 
chromosomal context i.e. “region of closed chromatin’’. We started to investigate this possibility 
by analyzing the thymic expression of the flaking regions of these gene loci. 
3.2.1. Regulation of the GAD65/GAD67 loci in human thymus 
Glutamic acid decarboxylase (GAD), a target of both auto-antibodies and autoreactive T-cells in 
insulin-dependent diabetes (IDD), exists as two homologous forms, GAD65 and GAD67. 
GAD65 is predominantly expressed in human islets (pancreas) and recognized by auto-antibodies 
in IDD, but which form primarily elicits GAD autoimmunity is unknown. Gotter and colleagues 
showed that GAD65 is apparently absent from mTECs of healthy humans and thus is likely to be 
absent from the human thymus while GAD67 is present in the thymus (in mTECs). Its absence 
in the thymus, i.e. lack of central tolerance could explain the occurrence of specific 
autoantibodies in the course of IDD, as an inverse expression pattern is observed between 
occurrence of GAD65 antibodies and thymic expression (Gotter et al., 2004). Why is GAD65 not 
expressed in the thymus? Are there certain molecular clues in terms of its genomic position? To 
answer the above questions the expression of the GAD65 locus spanning ~2 Mb was analyzed in 
the different mTEC subsets. 
The GAD65 and GAD67 clusters are evolutionary conserved in human and mouse (Figures 27 
and 28).  
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Figure 27 
Comparison of genomic location of GAD1 (GAD67) in mouse and human  
Red box depicts the location of GAD1 in each species.  
(A) GAD1 is located on the same chromosome in human and mouse i.e. chromosome 2. Blue box on the mouse 
chromosome 2 represents the GAD65 gene. 
(B) In depth view of the genomic location of GAD1 in human and mouse, showing the high degree of 
conservation of the gene cluster. Green lines indicate the common genes within this region, for which PCR was 
performed in human. 
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Figure 28 
Comparison of genomic location of GAD2 (GAD65) in mouse and human  
Red box depicts the location of GAD2 in each species. 
(A) GAD2 is located on a different chromosome in human and mouse i.e. chromosome 10 in human and 
chromosome 2 in mouse, 47 Mb down-stream of GAD1. Blue box on the mouse chromosome 2 represents 
the GAD1 gene. 
(B) In depth view of the genomic location of GAD2 in human and mouse, showing the high degree of 
conservation of the gene cluster. Green lines indicate the common genes within this region, for which PCR 
was performed in human. Even though the region is located on different chromosomes it is highly conserved, 
though the regulation differs in both species, that being expressed in mouse, while absent in human. 
 
Real-time PCR analysis of both loci in human, showed that all genes within the GAD67 cluster 
were expressed in the thymus, GORASP2 showed the lowest expression. Most genes were not 
differentially regulated between MHCIIhi and MHCIIlo mTECs, except for SP5 and GAD67. The 
entire gene locus had a rather regular expression with genes 5’ to GAD67 being more strongly 
expressed (Figure 29A; MYO3B, SP5, AC007405). Interestingly, in the GAD65 locus, most genes 
were expressed, though not differentially between the two mTEC subsets. Expression was 
however more variable than in the GAD67 locus, with low to almost absent levels of expression 
for GPR158 and GAD65 in the thymus or purified mTEC populations. Intriguingly, MYO3A 
that is located between these two genes was expressed at relatively high levels (Figure 29B). 
Moreover, genes immediately downstream 3’ to GAD65 showed a lower expression (Figure 29B; 
APBB1IP, PDSS1, SSH3BP). Thus, the lack of expression of GAD65 may be related to the low 
overall transcriptional activity 3’ to GAD65.  
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Figure 29 
Gene expression profile in the GAD1/GAD2 clusters in human thymus 
Purified mTECs, MHCIIlo and MHCIIhi mTECs from human thymus were used to perform real-time PCR analysis 
of GAD1 (A) and GAD2 (B) loci in human, spanning a region of ~1 Mb of the GAD1 locus and ~2 Mb of the 
GAD2 locus. The expression was normalized to GAPDH. Dotted line represents the level of Aire expression in 
MHCIIlo mTECs, which was considered as a minimal expression threshold. The GAD67 gene locus had a rather 
regular expression with genes 5’ to GAD67 being more strongly expressed while the expression was more variable in 
the GAD65 locus, with low to almost absent levels of expression for GPR158 and GAD65 in the purified mTEC 
populations. Moreover, genes immediately downstream 3’ to GAD65 showed a lower expression.  
B 
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3.2.2. Regulation of the MYH6/MYH7 locus in human and murine thymus 
The next target gene studied was the cardiac myosin heavy chain (MyHC), a primary contractile 
protein of the heart which is involved in the pathogenesis of myocarditis. Myocarditis is the most 
common cause of heart failure in young individuals (Towbin et al., 2006). Individuals after open-
heart surgery and myocardial infarction show auto-antibody responses against cardiac tissue-
specific antigens, the most prominent of which is MyHC (Wolfgram et al., 1985; Neu et al., 1987).  
The heart expresses two highly homologous isoforms of MyHC, that differ by 6.5 % in their 
amino acid sequence: α-MyHC (MYH6), is expressed exclusively in cardiac muscle and  
β-MyHC (MYH7), is expressed in both cardiac and slow (type I) skeletal muscle (Weiss and 
Leinwand, 1996). In humans, β-MyHC is the major isoform expressed in heart, though 
autoimmune myocarditis is initiated by Th1 CD4 T-cell immune responses against α-MyHC. It 
was shown that IgG auto-antibodies are initially directed against unique epitopes of α-MyHC, but 
these responses rapidly broaden to epitopes of α-MyHC that are shared with β-MyHC, followed 
by recognition of other cardiac proteins. The basis of the immunogenicity unique to the α-MyHC 
isoform had been unclear. It was plausible that the same reasoning could apply as in the case of 
GAD65 where its absence in the thymus, i.e. lack of central tolerance, could explain the frequent 
occurrence of specific autoantibodies. Thus, the thymic expression of MYH6 and MYH7 in 
different mTEC subsets was analyzed. 
The MYH6 and MYH7 gene loci are evolutionary highly conserved in human and mouse and 
present within a syntenic region on chromosome 14 (Figure 30). These two genes are adjacent to 
each other in both mouse and human (Figure 30B).  
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Figure 30 
Comparison of genomic location of MYH6 and MYH7 in mouse and human  
Red box depicts the location of MYH6 and MYH7 in each species. 
(A)  MYH6 and MYH7 are located on chromosome 14 in human and mouse.  
(B) In depth view of the genomic location shows a high degree of conservation of the MYH gene cluster. Green 
lines indicate human/mouse MYH6 and MYH7 orthologs, for which PCR was performed. In both species 
the genes are immediately adjacent to each other, ~ 28-30 kb apart. They differ by 6.5 % in their amino acid 
sequence. 
B 
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Real-time PCR of these two genes in mouse (Figure 31A) and human (Figure 31B) mTECs 
showed that the transcripts for α-MyHC (MYH6) were absent, while they were present for  
β-MyHC (MYH7). A similar situation was described above for GAD65 and GAD67. What is 
more striking is that MYH6 and MYH7 are not only present within the same gene cluster but are 
adjacent genes. Thus, the predominant autoimmune response to MYH6 in mouse and man is 
correlated with a lack of its expression in mTECs and thus is likely to be absent in the thymus. 
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Figure 31 
Expression patterns of MYH6 and MYH7 in mouse and human thymi 
Purified mTECs and cTECs from mouse (A) and human (B) thymi were used to perform real-time PCR analysis of 
MYH6 and MYH7. The expression was normalized to beta-actin in mouse and GAPDH in human and relative to 
the respective positive organ (red bars), i.e. Atria for MYH6 expression, Ventricle for MYH7 expression and Brain 
for GAD67 or GAD65 expression. GAD67 was taken as the positive control, while GAD65 as the negative control 
for human mTECs. Real-time PCR in both mouse and human mTECs showed that the α-MyHC transcripts 
(MYH6) were absent, while present for β-MyHC (MYH7).  
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3.3. Study of pGE in mTEC subsets expressing a particular antigen  
The population studies done prior in mouse and rat shows a fair representation of the genome in 
the thymic antigen repertoire. PGE was conserved between the studied species, however in the 
case of human the promiscuously expressed gene pool varied considerably. Previous studies 
showed that an individual gene is expressed in only few (~1-3 %) mTECs (Derbinski et al., 2001; 
Cloosen et al., 2007; Taubert et al., 2007) and that genes within the casein locus were stochastically 
expressed in single cells (Derbinski et al., 2008). What decides which given gene/group of genes is 
expressed in a single mTEC? Do individual mTECs have a free choice of selecting any 
combination of genes or do restrictions for co-expression exist? Conceivably the expression of a 
given gene would co-induce the expression of a certain set of linked genes. To address these 
intricate questions, mTECs that express a particular antigen were studied. The feasibility of this 
approach had been demonstrated by J. Arnold using antibodies to surface expressed antigens, 
mucin-1 (MUC1) and carcinoembryonic antigen (CEA) (Arnold, 2006).  
3.3.1. Co-expression studies of MUC1 expressing mTECs at the population 
level 
Previous studies at the population level indicated the existence of certain rules of co-expression; 
expression not does appear to be purely stochastic. Human MUC1+ mTECs co-express 
CEACAM5 and MUC4 (Arnold, 2006). The frequency of co-expression was far above that 
expected on a stochastic basis; this implied a co-expression at the single cell level as well.  
The same methodology of isolating MUC1 expressing mTEC as described by J. Arnold was used 
and extended in this study. MUC1+ and MUC1- mTECs were sorted by flow cytometry (Sections 
2.2.3.3.1, 2.2.3.3.4 and 2.2.3.3.5). From the sort profile (Figure 32) a clear population of MUC1+ 
mTECs could be distinguished. These cells were primarily MHCIIhi, while the MUC1- mTECs 
covered the entire range of MHCII levels. The top 2 % MUC1+ cells and the lower 4-5 % MUC1- 
cells were sorted (Arnold, 2006; Cloosen et al., 2007), yielding rather low cell numbers in the 
range of 10,000-50,000 sorted cells per thymus sample. Hence we were limited in studying these 
cell populations. 
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Figure 32 
Isolation of  MUC1 antigen expressing mTECs from human thymus 
The human MUC1 expressing mTECs were stained and sorted for their (A) MUC1 expression versus non-
expression negative control without MUC1 antibody (B). From the sort profile a clear population of  MUC1+ 
mTECs being primarily MHCIIhi could be distinguished (C). The top 2 % MUC1+ cells and the lower 4-5 % MUC1- 
cells were sorted. 
 
Nonetheless, RNA was isolated, cDNA was prepared (Section 2.2.6) and qPCR was performed 
(Section 2.2.8). MUC1 mRNA was enriched in all samples in the MUC1+ mTECs versus the 
MUC1- mTECs. Co-expression of MUC1 with MUC4 (a family member) and CEACAM5 at the 
population level was confirmed and further extended to other members of the CEA gene family. 
Interestingly the CEA family on chromosome 19 was only partially represented. MUC1 was also 
co-expressed with CEACAM6, though the expression of genes flanking CEACAM5 and 
CEACAM6, (CEACAM4, CEACAM7 and CEACAM3) were not up-regulated (low to absent) in 
MUC1+ mTECs (Figures 33 and 34). Results were consistent for two individuals shown here as 
well as for an additional one (data not shown). Thus, inter-chromosomal co-expression patterns 
at the population level were confirmed as MUC1 is located on chromosome 1 while MUC4 is on 
chromosome 4 and CEACAM5 and CEACAM6 are on chromosome 19. 
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Figure 33 
Genomic location of MUC1, MUC4 and CEA cluster in human 
Location of MUC1 on chromosome 1 (A) MUC4 on chromosome 4 (B) and the CEA cluster on chromosome 19, 
consisting of CEACM4, CEACM7, CEACAM5, CEACAM6 and CEACM3 (C). All genes for inter-chromosomal 
co-expression in human MUC1+ mTECs studied by qPCR are underlined in green. 
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Figure 34 
Co-expression patterns in human MUC1+ and MUC1- mTECs 
Purified MUC1+ and MUC1- sorted mTECs were isolated from human thymus of two individuals (83 and 94). The 
expression was normalized to GAPDH. MUC1 was enriched 7-19 fold in MUC1+ mTECs of both samples. Co-
enrichment of MUC4 was observed in MUC1+ mTECs, however within the CEA cluster only CEACAM5 and 
CEACM6 were co-expressed with MUC1 in MUC1+ mTECs. CEACAM3 was modestly up-regulated and 
CEACAM4 and CEACAM7 were hardly different between both subsets. Though, CEACAM3 and CEACAM7 were 
barely detected in only one of the duplicates of both samples tested by PCR hence, it was considered low to absent. 
 
To obtain a broader view of co-expression patterns, genome-wide microarrays were performed. 
Owing to the low cell number a modified protocol had to be established. We opted to use the 
µMACS™ SuperAmp™ Technology (Miltenyi Biotech), which can linearly amplify RNA of 
small/rare cell populations. We established this technology to hybridize the amplified labelled 
cDNA onto Illumina’s expression profiling whole genome BeadArrays (Section 2.2.10) (Pinto et 
al., 2009). For this method RNA from only 6000 cells was used.  
Technical replicates of individual samples confirmed the reproducibility of the procedure of 
µMACS™ SuperAmp™ Technology for Illumina’s expression profiling whole genome 
BeadArrays hybridization microarray analysis. The array results showed high degrees (~46-54 %) 
of overlap between the 3 individuals (Figure 35). This was a striking result as prior analysis of 
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51%46%
54%
11%26%
36%
immature versus mature mTECs using 11 individuals showed little to no overlap between any 2 
individuals. Thus, the variability was reduced by precisely defining the mTEC population.  
Since gene array results of the individuals were so similar, a combined analysis of individuals 94 
(2 technical replicates), 96 and 97 was performed. A total of 633 probes were considered to be 
differentially expressed, fitting the criteria p value ≤ 0.01, out of which 412 were up-regulated and 
221 were down-regulated in MUC1+ mTECs. In all samples MUC1 was enriched in the positive 
fraction. A comparison of fold change of qPCR and array results for individual 94 showed a good 
correlation (Table 3.6), except for CEACAM5. Differences in the fold change between 
microarrays and qPCR are a well known phenomenon, as the dynamic range of the microarray is 
limited to 4-5 logs whereas with qPCR typically 7 logs are achieved. Therefore, microarray data 
are more compressed, when compared to qPCR data. 
 
Figure 35 
Overlap of differentially expressed genes between three human samples sorted for MUC1+ and MUC1- 
mTECs 
The µMACS™ SuperAmp™ Technology was used to amplify RNA from 6000 cells of each population (i.e. MUC1+ 
and MUC1- mTECs) sorted from three individuals. The resulting labeled cDNA was then hybridized to Illumina’s 
expression profiling whole genome BeadArrays. Log Fc ≥ or Log Fc ≤ 2 was the criteria used to identify the set of 
differentially expressed genes for each individual. The array results show a high degree of overlap of ~46-54 % 
between the individuals within the up-regulated genes (A) and a lesser degree of overlap (~11-36 %) in the down-
regulated gene set (B). An example of how the percentage of overlap between the patients was calculated is as 
follows: Between individual 94 and 96; 54 %= [sum of gene overlap (50 + 92) x 100]/sum of  genes of the individual 
having the smaller gene pool (individual 94; 92 + 50 + 92 + 30 = 264).  
B A 
  Results 
108 
Genes 
Fold change 
between MUC1+ 
and MUC1- 
mTECs qPCR 
(Ind. 94) 
Fold change 
between MUC1+ 
and MUC1- 
mTECs Arrays 
(Ind. 94) 
Fold change 
between MUC1+ 
and MUC1- 
mTECs Arrays 
(Ind. 94 (2x), 96, 
97) 
Adjusted 
p value 
MUC1 6.84476 2.59065 2.173945676 0.005385109 
MUC4 14.1723 3.77751 4.023302348 0.018842202 
CEACAM4 0.08021 0.31846 0.158109299 0.500033168 
CEACAM7 6.16884 0.70515 0.477344922 0.09432146 
CEACAM5 66.7178 2.40615 2.999483104 0.026334518 
CEACAM6 11.3924 3.19566 3.45087004 0.004138704 
CEACAM3 8.11168 1.64549 0.750290376 0.415159836 
 
Table 3.6 
Comparison of fold change between MUC1+ and MUC1- mTECs using qPCR and microarray data 
There was a good correlation of the fold change using qPCR and array data for the genes studied. Single array data 
for individual 94 only gave very similar results as the combined analysis of individuals 94 (2 technical replicates), 96 
and 97. The qPCR results for CEACAM7 and CEACAM3 are in italics as they were barely detected and their 
expression was considered low to negative. 
 
MUC1+ mTECs were MHCIIhi and did not co-express AIRE at the protein level as shown by 
Arnold J. (Arnold, 2006). The corresponding mouse ortholog is also Aire-independent and up-
regulated in mature MHCIIhi mTECs. This would classify MUC1 as an Aire-independent gene. 
Consistent with this, the top 50 up-regulated and down-regulated genes showed enrichment for 
TRAs, most of which fell into the same category of MUC1 as being “Aire-independent” (data not 
shown). 
An enrichment test for entire chromosomes in the human genome showed that a large number 
of up-regulated genes tend to significantly localise to chromosome 19 (p= 0.0048 and Table 3.7). 
Thus, not only were CEACAM5 and CEACAM6 co-enriched but other genes of chromosome 
19. The population studies were complemented by SC-PCR using the above defined set of genes. 
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Table 3.7 
Fisher test for the preferential localization of genes up- and down-regulated in MUC1+ mTECs on 
particular chromosomes 
A number of up-regulated genes tend to significantly localise to chromosome 19 (p = 0.0048), where the CEA gene 
family is located. This chromosome was the only one with a significance value. 
Up-regulated genes Down-regulated genes 
Chromosomes Fisher test score Chromosomes Fisher test score 
19 0.00489853936955524 3 0.088787764601465
1 0.0816691250640902 6 0.092421721283648
18 0.166085241762275 8 0.210147860171922
22 0.18291302286992 14 0.226571280995458
16 0.221558377398973 13 0.238474155017593
15 0.259295911021636 20 0.243507533923685
9 0.357044000184515 18 0.285992935578891
3 0.364399857096554 7 0.309906976056937
2 0.389452436158082 21 0.421170912248371
20 0.411148118189128 9 0.513070795808045
12 0.550615928953208 5 0.517757400342489
6 0.556374291646211 X 0.533390033624122
5 0.563332106438259 16 0.541432217163013
11 0.620224867831966 17 0.561330577229494
8 0.640779061541043 10 0.600634402512559
17 0.837596594112363 19 0.640308053093802
21 0.846710840867452 12 0.643663170054273
4 0.852563561987315 4 0.739819470812997
13 0.894241119691976 2 0.796389567788603
14 0.94185061722219 11 0.868535879269216
10 0.953747238622854 1 0.905083225255293
7 0.973911213370496 22 0.942657592338499
X 0.974752967184606 15 0.98771466552169
Y 1 Y 1
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3.3.2. Co-expression studies of MUC1-expressing mTECs at the single cell 
level 
Population studies on co-expression patterns were complemented by single cell analysis. 
Multiplex reverse-transcription PCR for EpCAM, MUC1, MUC4, CEACAM3, CEACAM5 and 
CEACAM6 was applied. The method was performed as described by Derbinski et al. ((Derbinski 
et al., 2008) and Section 2.2.11).  
Single-cell PCR analysis was performed on sorted MUC1+ and MUC1- mTECs purified from two 
human thymus samples (156-158 single cells per individual analyzed). The MUC1+ cells of both 
patients studied for SC-PCR gave highly consistent results. Surprisingly, EpCAM which was run 
as a marker gene for mTECs was barely present within either MUC1+ or  MUC1- mTECs (0 % in 
MUC1- mTECs and 6-30 % MUC1+ mTECs). Approximately 90 % of all MUC1+ mTECs 
analyzed were positive for MUC1, hence a good correlation between mRNA and protein was 
observed. Only 8-11 % MUC1- mTECs (6-9 single cells) expressed MUC1. All the other genes 
analyzed were absent in MUC1- mTECs. In contrast, in MUC1+ mTECs, CECAM6 was 
expressed in a large number of cells, up to 67-68 % followed by MUC4 (55-67 %) and 
CEACAM5 (32-35 %). CEACAM3 was barely detectable in both individuals analyzed; hence it is 
present at low levels, which would fit the qPCR and array data (Figures 36 and 37). All together, 
the data shows that MUC1 is co-expressed with CEACAM6, MUC4 and CEACAM5 not only at 
a population level but also at the single cell level.  
A correlation analysis of this dataset confirmed that co-expressed gene pairs MUC1- CEACAM6 
and MUC1-MUC4 showed a high concordance index κ (Table 3.8). A weak concordance was 
observed for MUC1-CEACAM5, while MUC1-CEACAM3 showed no correlation at all.   
In single mTECs analyzed from individual 105, the same was observed for EpCAM which was 
barely detected in ~10 % single cells. The basal expression frequency on random bases in single 
mTECs was in the range of 3-13 % (Figure 38). This was higher than comparable data published 
previously by Derbinski et al. in mice (Derbinski et al., 2008).  
From the single cell data, it appears that there is a highly regulated rather than stochastic co-
expression pattern in MUC1+ mTECs. The co-expression frequencies of the analyzed gene pool 
were much higher in MUC1+ mTECs than expected on a random base in single mTECs (~ 1 %).  
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Figure 36 
Co-expression patterns of single MUC1+ and MUC1- mTECs from individual 103 
(A) Each row represents a single MUC1+ mTEC from individual 103 as analyzed for expression of the genes listed 
above the columns; the last column is the total number of genes expressed by each cell. Black stripes denote 
detected expression; gray stripes denote lack of expression. Expression patterns were arranged from top to 
bottom according to increasing numbers of genes expressed per cell.  
(B) Represents the same as in A only in MUC1- mTECs from individual 103. 
(C) Percentage of single cells expressing each of the tested genes in MUC1+ and MUC1- mTECs from individual 
103.  
(D) The percentage of cells co-expressing 0-6 of the genes assessed was counted among MUC1+ and MUC1- 
mTECs from individual 103. 
C 
D 
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Figure 37 
Co-expression patterns of single MUC1+ and MUC1- mTECs from individual 105 
(A) Each row represents a single MUC1+ mTEC from individual 105 as analyzed for expression of the genes listed 
above the columns; the last column is the total number of genes expressed by each cell. Black stripes denote 
detected expression; gray stripes denote lack of expression. Expression patterns were arranged from top to 
bottom according to increasing numbers of genes expressed per cell.  
(B) Represents the same as in A only in MUC1- mTECs from individual 105. 
(C) Percentage of single cells expressing each of the tested genes in MUC1+ and MUC1- mTECs from individual 
105.  
(D) The percentage of cells co-expressing 0-6 of the genes assessed was counted among MUC1+ and MUC1- 
mTECs from individual 105. 
C 
D 
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Kappa Index
Less than 0.1 No Concordance
0.10‐0.40 Weak Concordance
0.41‐0.60 Clear Concordance
0.61‐0.80 Strong Concordance
0.81‐1.00 Nearly complete Concordance  
Co‐expression Analysis MUC 1+ & MUC1– mTECs (Kappa Index)
CEACAM6 CEACAM5 CEACAM3 MUC4 EPCAM
MUC1
(Pt 103)
0.6067 0.3158 ‐ 0.6239 0.2071
MUC1
(Pt 105)
0.5413 0.3399 ‐ 0.5069 0.0373
MUC1
(Pt 103+105)
0.5753 0.3278 ‐ 0.5730 0.1298
 
Table 3.8 
Correlation analysis of gene expression in MUC1+ and MUC1- mTECs from individuals 103 and 105 as 
detected by single-cell PCR 
(A) Degree of concordance according to the kappa index. 
(B) Kappa index of correlation, between MUC1 and the genes listed above each column. 
 
 
A 
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Figure 38 
Co-expression patterns of single mTECs from individual 105 
(A) Percentage of single cells expressing each of the tested genes in mTECs from individual 105. 
(B) The percentage of cells co-expressing 0-6 of the genes assessed was counted among mTECs from individual 
105. 
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3.3.3. Co-localization studies of chromosomes 1 and 19 in MUC1 
expressing mTECs using FISH 
Population and single cell studies of MUC1 expressing mTECs revealed the same co-expression 
pattern. Population studies showed that not only were CEACAM5 and CEACAM6 co-enriched 
with MUC1 but many more genes on chromosome 19. From the single cell data, it appears that 
there is a highly regulated rather than stochastic co-expression pattern in MUC1+ mTECs. We 
wanted to investigate if genes present on these two different chromosomes i.e. chromosomes 1 
and 19 could possibly be coordinately expressed through a mechanism that brings them together 
in a region of active transcription in the nucleus (transcription factories) as shown in earlier 
studies (Spilianakis and Flavell, 2006). Hence, fluorescent probes spanning regions on 
chromosomes 1 and 19 were used to perform FISH on MUC1+ mTECs (Table 3.9). 
TRIM46 
THBS3
SCAMP3 
RAG1AP1
PKLR 
MUC1
MTX1 
EFNA1 
HCN3 
KRTCAP2 
BAC clone: RP11‐263K19
14 genes on chromosome 1 are 
completely covered by this clone:
C1orf2 
CLK2 
DPM3 
GBA
There are no genes partially covered 
by this clone.
2 genes partially covered by this clone
BAC clone: RP11‐343B1
CEACAM7 
4 genes on chromosome 19 are 
completely covered by this clone:
CEACAM3 
CEACAM5
CEACAM6 
LYPD4 
DMRTC2 
 
Table 3.9 
Genes spanned by the labeled BAC clones (FISH probes)  
The BAC clones were ~18 kb and completely spanned 4 genes on chromosome 19 including CEACAM3, 
CEACAM5, CEACAM6 and 14 genes on chromosome 1 including MUC1. 
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The method for hybridization, image analysis and co-localization was performed as described in 
Section 2.2.12. FISH studies for two human thymus samples (individuals 106 and 108) of MUC1+ 
and MUC1- mTECs gave highly consistent results. There existed a population of MUC1+ mTECs 
having distances ≤ 1.2 µm between either one or both allele pairs, which, as per our criteria are 
co-localized. This population was lacking or lower in MUC1- mTECs (Figure 39).  
 
  
Figure 39 
Distance measurements between alleles of chromosomes 1 and 19 in MUC1+ and MUC1- mTECs of 
individuals 108 and 106  
(A) Distance measurements (x-axis) versus fraction of cells (y-axis) of single MUC1+ and MUC1- mTECs of 
individual 108. 
(B) Represents the same in individual 106. 
A 
B 
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Three different scenarios exist for co-localization of two different chromosomes having each 2 
alleles. Co-localization can be: mono-allelic- any one allele pair; bi-allelic- both allele pair; 
asymmetric mono- and bi-allelic- any one allele of one chromosome with both alleles the other 
chromosome (Figure 40). 
As described earlier promiscuously expressed genes in mTECs could be mono- or bi-allelically 
transcribed (Villasenor et al., 2008; Sinemus, 2009). In MUC1+ mTECs of individual 108, 39 % 
showed mono-allelic and 3.5 % showed bi-allelic co-localization versus 16 % MUC1- mTECs 
showed mono-allelic co-localization (Figures 40 and 41). While for individual 106, MUC1+ 
mTECs showed: 18.5 % mono-allelic co-localization, 13 % bi-allelic co-localization and 9.3 % 
had asymmetric mono- and bi-allelic co-localization. The bi-allelic and asymmetric mono- and bi-
allelic co-localization was significant when compared with the MUC1- mTECs of this individual 
(Figures 40 and 42). Taken together, it appears that these two chromosomes i.e. chromosomes 1 
and 19 tend to either show all three co-localization patterns in MUC1+ mTECs to a significant 
extent when compared to the MUC1- mTECs. Most probably the alleles co-localize in a region of 
active transcription resulting in co-expression pattern seen at the population and single cell level.   
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All alleles separate Mono‐allelic co‐localization Bi‐allelic co‐localization Asymmetric mono‐ and bi‐ allelic
co‐localization
 
 
Pt 108 Number of cells
Mono-allelic 
co-localization
Bi-allelic 
co-localization
Asymmetric mono- 
and bi-allelic  
co-localization 
MUC1+ mTEC 56 22 (39 %) 2 (3.5 %) 0 
MUC1- mTEC 49 8 (16.3 %) 0 0 
 
Pt 106 Number of cells
Mono-allelic 
co-localization
Bi-allelic 
co-localization
Asymmetric mono- 
and bi-allelic  
co-localization 
MUC1+ mTEC 54 10 (18.5 %) 7 (13 %) 5 (9.3%) 
MUC1- mTEC 42 10 (23.8 %) 0 1 (2.3 %) 
 
 
Figure 40 
Co-localization between alleles of chromosomes 1 and 19 in MUC1+ and MUC1- mTECs of individuals 108 
and 106  
Co-localization studies of mono-allelic, bi-allelic and asymmetric mono- and bi-allelic co-localization in individual 
MUC1+ and MUC1- mTECs of individuals 108 and 106. For both individual samples, MUC1+ mTECs either show a 
significant co-localization of chromosomes 1 and 19 for all three scenarios. 
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Figure 41 
Co-localization studies of alleles of chromosomes 1 and 19 in MUC1+ and MUC1- mTECs of individual 108  
Mono-allelic co-localization observed in MUC1+ mTECs. There was no co-localization (all alleles separated) in 
MUC1- mTECs of individual 108. 
 
MUC1+ mTECs MUC1‐mTECs
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MUC1+ mTECs MUC1‐mTECs
 
Figure 42 
Co-localization studies of alleles of chromosomes 1 and 19 in MUC1+ and MUC1- mTECs of individual 106 
MUC1+ mTECs of individual 106 showed mono-allelic co-localization (A), bi-allelic co-localization (B) and 
asymmetric mono- and bi-allelic co-localization (C), maximum projection across slices 9 to 11 was performed, as the 
other allele lies in a different confocal plane (C). There was no co-localization in MUC1- mTECs of individual 106 
(D). 
 
Note: Additional information on data bases of microarray analysis and gene cluster distribution 
is available on request. 
 
A 
B 
D 
C 
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4. Discussion 
In view of the essential role of pGE by mTEC in central tolerance induction, we addressed the 
issues of defining the scope, regulation and evolutionary conservation of pGE. The precise 
genomic organization of the promiscuously expressed gene pool in mouse, rat and human was 
defined at the population level. Since, the complete representation at the population level is an 
additive result of the expression pattern in single mTECs, expression and co-regulation was also 
addressed at the single-cell level. Here we show that pGE is highly conserved between species, 
clustered in the genome at the population level and is governed by certain co-expression rules at 
the single cell level.  
4.1. Evolutionary conservation of pGE 
In order to define the scope and extent of pGE we focused on genes which are up-regulated 
upon maturation of mTECs. A comparative global gene expression was performed on the 
different differentiation stages of mTECs (immature, MHCIIlo and mature, MHCIIhi mTECs), 
thus restricting our study to one cell-lineage. We could have opted for the separation of complete 
mTECs from cTECs in order to gain an insight into the above queries. Since they represent two 
distinct lineages, it would have been however difficult to delineate the gene pools of 
promiscuously expressed from lineage-specific genes. Hence, we decided to study gene 
expression within the mTEC cell-lineage. Our analysis further extended to a species comparison 
between mouse, rat and human in order to assess evolutionary conservation of pGE. The mTEC 
population was separated on the basis of EpCAM and further distinguished into its lineage-
specific differentiation stages on the basis of MHCII levels. Moreover, although the cTEC 
markers stained exclusively TECs in the cortex in histology, it is unclear whether they represent 
the same molecule in the studied species (i.e. His38 for rat (Kampinga et al., 1987), CDR1 (Ly51) 
for mouse and CDR2 for human (Rouse et al., 1988)). 
Keeping in mind the importance of pGE in tolerizing T-cells towards self-antigens, one would 
expect the phenomenon of pGE to be evolutionary conserved and to date back to early 
vertebrates, though this prediction has yet to be tested. An ortholog of Aire, serving as a 
molecular tracer of pGE has been identified in zebrafish. It shows a remarkable resemblance to 
AIRE in man and its predominant intra-thymic expression suggests that pGE dates back to 400 
million years (Saltis et al., 2008). Here for the first time a side by side comparison of pGE 
between three species, mouse, rat and man was performed. A comparative analysis of gene 
expression at a global level between immature and mature mTECs in mouse, rat and human 
revealed a similar extent of pGE between the species, i.e., in terms of number of differentially 
expressed genes (Table 3.1). There is a methodological limitation to these results in that 
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microarray data under-estimate the true expression level due to low sensitivity. The use of a more 
sensitive semi-qualitative PCR on a particular gene locus (cluster 13 on mouse chromosome 13, 
Figure 23) gave a more sensitive insight into the extent of pGE, as more genes scored as positive. 
The PCR data was in concordance with those obtained by Derbinski et al. on the casein gene 
locus, which showed contiguous expression without a well defined boundary (Derbinski et al., 
2005). Extrapolating from this analysis, we estimate at least ~10 % of all known genes to be 
turned on in mTECs in addition to differentiation-dependent genes. The bulk of the 
promiscuously expressed genes is turned on only in the MHCIIhi mTECs, which strongly 
supports the “terminal differentiation model” and is in concordance with previous data in mice 
from our group (Derbinski et al., 2005). This estimation of the scope of pGE needs to be 
reassessed by Deep Sequencing technology. Nonetheless, in spite of these limitations which apply 
for all the species we studied, the data demonstrate a high degree of conservation of pGE. 
While studying pGE in rats for the first time we observed that a fairly large proportion  
(~65-75 %) of regulated genes followed the same regulation pattern in rats and mice (Table 3.4). 
A slightly lower TRA enrichment of ~40 % was observed in mature rat mTECs than in mouse 
(~50 %, Figures 22 and 25). This highlights the fact that the percentage of TRA content in 
mTECs is highly significant and far above the background of 10.8 % in the genome. Additionally 
a similar degree of TRA clustering (highly significant) was observed in all three species  
(Figure 19). These findings corroborate the notion of an evolutionary conservation of pGE. The 
comparison of pGE could not be further extended to man, as the inter-individual differences of 
the promiscuously expressed gene pool were too large and could not consolidate into a common 
signature (Table 3.5).  
4.2. TRAs cluster genome-wide and project onto the thymus  
The TRAs that we defined using robust computational methods tend to co-localize in clusters in 
the genome. A highly significant similar degree of clustering was observed in all three species 
(Figure 19). For the first time we directly link two features of pGE, i.e. enrichment for TRAs and 
clustering (Figure 15). Preferential chromosomal clustering has been reported for genes co-
expressed in certain cell lineages and serving a common function i.e. muscle or red blood cell 
development (Wang et al., 2001; Ramalho-Santos et al., 2002; Hurst et al., 2004). Clustering of co-
regulated genes is frequent in eukaryotic genomes (Hurst et al., 2004). In the simplest of cases, 
gene clusters are formed by gene duplication (Lercher et al., 2003; Hurst et al., 2004). In other 
cases, clusters of genes exist that participate in the same pathways or encoding organelle-related 
proteins or operons i.e. functionally related genes (Lefai et al., 2000; Boutanaev et al., 2002; 
Spellman and Rubin, 2002; Teichmann and Veitia, 2004). Here, we observed that TRAs are 
clustered irrespective of their structurally relatedness, tissue-specific expression patterns or 
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putative antigenic properties (Figure 21). Gene order in these clusters in mouse and man was 
mostly conserved and present in syntenic regions on the same or on different chromosomes 
(Figure 20). Previous reports show that clusters of both housekeeping genes and co-expressed 
genes are conserved in both mouse and human genomes by natural selection (Singer et al., 2005; 
Sémon and Duret, 2006). This lends support to the hypothesis that these clusters have regulatory 
advantages: the same enhancers or locus control regions are shared and ensure coordinated 
expression in single cells. These types of genes play a fundamental role in the operation of every 
eukaryotic cell, and thus, if there is any benefit to arranging co-expressed genes together in the 
genome, housekeeping genes will likely be subject to the strongest selection to form such 
clusters. However, the reason for having an evolutionary conservation of clusters of structurally 
unrelated TRAs in the genome still poses the question of its selective benefit. Knowing that the 
arrangement of genes in the mammalian genome is non-random, a somewhat far-fetched 
speculation could be that gene-order has been influenced by pGE, in order to facilitate the 
preferential expression of TRAs in one cell-type of the thymus. This would reflect the co-
evolution of TRA clustering and pGE.   
Genome‐wide TRA clusters
Thymus (mTECs)
Regulated TRAs
Unregulated TRAs
RegulatedNon‐TRAs
Unregulated Non‐TRAs
 
Figure 43 
Projection of pGE in the thymus onto pre-existing genome-wide TRA clusters   
TRAs are clustered in the genome. Within each cluster TRAs are intermingled with non-TRAs and it was rather rare 
that a cluster comprised purely TRAs.  
In the thymus, the genomic TRA clusters are: 1) only partially represented (~10 %) in mTECs and enriched for 
TRAs in the projection onto the thymus  
We propose the cluster to be the “operational genomic unit” of pGE in the thymus.  
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Taken together, our results show that TRAs per se are clustered in the genome in all three species 
irrespective of structural relatedness or apparent antigenic properties. In the thymus, 
promiscuously expressed genes are enriched in TRAs that are partitioned into clusters, again 
conserved between species. TRA and non-TRAs are harbored within individual clusters, with 
TRAs being preferentially regulated during mTEC differentiation. Moreover, genes within a 
particular gene cluster are subject to partial co-regulation (for e.g. human CEA gene family on 
chromosome 19). Based on these data, we propose these clusters to be the “operational genomic 
unit” of pGE in the thymus (Figure 43). 
4.3. Aire’s action: cluster-wide or gene-specific? 
The transcriptional regulator Aire is known to regulate the expression of hundreds to thousands 
of promiscuously expressed genes, with a predilection for TRAs (Anderson et al., 2002; Derbinski 
et al., 2005; Johnnidis et al., 2005). We show in mouse that MHCIIhi mTECs express a large 
number of Aire-dependent and -independent genes, while in the MHCIIlo mTECs the genes are 
Aire-independent. The MHCIIhi are enriched for TRAs (53 % of Aire-dependent genes are 
TRAs; 48 % of Aire-independent genes are TRAs) and MHCIIlo mTECs have a much lower 
absolute number of Aire-dependent genes (32 genes) though they have similar percentages of 
TRAs (50 % of Aire-dependent genes are TRAs; 39 % Aire-independent genes are TRAs)  
(Table 3.3 and Figure 22). From our data, it appears that the maturation stage i.e. MHCIIhi 
mTECs and not Aire per se has an effect on both number and fraction of TRAs. The unabated 
expression of a sizable number of genes, especially TRAs (48 %) in the absence of Aire could 
explain the relatively mild autoimmune phenotype in Aire-/- mice. Within the clusters Aire-
dependent and -independent genes were interspersed among each other and subjected to 
differential regulation. In several cases, such as the cluster 13 on chromosome 13 (Figure 23), an 
Aire-dependent TRA was directly adjacent to an Aire-independent TRA, as also observed in the 
casein cluster by others (Derbinski et al., 2005; Johnnidis et al., 2005). These results indicated that 
the impact of Aire was much more punctuate within the chromosomal stretches, often affecting 
only two or three genes while leaving neighboring and interspersed genes unaffected. Thus, it 
does not seem likely that this protein’s influence can only be explained by locus-wide epigenetic 
alterations. Instead it has been recently shown that more complex mechanisms involving 
chromatin binding/structure, transcription and pre-mRNA processing come into play (Abramson 
et al., 2010). By this model, Aire may still work in a gene-specific manner. The above data reflect 
the scenario at the population level. However, in single mTECs Derbinski et al. pointed out that 
although the expression of Aire-dependent genes was restricted to Aire+ mTECs, majority of the 
Aire-dependent genes were not preferentially co-expressed in a single mTEC. Thus, suggesting 
that Aire is necessary but not sufficient for expression of a particular Aire-dependent gene 
(Derbinski et al., 2008). 
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4.4. Highly variable promiscuously expressed gene pool in human thymus 
The study of pGE between immature and mature mTECs from 11 human thymi showed 
substantial variation in the number of differentially expressed genes (~700-6000 genes) 
irrespective of the isolation method used. The extent of variability was so profound, that only 24 
genes were common between all patients (Table 3.5).  
This is the first time that such a striking inter-individual difference in pGE was found, though 
Taubert et al.  also reported considerable quantitative variability in the expression of several target 
auto-antigen in mTECs (Taubert et al., 2007). Possible parameters causing these variations could 
be: 1) (epi) genetic differences and non-genetic influences between the individuals; 2) short-term 
temporal fluctuations (e.g. circadian rhythms). Such variations in vivo at the single-cell level 
cannot be excluded. It is worth noting that clock genes steering circadian rhythms do not seem to 
be active in the thymus and testis (incidentally also displaying pGE) (Alvarez and Sehgal, 2005). 
All samples were collected around the same daily time, between 9 a.m.-11 a.m.; 3) one also 
cannot exclude that the particular anatomical region of the thymus removed during surgery could 
add to the variations. Gene expression and the proportion of Aire+ cells could vary with the 
region of the thymus (for instance, outer versus deeper medulla) and disease status; 4) moreover, 
the pre-medication history of these individuals could be a further influence. The administration 
of immunosuppressants or high dosages of other drugs can induce immunosuppressive stress 
responses (Dhabhar et al., 1994; Pruett et al., 1999; Pruett et al., 2000). Immunosuppressants have 
been shown in mice to cause extensive loss of tolerance-inducing Aire+ mature mTECs (Fletcher 
et al., 2009), which could also explain the high variability of mTEC subset composition observed 
in our human dataset.  
The most likely reason for the highly variable promiscuous gene pool in human is the difference 
in mTEC subset composition. We used a four color sort to separate the lower and upper 30 % of 
MHCIIlo and MHCIIhi expressing mTEC stages and noticed a highly variable MHCII mTEC 
profile between individuals which was not the case in mouse and rat. Not only did it differ in the 
absolute fluorescence values, but also a shift in profile i.e. monophasic or biphasic was observed. 
These inter-individual profiles most likely relate to differences in the promiscuously expressed 
gene pool, which could not consolidate into a common set of differentially expressed genes 
(Table 3.5) in contrast to mouse and rat. Even though a standard criterion i.e. the upper and 
lower one-third MHCII was used to separate the immature and mature mTECs, it obviously did 
not result in a reproducible separation of comparable mTEC subsets in humans. AIRE is up-
regulated along with mTEC differentiation and the ratio of AIRE in MHCIIhi vs. MHCIIlo 
mTECs can be considered as a measure for the degree of enrichment of the individual samples. 
Since AIRE is the driving force for about half of the promiscuously expressed genes in the 
mature mTEC population, the correlation between the number of differentially expressed genes 
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(between immature and mature mTECs) and fold change in AIRE expression was determined. 
We observed a correlation between the number of differentially expressed genes and fold change 
in AIRE expression (correlation coefficient, r = 0.5, Figure 26). Thus, AIRE could serve as a 
surrogate marker for the quality of cell separation. AIRE being a transcription factor requires 
fixing cells for intra-cellular staining after which it is not feasible to use these cells for down-
stream applications. Hence, due to the lack of available markers, the distinction of immature and 
mature mTEC subsets in humans based on MHCII is the best that can be performed at present. 
Incidentally similar inter-individual differences were observed when genome-wide methylation 
patterns and miRNA level were assayed. Thus, immature and mature mTECs isolated from one 
patient were more closely related to each other than to the respective cell types isolated from a 
different patient. Thus, the signature in mTECs typifies the individual rather than the cell type  
(L. Tykocinski, unpublished). In contrast, thymocytes from the same individual were far less 
variable in the same assays. Thus, these variations appear to be a peculiarity of mTECs  
(L. Tykocinski, unpublished) and the differences observed when using different parameters to 
study various aspects of pGE in humans are biased by the heterogeneity of the samples. MTECs 
may be highly responsive to stress or other cytotoxic factors. 
The observed variations in antigen expression are likely to influence T-cell repertoire selection 
and thus tolerance thresholds in human provided they reflect steady state values. Note that in 
genetic disorders like myasthenia gravis differences in the magnitude of 4-fold correlate with 
disease onset in the human population (Taubert et al., 2007). According to the “threshold model 
of central tolerance’’ the degree of central tolerance towards a TRA is surprisingly sensitive to 
minor shifts in thymic antigen expression levels (Liston et al., 2005; Taubert et al., 2007). This 
could result in a shift in the threshold of self-tolerance to an extent that translates into significant 
alterations of disease susceptibility. In transgenic mice with defined copy numbers of intra-
thymically expressed autoantigens, subtle differences in expression levels (two- to four- fold) can 
be sufficient to significantly modulate susceptibility or be the cause of autoimmunity (Chentoufi 
and Polychronakos, 2002; Miyamoto et al., 2003). A similar threshold range seems to matter for 
self-antigens in humans as well. 
No common signature was observed in human while separating immature and mature mTEC 
based on MHCII. However, when sorting for a defined mTEC population expressing a particular 
antigen i.e. MUC1, the inter-individual differences were greatly reduced. A high degree of over-
lap ~46-54 % was observed (Figure 35). Narrowing down onto a more restricted mTEC 
subpopulation merges pGE signatures, thus emphasizing the heterogeneity of the human mTEC 
population (discussed in detail in later chapters).  
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4.5. Lack of antigen expression in the thymus subverts central tolerance 
The mature mTEC subset shows a broad representation of pGE, though the upper threshold of 
this expression still remains ill defined. There exist examples in which missing expression of 
certain antigens in the thymus correlates with the existence of auto-antibodies and a break-down 
of central tolerance for these particular antigens (Chentoufi and Polychronakos, 2002; Gotter et 
al., 2004). Some prominent examples are GAD65 and MYH6, both of  which are involved in 
autoimmune diseases, i.e. insulin-dependent diabetes (IDD) (Tisch, 1996; Yoon et al., 2000; 
Lernmark, 2002) and myocarditis, respectively (Wolfgram et al., 1985; Neu et al., 1987; Rose, 
2000). Their expression is absent in the thymus and is predominant in the respective peripheral 
tissue. In both cases their homologous counter-parts i.e. GAD67 and MYH7 show the inverse 
expression pattern i.e. are well expressed in mTECs and at low levels in peripheral tissue  
(Figures 29 and 31). It was noted that the two GAD isoforms are located in the same 
chromosomal context in human and mouse (Figures 27 and 28), GAD67 is expressed in mTECs 
in both species while GAD65 is absent in human and expressed at basal levels in mouse 
(Derbinski, J, unpublished). The MYH6 and MYH7 isoforms are immediately adjacent to each 
other and present in syntenic regions in mouse and human (Figure 30). This lack of expression 
obviously represents one “pitfall” of pGE. It is possible that the non-expressed isoform is 
embedded in a silent chromosomal context i.e. “regions of closed chromatin’’. We started to 
investigate this supposition by studying the thymic expression of the flaking regions of the GAD 
gene loci. The lack of expression of GAD65 may indeed be related to the low overall 
transcriptional activity 3’ of GAD65 (Figure 29). Similar studies have to be extended to the MYH 
gene locus. 
Future work will probe into the plausible reasons for this differential expression of the different 
isoforms which could be: 1) structural constraints/restrictions exist that block pGE by affecting 
either the access or the DNA binding of transcription (co)factors? 2) the lack of expression in 
mTECs might safe-guard the mTECs, as expression of these antigens could be toxic? The two 
examples (GAD65 and MYH6) show that expression of the entire antigen can be lacking in the 
thymus. In the case of PLP this is only true for a particular exon. In the case of MBP, the fetal 
form of golli-MBP which is expressed in mTECs differs from the peripherally expressed adult 
classic-MBP in its transcriptional start site. Thus, non-censored T-cells specific for epitopes 
encoded only by the full-length form of PLP or classic MBP, respectively, can escape thymic 
selection, which again might predispose to autoimmunity (Klein et al., 2000; Kyewski and Klein, 
2006).  
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4.6. Co-regulated gene expression in single mTECs  
Previous studies showed that a given individual gene is expressed in only few ~1-3 % mTECs 
(Derbinski et al., 2001; Cloosen et al., 2007; Taubert et al., 2007). Moreover, an apparent stochastic 
gene expression pattern of the casein gene cluster as well as other genes was observed at the 
single cell level (Derbinski et al., 2008; Villasenor et al., 2008). Yet, initial hints for the existence of 
co-regulated rather than stochastic gene expression patterns came from population studies by 
J. Arnold (Arnold, 2006; Cloosen et al., 2007), where two tumor-associated differentiation 
antigens, MUC1 and CEA were co-expressed far above the expected expression frequency based 
on each antigen alone in the same mTEC. Hence, we wanted to more precisely define these co-
expression patterns and the underlying mechanisms. 
The antigen pool expressed in mTECs, also includes tumor-associated antigens (i.e. cancer germ 
cell antigens) previously thought to be secluded from the immune system (Gotter et al., 2004; 
Cloosen et al., 2007). The feasibility of isolating mTECs expressing a particular antigen had been 
demonstrated by J. Arnold using antibodies to surface expressed antigens, mucin-1 (MUC1) 
(Arnold, 2006). We further extended this approach to our studies, isolating MUC1+ and MUC1- 
mTECs from human thymus. The initial observations by J. Arnold were confirmed not only at 
the population level using real-time PCR and genome-wide microarrays, but also by single cell 
studies of MUC1+ mTECs. The results obtained from all three methodological approaches were 
highly concordant revealing co-expression of MUC1 with MUC4, CEACAM5 and CEACAM6 
(Figures 34, 36 and 37). MUC1 is located on Chromosome 1 while MUC4 is on Chromosome 4 
and CEACAM5 and CEACAM6 are on Chromosome 19, thus co-expression groups in single 
cells not only defined intra-chromosomal but also inter-chromosomal gene co-regulation. The 
CEA family gene cluster however was not completely co-expressed (Figure 34 and Table 3.6). 
For the first time we show that neighboring genes within a particular gene cluster  
(i.e. CEACAM5 and CEACAM6) are consistently co-expressed in single mTECs which was not 
observed by Derbinski et al. when studying the casein gene cluster (Derbinski et al., 2008). 
We showed that pGE is highly conserved between the species, however in human the 
promiscuously expressed gene pool varied considerably. Yet, sorting for a restricted mTEC 
subpopulation i.e. MUC1+ mTECs, a high degree of over-lap ~46-54 % was observed (Figure 
35). Thus, narrowing down onto a restricted mTEC subpopulation merges the pGE signature 
again attesting to be the heterogeneity of the human mTEC population.  
The single cell data reveal a deterministic component in the regulation of pGE. The co-
expression frequencies of the analyzed gene pool were much higher in MUC1+ mTECs (30-82 %) 
than expected on a random base in total mTECs (3-13 %) or MUC1- mTECs (0-11 %)  
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(Figures 36, 37 and 38), showing a high degree of concordance (Table 3.8). The observed co-
expression patterns in MUC1+ mTECs are not mimicked in other normal peripheral epithelial 
derived cells (Zotter et al., 1998; Hammarstrom, 1999; Scholzel et al., 2000). The co-expression 
patterns appear to be due to pGE rather than due to progressive differentiation of mTECs. Note 
that MUC1 and CEA are epithelial antigens. Being tumor antigens one would expect the MUC 
and CEA families to be expressed in malignant tissues, though this extended co-expression 
pattern as observed in mTECs has never been reported. Only selected expression pairs like 
MUC1-MUC4, CEACAM5-CEACAM6 and MUC1-CEACAM5 have been described to be 
expressed in malignant tissues either as unaltered or post-translational modified forms (Kinugasa 
et al., 1998; Hammarstrom, 1999; Scholzel et al., 2000; Rakha et al., 2005). Hence, the co-
expression pattern observed in mTECs does not appear to reflect that of peripheral counterpart 
tissues (Derbinski et al., 2008; Villasenor et al., 2008). 
Gotter and co-workers showed that mTEC-over-expressed genes show no preference for any 
chromosome (Gotter et al., 2004). When selecting for MUC1+ mTECs, we found over-expressed 
genes to preferentially co-localize to chromosome 19 (Table 3.7). Strikingly, these co-expression 
patterns and chromosomal preferences correlated with in situ co-localization of the respective 
chromosomal domains (on chromosomes 1 and 19) upon mTEC maturation as analyzed by 
fluorescence in situ hybridization. For the first time, we document a direct interchromosomal 
interaction between two gene loci ex vivo in mTECs. The functional significance of the 
interchromosomal association is of great interest. MUC1+ mTECs either show a significant 
mono-allelic, bi-allelic and asymmetric mono- and bi-allelic co-localization (Figures 40, 41 and 
42). This fits with previous observations that pGE is neither strictly mono- nor bi-allelic and thus 
is distinct from known patterns of strict allele-specific gene expression as observed in peripheral 
tissues (Derbinski et al., 2008; Villasenor et al., 2008; Sinemus, 2009). The interchromosomal 
associations described here may be a more general phenomenon of pGE occurring at multiple 
genetic loci where coordinate regulation occurs. 
Although the functional significance of association of co-regulated gene loci is still unclear, direct 
physical interactions between chromosomes are known to have regulatory functions as described 
in the case of T-cell differentiation. This has recently been established by the analysis of the Ifnγ 
and TH2 cytokine loci in naive T cells (Spilianakis et al., 2005). After antigen stimulation, the naive 
TH cells develop into either TH1 cells, which produce one set of effector molecules (i.e. interferon 
(IFN)-γ), or TH2 cells, which produce a different set (i.e. interleukin (IL)-4, -5). In order to 
investigate what determines the fate of the naive TH cells, the authors explored the organization 
of two genomic regions: the gene encoding IFN-γ (called Ifng, chromosome 10) and a multi-gene 
complex encoding IL-4 and IL-5 (Il4 and Il5, chromosome 11). Using the chromosome 
conformation capture (3C) method and FISH, they found Ifng seems to be regulated by elements 
found near it on chromosome 10, whereas expression of Il4 and Il5 on chromosome 11 seems to 
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be regulated by a ‘locus control region’ (LCR) on the same chromosome. They observed inter-
chromosomal interactions between the promoter region of the IFN- γ gene and the LCR of the 
TH2 cytokine locus in naive bipotent TH cells which are poised for transcription. Upon receiving 
an appropriate stimulus, one gene locus is activated (for example Ifng after a TH1 stimulus), 
whereas the counterpart locus that is to remain silent (in this case the TH2 genes) moves apart, 
presumably to a region of the nucleus, which is not transcriptionally active. So, at the time point 
of the association of the two loci, the TH cells have the choice to select either signature. In 
contrast, in mTECs co-localization goes along with co-expression. 
Similarly, in sensory neurons only a single olfactory receptor (OR) gene from a very large super-
family (1300 genes in mouse), which is organized in multiple clusters, is selected for expression in 
individual olfactory neurons. Different choices are made in different neurons, such that the 
whole repertoire is deployed in the olfactory epithelium. It poses the question, how is the OR 
gene choice made? Lomvardas and colleagues showed that an odorant receptor gene on one 
chromosome is selected for expression by physical association of an odorant receptor- regulatory 
element (the H enhancer) on chromosome 14. Therefore, this work supports the hypothesis that 
a single element may drive the expression of all the OR genes in the genome by inter-
chromosomal co-regulation (Lomvardas et al., 2006). 
Another remarkable finding was the initiation of X-chromosome inactivation (XCI) that involves 
‘counting’ of the X chromosomes to ensure that only one X remains active per autosome set, and 
a random ‘choice’ as to which chromosome to inactivate. The molecular mechanisms underlying 
this remained one of the most challenging enigmas. Two studies, from Bacher et al. and Xu et al. 
showed that at the onset of XCI, and concomitant with the timing of counting and choice, the 
two X-chromosomes of female cells transiently come into close proximity with each other. The 
initial differential treatment of the two X chromosomes during X-chromosome inactivation is 
controlled by the X-inactivation centre (Xic). Critical control sequences in the Xic include the 
non-coding RNAs Xist and Tsix, and long-range chromatin elements (Bacher et al., 2006; Xu et 
al., 2006). 
In each case the question still remains, what are the mechanisms that bring about the functional 
interactions between regulatory elements on the one hand and target genes on the other hand 
that are located on different chromosomes? Why do mTECs show co-regulation and co-
localization of chromosomes? It is known that eukaryotic chromosomes occupy distinct 
territories in the cell nucleus. These territories intermingle little with each other. Contacts 
between different chromosomal loci, is called chromosome kissing. Chromosome kissing is not 
only restricted to vertebrate, but also found in Drosophila, plants and yeast, suggesting that this is 
a fundamental feature of nuclear organization that may contribute to either coordinate gene 
silencing or activation. Genes being actively expressed loop out from their condensed chromatin 
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territory and localize to a region of transcriptional activity, associated with “transcription 
factories” that are enriched in RNA polymerase II - in order to be efficiently transcribed. Owing 
to the limited number of factories, many genes share the same factory (Branco and Pombo, 2006; 
Branco and Pombo, 2007; Cavalli, 2007; Lanctôt et al., 2007). The unentangled chromatin 
conformation along with nuclear actin and myosin provide molecular motors that drive gene 
mobility and direct movement towards a target region in the nucleus (Chuang et al., 2006; Dundr 
et al., 2007; Lieberman-Aiden et al., 2009). From the initial results, we hypothesis that these two 
chromosomes i.e. chromosomes 1 and 19 tend to co-localize in MUC1+ mTECs probably in a 
region of active transcription in the nucleus resulting in co-expression pattern seen at the 
population and single cell level (Figure 44). Obviously, many questions remain to be answered: 
Do other chromosome pairs also preferentially co-localize? What factors regulate these 
interactions? If we inversely sorted mTECs expressing an antigen on chromosome 19 would we 
select now for genes on chromosomes 1?  
 
Chromosome territory
Chromatin
Chromatin
Chromosome loops at the transcription factory
(e.g. interacting gene loci-MUC1 and CEACAM)
 
Figure 44 
Schematic interpretation of FISH studies in MUC1+ mTECs   
FISH studies show an inter-chromosomal association possibly at transcription factories (Chromosome 1-MUC1 and 
Chromosome 19-CEACAM) leading to the co-regulation and co-expression patterns observed at the population and 
single cell level in MUC1+ mTECs. 
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4.7. Analysis of mTECs reveal partially overlapping co-expression groups  
From our population and single cell studies we observed co-expression of CEACAM5, 
CEACAM6 and MUC4 along with MUC1 in MUC1+ mTECs (Figure 45A). J. Arnold, when 
selecting for CEACAM5+ mTECs observed co-expression not only of MUC1, CEACAM5, and 
CEACAM6 but also of CEACAM3 (Figure 45B) (Arnold, 2006). Thus, mTECs isolated for two 
different but largely co-expressed antigens display overlapping but not identical co-expression 
groups. It appears that there exists a sliding pattern, that when sorting for MUC1+ or 
CEACAM5+ mTECs an over-lapping gene set but also a “new” set i.e. CEACAM3 in 
CEACAM5+ mTECs is found. Selecting CEACAM3+ mTECs might enrich for yet another 
partially overlapping gene pool. Conceivably as one slides along these group one may ultimately 
end up with a complete distinct expression pattern compared to the initial one (Figure 45C and 
45D). Hence, it appears that selecting for a given gene also selects a distinct co-expression group. 
The genealogy of each of these co-expression groups is unknown. Does for instance MUC1 
expression drive the subsequent expression of its co-expression partners, or are all genes 
concomitantly expressed? (Figure 46) 
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Figure 45 
Schematic representation of co-expression groups in mTECs   
(A) Co-expression group of sorted MUC1+ mTECs. 
(B) Co-expression group of sorted CEACAM5+ mTECs as described by J. Arnold (Arnold, 2006). 
Both subsets reveal over-lapping and non-overlapping genes (e.g. CEACAM3) 
(C) Model of sliding co-expression patterns in mTECs. 
(D) An example of an unrelated co-expression group encomposing presumably Aire-dependent genes from  
J. Arnold (Arnold, 2006). 
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Figure 46 
Possible genealogy of co-expression patterns 
It is unknown what drives co-expression groups. Does initial MUC1 expression drive the subsequent expression of 
its co-expressed partners, or are all genes concomitantly expressed? 
 
Previous work showed that an individual gene is expressed in only few ~1-3 % mTECs 
(Derbinski et al., 2001; Cloosen et al., 2007; Taubert et al., 2007). Moreover an apparent stochastic 
gene expression was observed at the single cell level (Derbinski et al., 2008; Villasenor et al., 2008). 
For the first time our results highlight a new aspect of pGE that is a regulated, non-random 
component. What is the selective advantage of a single mTEC having such co-regulated co-
expression patterns? At face value it is not apparent why a single mTEC should co-express genes 
from particular chromosomes (for example chromosomes 1 and 19). Co-expression patterns may 
be an economical way of preventing the same genes being redundantly expressed by other 
mTECs as would be expected, if pGE was entirely random. Having partially over-lapping co-
expression patterns however makes the mechanism of pGE full-proof, thus safeguarding the 
completeness of the antigen repertoire. Thus, the sets of promiscuously expressed genes in single 
mTECs ultimately add up to a complete representation of the entire gene pool at the population 
level. Interestingly, despite dynamic mTEC renewal, the spectrum of expressed self-antigens in 
the mTEC population remains unchanged at the population level. Thus, at any time incoming 
thymocytes entering the medulla will encounter the full spectrum of promiscuously expressed 
genes, despite continuous de novo generation and possibly in situ redistribution of antigen display 
by mTECs. 
  
?  ? 
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4.8. Conclusions and future perspectives 
The regulatory mechanisms governing pGE in mTECs still remain poorly understood. This study 
adds new perspectives to this issue. 
1. The phenomenon of pGE is highly conserved between species and maps to gene clusters. 
We propose these clusters to be the “operational genomic unit” of pGE in the thymus.  
2. PGE is characterized by certain intra- and inter-chromosomal co-expression patterns at 
the single cell level. 
 
Future experiments need to: 
1. More precisely delineate the complete extent of pGE in mouse, rat and human by new 
sequencing techniques. 
2. Decipher the molecular explanation of “holes” in the thymic antigen repertoire. 
3. Dissect the co-expression patterns, co-regulation rules and underlying mechanisms 
governing pGE and explore the functional implications of this phenomenon. 
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